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People living with dementia (PLWD) often experience behavioral and psychological 
symptoms of dementia (BPSD) which are burdensome to those diagnosed, their 
families, and society. Many non-pharmacologic interventions have demonstrated 
efficacy in reducing BPSD in research but have had limited uptake in the community, 
possibly due to lack of feasibility and limited acceptance by PLWD and their family 
caregivers. Acutherapy and weighted blankets are non-pharmacologic interventions that 
have improved outcomes among older adults, but few studies have focused on PLWD 
and BPSD. The purpose of this research was to explore the potential of acutherapy and 
weighted blankets as non-pharmacologic interventions to reduce BPSD in PLWD. The 
research presented in this 3-paper dissertation was guided by 6 specific aims: 
1. Identify, examine, and synthesize the state of the science relating to the effects of 
acutherapy on BPSD. (Paper 1) 
2. Explore perspectives of family caregivers of community dwelling older adults with 
Alzheimer’s disease or related dementias (ADRD) regarding BPSD and use of non-
pharmacologic interventions for BPSD management. (Paper 2) 
3. Explore perspectives of family caregivers of community dwelling older adult family 
members with ADRD regarding changes in their caregiving experiences, BPSD 
displayed by their relatives with ADRD and BPSD management strategies used 
during the COVID-19 pandemic. (Paper 2) 
4. Explore initial perceptions of family caregivers regarding weighted blankets as an 
in-home care strategy for community dwelling PLWD following a brief description 
and visual presentation of weighted blankets. (Paper 3) 
5. Examine feasibility and acceptability of a virtually delivered, in-home weighted 
blanket intervention for older adults with ADRD living in the community as perceived 





6. Examine feasibility of collecting outcome measures of BPSD, cognitive function, 
and quality of life of care recipients with ADRD, and well-being and self-reported 
health status of family caregivers. (Paper 3) 
Aims were addressed using: a scoping review methodology (Aim 1); a qualitative 
approach using semi-structured interviews with 21 family caregivers living with 
community dwelling PLWD (Aims 2, 3, and 4); a prospective, within subjects, pre-post 
design study with 21 community dwelling PLWD and their family caregivers (Aims 5 and 
6). This dissertation research had 6 key findings: 1) Acutherapy is a safe non-
pharmacologic care strategy for PLWD and a potential treatment for BPSD, but 
additional research is needed to determine efficacy; 2) The caregiving experience of 
family caregivers of community dwelling PLWD was described as an interdependent 
partnership between the caregiver and the PLWD; 3) Family caregivers and PLWD 
experienced challenges to in-home care prior to the COVID-19 pandemic, many of 
which were compounded by it; 4) The virtually delivered, in-home weighted blanket 
intervention was feasible and acceptable to PLWD and their family caregivers; 5) 
Collecting outcome measures of care recipient cognitive function, caregiver well-being 
and caregiver self-reported health was feasible; 6) Collecting outcome measures of care 
recipient BPSD and quality of life was feasible through measures completed by 
caregiver report, but not by care recipient self-report. The efficacy of feasible and 
acceptable care strategies for community dwelling PLWD must be determined to 
promote broader uptake by clinicians, support service providers, and families. As BPSD 
are overwhelming for PLWD, their families, and society, we are in dire need of 
evidence-based non-pharmacological interventions to reduce the burden and improve 









Nearly 47 million people worldwide live with Alzheimer’s disease or other related 
dementias (ADRD), and nearly 10 million more will be diagnosed each year as the 
population continues to age (World Health Organization, 2020). Of the 5.8 million 
Americans over the age of 65 living with ADRD, over 4 million (~70%) live in the 
community and receive most of their care (83%) from unpaid, informal caregivers such 
as family members and friends (Lepore et al., 2017; Spillman et al., 2014). 
Behavioral and psychological symptoms of dementia (BPSD) are experienced by 
virtually all community dwelling people living with dementia (PLWD) and have 
devastating effects on the health and quality of life of not only those diagnosed, but also 
on caregivers (Banerjee et al., 2006; Cerejeira et al., 2012; Fonareva & Oken, 2014; 
Majer et al., 2019). BPSD represent a major societal issue as they account for a large 
portion (~30%) of the $305 billion in total annual healthcare costs of ADRD care in the 
United States (Alzheimer's Association, 2021; Hurd et al., 2013; Schnaider et al., 2002). 
Background 
Although ADRD are typically considered cognitive related conditions, ADRD can 
have devastating effects on many other components of life including physical, 
functional, behavioral, and social health. BPSD is a distinct cluster of symptoms that is 
considered one of the most debilitating aspects of ADRD that has proven to be very 
difficult to treat by clinicians and is a major contributing factor to early institutionalization 
(Stall et al., 2019). Throughout this dissertation BPSD is conceptualized as a 
multidimensional cluster of many different types of non-cognitive symptoms and 
behaviors that result from changes in and interactions between cognitive, 
environmental, social, functional, neurologic, physiologic, and psychologic factors 





symptoms of ADRD such as declining memory and impaired comprehension. As BPSD 
are known to significantly increase the burden of having ADRD and of caring for 
someone with the disease (Majer et al., 2019), this dissertation focuses specifically on 
BPSD as opposed to other hallmark symptoms of ADRD such as cognitive decline. 
BPSD include a variety of symptoms and behaviors including agitated, aggressive, 
depressive, psychotic, manic, and apathetic types (McShane, 2000). Psychotropic 
medications are commonly prescribed to manage BPSD but have minimal effectiveness 
and are associated with several life-threatening risks including, falls, fractures, injuries 
and in worst cases, death in older adults with ADRD (Defrancesco et al., 2015; Jeste et 
al., 2008; Seyfried et al., 2011; Van Strien et al., 2013). Due to the ineffectiveness and 
many dangers associated with pharmacologic interventions, current practice guidelines 
and recommendations emphasize non-pharmacologic care strategies as first line 
treatment of BPSD (Austrom et al., 2018; Reus et al., 2016). Many non-pharmacologic 
strategies have demonstrated effectiveness in reducing BPSD experienced by PLWD in 
controlled clinical trials (e.g., caregiver education, training and skills building programs, 
multicomponent interventions comprised of 2 or more non-pharmacologic interventions, 
psychological and psychosocial support interventions) (Dyer et al., 2018; Trivedi et al., 
2018). Despite the availability of research in support of non-pharmacologic interventions 
for treating BPSD, there has been limited implementation and sustained use in the 
community. This limited use may be due to inadequate use of theory in the development 
and testing of non-pharmacologic interventions, limitations in the feasibility of these 
interventions for the community setting and the degree of acceptance by PLWD and 
their family caregivers (Gitlin et al., 2015). Further research is needed to evaluate safe, 
feasible, effective, theory-based non-pharmacologic interventions that will be accepted 
and used by PLWD and their caregivers in real world, community settings (Gitlin et al., 
2016; Gitlin et al., 2010). 
This dissertation focuses on a specific class of non-pharmacologic interventions, that 
being sensory stimulation therapies. Sensory stimulation uses objects and tools to 
arouse at least one of the five sense (i.e., hearing, sight, smell, taste, touch) with the 
intent of promoting positive feelings and well-being (Strøm et al., 2016). Even more 





as non-pharmacologic care strategies for PLWD. Acutherapy involves stimulation of 
multiple points across the body with manual hand pressure, needles, or other tools to 
promote healing and comfort. Weighted blankets are similar to traditional comforters but 
have added weight (they typically weigh between 10-15 pounds) and are designed to 
apply stimulation to broad areas of the body (these therapies are further described in 
the Theoretical Foundations section of this chapter). 
Acutherapy has been shown to be a safe care strategy for older adults with ADRD 
and has demonstrated improvements in psychological outcomes among non-cognitively 
impaired adults, including those with psychiatric conditions (Kim et al., 2013; Smith et 
al., 2018). Despite the high degree of safety and potential for therapeutic effects, there 
is limited research on acutherapy among community dwelling PLWD (Zhou et al., 2015). 
Additionally, the overall effects of acutherapy on BPSD demonstrated in prior research 
has not been synthesized, likely precluding further research and widespread 
implementation.  
Weighted blankets have been shown to be safe for use by older adults (Parker, 
2016), and have demonstrated improvements in psychological outcomes and well-being 
among older adults without cognitive impairment (Eron et al., 2019). Yet no previous 
studies have explored the effects of weighted blankets on BPSD. As this population has 
the potential to benefit from safe in-home care strategies, there is a critical need for 
research to explore the potential of these sensory stimulation therapies for community 
dwelling PLWD. 
A critical step to intervention development is to first understand the needs and 
preferences of the target population (Sekhon et al., 2017). As community dwelling 
PLWD receive most of their care from family caregivers, understanding the lived 
experiences of family caregivers represents a key piece of the puzzle to identifying the 
needs of PLWD. Although the experiences of family caregivers’ of PLWD are known to 
be distinct from caregivers of people with other chronic conditions, prior research 
demonstrates that there is a gap in the prioritization of insights, perceptions, and needs 
of family caregivers of PLWD in BPSD management research (Feast et al., 2016).  
The COVID-19 pandemic that began in the Spring of 2020 added another layer of 





placed on many of the in-person support services, healthcare programs, and community 
resources often used by PLWD and their families. Given this decreased access to care 
supports, older adults with ADRD and their family caregivers have experienced unique 
pandemic-related stress (Cohen et al., 2020). To further inform intervention 
development designed for the home setting, it is necessary to identify care needs both 
in general, and those that emerged due to the pandemic. It is essential to reach a 
deeper understanding of unique experiences of PLWD and their caregivers to inform 
intervention development as well as community focused ADRD research more broadly. 
Statement of the Problem 
Many non-pharmacologic interventions tested among community dwelling PLWD 
have demonstrated improvements in BPSD but these interventions have had minimal 
uptake and sustained use in the community (Gitlin et al., 2015). This limited use in the 
community may be due to the lack of feasibility and acceptability of these interventions 
by PLWD and their family caregivers. Sensory stimulation therapies, including 
acutherapy and weighted blankets are safe non-pharmacologic care strategies that 
have shown improvements in a variety of outcomes among non-cognitive impaired older 
adults, but there is a paucity of studies examining these interventions for community 
dwelling PLWD and limited focus on BPSD outcomes (Eron et al., 2019; Strøm et al., 
2016; Smith et al., 2018). Exploring the perceptions of family caregivers has not always 
been prioritized in BPSD management research but is necessary to understand the 
needs of community dwelling PLWD and their families. This information is needed to 
maximize the potential of developing interventions that will be accepted and used by 
families affected by ADRD, particularly during the COVID-19 pandemic which has 
posed new challenges to in-home care. 
The Purpose 
The purpose of this research was to explore the use of non-pharmacologic care 
strategies, specifically acutherapy and weighted blankets as potential interventions for 
treating BPSD among PLWD, with a specific focus on community dwelling PLWD and 
their family caregivers. To accomplish this overarching goal, this research was carried 
out in three phases and is presented through 3 papers of this dissertation. The first 





relating to acutherapy and its effects on behavioral and psychological symptoms among 
older adults with ADRD using a scoping review methodology (Aim 1).  
The second phase (Paper 2) explored perspectives of family caregivers of 
community dwelling older adults with ADRD regarding their caregiving experiences, 
BPSD displayed by the person with ADRD, and their use of non-pharmacologic 
interventions for BPSD management in the home (Aim 2). Also explored were the 
changes in family caregivers’ experiences, BPSD displayed by their family members 
with ADRD, and BPSD management strategies used during the COVID-19 pandemic 
(Aim 3).  
The third phase (Paper 3) was comprised of three components. First, to explore the 
initial perceptions of family caregivers regarding weighted blankets as an in-home care 
strategy for PLWD following a brief description and visual presentation of weighted 
blankets (Aim 4). Second, to explore the feasibility and acceptability of a virtually 
delivered in-home weighted blanket intervention for older adults with ADRD living in the 
community as perceived by the family caregiver and the person with ADRD (Aim 5). 
Third, to examine the feasibility of collecting outcome measures of BPSD, cognitive 
function, and quality of life of care recipients with ADRD, and well-being and self-
reported health status of family caregivers (Aim 6). 
Theoretical Foundations 
Theoretical and conceptual frameworks are important for intervention research to 
help identify related factors, predict, and interpret behaviors, and evaluate potential 
relationships among variables (Foy et al., 2007). There has been limited research 
focused on sensory stimulation therapies among community dwelling individuals with 
ADRD and no universal theory exists on the use of these therapies for reducing BPSD 
in this population. A conceptual framework was developed for this dissertation research 
(See Figure 1.1) that is based on prior theoretical models used to understand the 
occurrence of BPSD (Algase et al., 1996; Hall & Buckwalter, 1987), and current 
research on non-pharmacologic interventions for reducing BPSD among community 
dwelling PLWD, as well as sensory stimulation therapies for improving outcomes among 
PLWD (Haigh & Mytton, 2015; Kwan et al., 2016, 2017; Strøm et al., 2016). This 





caregivers and the relationship between the well-being of care recipients with ADRD 
and their caregivers (Campbell, J., 2009; Griffin et al., 2019; Kershaw et al., 2015; 






   
Figure 1.1 







Table 1.1  
Concepts and Conceptual Definitions Included in Framework of Sensory Stimulation Therapies for Reducing 
Behavioral and Psychological Symptoms of Dementia 
Concepts Conceptual Definitions 
Person living with 
dementia (PLWD) 
An individual diagnosed with Alzheimer’s disease or related dementias (e.g., vascular 
dementia, frontotemporal dementia, dementia with Lewy bodies, Parkinson’s disease 
dementia and mixed-type dementia), defined as chronic, progressively debilitating, 
neurodegenerative diseases that affect not only cognitive function, but also physical, 
psychological, behavioral, and social function (National Institute on Aging, 2019). 
Cognitive function A mental action or process of acquiring knowledge and understanding through thought, 
experience, and the senses, which includes interrelated functions including attention, 
memory, language, perception, decision making and problem solving (Glisky, 2007). 
Decreased stress 
threshold 
Decreased ability to tolerate stress due to neurocognitive changes resulting from the 
progression of cognitive decline in ADRD (Hall & Buckwalter, 1987; Smith et al., 2004). 
Heightened perception 
of stress 
Increased reception and perception of stressful stimuli due to neurocognitive changes 
resulting from the progression of cognitive decline in ADRD (Hall & Buckwalter, 1987; 
Smith et al., 2004). 
Decreased ability to 
cope with stress 
Decreased ability to manage and respond to stress due to the Progressively Lowered 
Stress Threshold inherent in dementia, which results from the dynamic interaction 
between the decreased stress threshold and heightened perception of stress in people 
with ADRD (Hall & Buckwalter, 1987; Smith et al., 2004). 
Internal factors Individual level characteristics, conditions and behaviors that can impact a person’s 
stress threshold and perception of stress (e.g., health status, demographics, 
psychosocial characteristics, physiologic needs, psychosocial needs) (Algase et al., 
1996; Judge et al., 2009). 
External factors Characteristics, behaviors, and conditions that are external to the individual that can 
impact a person’s stress threshold and perception of stress (e.g., physical environment, 
caregiver behaviors, contextual characteristics, social environment) (Algase et al., 1996; 
Judge et al., 2009).   
Behavioral and 
psychological 
symptoms of dementia 
(BPSD) 
Non-cognitive symptoms of disturbed perception, thought content, mood, and/or 
behavior resulting from the decreased ability to manage and respond optimally to stress 
(Cerejeira et al., 2012; Steinberg et al., 2008) 
Caregiver well-being Multicomponent concept comprised of caregiver health status, assets, and resources 
from a strength-based perspective. Health status encompasses physical and mental 
well-being, while assets and resources include a basic needs dimension and an 
activities of daily living dimension (George & Gwyther, 1986; Tebb, 1995). 
Care recipient with 
ADRD well-being 
Multifaceted concept reflective of the quality of life of the person with ADRD, which is 




Methods and approaches to managing symptoms and disease without the use of drugs 
or medications  
Sensory stimulation 
therapies 
Therapies that use everyday objects and tools to arouse at least one of the five sense 
(i.e., hearing, sight, smell, taste, touch) with the intent of promoting positive feelings and 
well-being (Strøm et al., 2016). 
Acutherapy Any therapy that involves the stimulation of acupoints with the intent of having a 
therapeutic effect on an individual’s experience of symptoms or disease   
Weighted blanket The use of weighted blankets, which are deep pressure, tactile stimulation tools that are 










Description of the Model 
Figure 1.1 outlines the conceptual framework, which incorporates concepts and 
relationships from multiple areas of study including the following: the Progressively 
Lowered Stress Threshold (PLST) model (Hall & Buckwalter, 1987), the need driven 
dementia-compromised behavior model (Algase et al., 1996), non-pharmacologic 
intervention research in community dwelling older adults with ADRD, intervention 
studies on sensory stimulation therapies for people with ADRD (Harris et al., 2019; 
Trivedi et al., 2018; Zhou et al., 2015), and research on family caregivers of people with 
ADRD (Bom et al., 2019; Kershaw et al., 2019; Norton et al., 2009). Concepts and 
definitions are listed in Table 1.1. The following narrative describes the concepts in the 
model and provides evidence to support hypothesized relationships of how sensory 
stimulation therapies may reduce BPSD. 
Occurrence of BPSD 
BPSD is a broad, multidimensional concept composed of clusters of behaviors and 
symptoms such as agitation, aggression, depression, psychosis, mania, and apathy 
(See Figure 1.2). Even healthy people may experience behavioral and psychological 
symptoms at any given time, but research supports that PLWD are increasingly 
susceptible to such symptoms due to changes in cognitive and physiologic processes 
related to ADRD (Hall & Buckwalter, 1987). 
Figure 1.2, modified from McShane (2000) illustrates examples of the different 
clusters of behaviors and symptoms of BPSD (Finkel et al., 1997; McShane, 2000). 
Examples of verbal aggression include those such as screaming, cursing or verbal 
threats, while examples of physical aggression include hitting, kicking, pushing, 
scratching or grabbing. Individuals may experience a single or multiple symptoms and 
behaviors of BPSD at the same time (e.g., physically kicking and verbally threatening to 
resist assistance with care). There can also be overlap among symptom and behavior 
types. For example, sadness and hopelessness commonly labeled as depression, may 










Figure 1.2  
 




This conceptual framework supports that BPSD occur as a response to stress. 
According to the Progressively Lowered Stress Threshold model, individuals with ADRD 
have a heightened perception of stress and a decreased tolerance for stress, referred to 
as a progressively lowered stress threshold (Hall & Buckwalter, 1987). The 
progressively lowered stress threshold results from neurocognitive changes in the brain 
that are associated with cognitive decline, which impact a person’s ability to receive, 
process, and respond to stressful stimuli (Hall & Buckwalter, 1987). The need-driven 
dementia-compromised behavior model, another commonly used theoretical model to 
understand BPSD, posits that internal (e.g., unmet physiologic, psychologic and social 
needs, cognitive and neurological factors, health status and psychosocial factors) 
and/or external factors (e.g., physical environmental characteristics and conditions, 
social environment characteristics, sensory overload, under stimulation, interactions 
with caregivers, caregiver reactions) can influence manifestations of disruptive, need 





When applied to the PLST model, these internal and external factors are 
hypothesized to influence the individual’s heightened perception and decreased 
tolerance for stress. Together, the heightened perception and decreased tolerance for 
stress decreases the person’s ability to cope with stress resulting in an accumulation 
that manifests as an array of behavioral and psychological symptoms (Hall & 
Buckwalter, 1987; Smith et al., 2004). 
The PLST model was developed to educate caregivers and care teams on 
environmental and behavioral modifications that can be made to reduce environmental 
stress and BPSD. It has also been used to support interventions, such as massage, 
therapeutic touch and music therapy that are designed to affect sensory-related factors 
that influence the stress level among PLWD (Cheung et al., 2011; Kim & Buschmann, 
1999, 2004). 
Non-Pharmacologic Interventions for Community Dwelling PLWD 
Many intervention studies have tested non-pharmacologic interventions for treating 
BPSD in community dwelling older adults with dementia, yet classification systems and 
definitions of non-pharmacologic interventions have been inconsistent and oftentimes 
unclear across prior research (Aguirre et al., 2013; Bahar‐Fuchs et al., 2013; Bahar‐
Fuchs et al.,  2019; Barreto et al., 2018; Carrion, Folkvord et al., 2018; Deshmukh et al., 
2018; Huang et al., 2015; Livingston et al., 2014; Noone et al., 2019; Regan & Varanelli, 
2013; Trivedi et al., 2018; Woods et al., 2018). Only one review article included 
acutherapy as a potential non-pharmacologic treatment option for BPSD (Oliveira et al., 
2018), while no reviews included weighted blankets. 
 Classification System. I developed a classification system based on a database 
search and prior reviews of non-pharmacologic interventions for BPSD in community-
based settings. In this classification system, non-pharmacologic interventions for BPSD 
are classified the following types: caregiver education, training and skills-building 
programs (e.g., behavioral management education and training, communication skills 
training, home safety and environmental skills building education), cognitive-theory 
based therapies (e.g., cognitive stimulation therapy, cognitive rehabilitation), 
multicomponent interventions (e.g., combined non-pharmacologic approaches such as 





reminiscence and music therapies), physical exercise and activity (e.g., Tai Chi, 
individualized walking programs, chair based yoga), psychological and psychosocial 
support programs (e.g., reminiscence therapy, caregiver support groups, mental health 
counseling), sensory stimulation therapies (e.g., art therapy, music therapy, massage, 
therapeutic touch, acutherapy), sleep improvement programs (e.g., bright light therapy, 
sleep education programs), and system or organizational level programs (e.g., 
collaborative care planning, interdisciplinary transitional care, case management 
programs). Definitions for each of these classes, along with examples and relevant 
reviews and studies are in Table 1.2. 
Sensory Stimulation Therapies 
Sensory stimulation therapies, the focus of this dissertation, involve use of objects 
and tools to arouse at least one of the five senses (i.e., hearing, sight, smell, taste, 
touch) with the goal of promoting positive feelings and well-being (Strøm et al., 2016). 
Examples of sensory stimulation therapies tested with community dwelling PLWD 
include art therapy, music therapy and multi-sensory stimulation therapies (also referred 
to as Snoezelen therapy) (Deshmukh et al., 2018; Trivedi et al., 2018; Ueda et al., 
2013). 
There has been limited research conducted on sensory stimulation therapies for 
treating BPSD in community dwelling PLWD (Trivedi et al., 2018). Yet, there is research 
that supports that sensory stimulation therapies can reduce challenging behaviors and 
improve emotional well-being, as well as other important outcomes such as quality of 
life and functional ability in PLWD residing in long term care settings (Haigh & Mytton, 
2015; Strøm et al., 2016). Systematic reviews have recommended additional research 
be conducted focused on sensory stimulation therapies in PLWD residing in the 
community with broader outcomes examined, such as BPSD and quality of life (Haigh & 






Table 1.2  
Classification System of Non-Pharmacologic Interventions for BPSD Management in Community Dwelling Older Adults with ADRD 
Classification 
Category  
Definition Example(s) of Intervention Types in the 
Classification Category  
Examples of Reviews and Studies 
Testing These Types of 
Interventions * 
Caregiver education, 
training and skills 
building programs 
Programs designed to promote caregivers’ 
understanding and ability to care for the care 
recipient with ADRD through education, training 
and/or skills building activities. 
Functional behavioral analysis 
interventions 
Behavioral management education and 
training 
Dyadic communication skills training 
Home safety and environmental skills-
building and education 
Corbett et al. (2012) 
Eggenberger et al. (2013) 
Gitlin et al. (2001) 
Gitlin et al. (2003) 
Gitlin et al. (2005) 
Moniz Cook et al. (2012) 
Cognitive theory-based 
interventions 
Interventions aimed at assessing and modifying 
cognition as a means of changing how people 
think, feel, and behave (Bahar-Fuchs et al., 
2013) 
Cognitive stimulation therapy-engagement 
in a range of activities and discussions 
aimed at general enhancement of 
cognitive and social function. 
 
Cognitive training- guided practice on a 
set of standardized tasks designed to 
reflect cognitive function. 
 
Cognitive rehabilitation-individualized 
approach to help people with cognitive 
impairments to identify personal goals and 
devise strategies to address them. 
Aguirre et al. (2013) 
Bahar-Fuchs et al. (2013) 
Bahar-Fuchs et al. (2019) 
Gonyea et al. (2016) 
Kwok et al. (2014) 
Paddick et al. (2017) 
Multicomponent 
interventions 
Programs that consisted of two or more non-
pharmacologic approaches to manage behavior 
and/or improve cognitive function, without solely 
using medication. 
Combined exercise and music therapy 
interventions 
Education or training combined with 
psychological support groups for 
caregivers 
Use of art and music therapy to invoke 
reminiscence and discussion of past life 
events 
Brodaty & Arasaratnam, (2012) 
Chew et al. (2015) 
Han et al. (2017) 
Cheung et al. (2015) 
Fernandez-Calvo et al. (2015) 
Gitlin et al. (2018) 
Koivisto et al. (2015) 
Novelli et al. (2018) 
Oliveira et al. (2018) 
Prick et al. (2016) 
Physical exercise and 
physical activity 
Interventions designed to promote bodily 
movement by skeletal muscles that requires 
energy expenditure (World Health Organization, 
2020). 
Tai Chi 
Individualized walking programs 
Group-based chair yoga 
Barreto et al. (2015) 
Forbes et al. (2015) 
Hoffmann et al. (2016) 
Park et al. (2019) 
Canonici et al. (2012) 








Programs designed to promote the 
psychological and/or social factors, condition 
and/or experiences of individuals through 
individual and/or group level therapeutic 
processes Noone et al. (2019). 
 
Reminiscence therapy 
Caregiver support groups 
Mental health counseling 
Spiritual support programs 
Huang et al. (2015) 
Woods et al. (2018) 
Noone et al. (2019) 
Orgeta et al. (2014) 
Regan & Varanelli (2013) 
Van’t Leven et al. (2013) 
Young et al. (2014) 
Robinson et al. (2018) 
Sensory stimulation 
therapies 
Therapies that use everyday objects and tools to 
arouse at least one of the five senses (i.e., 
hearing, sight, smell, taste, touch) with the intent 
of promoting positive feelings and well-being 
(Strøm et al., 2016). 
Art therapy 
Music therapy 




Deshmukh et al. (2018) 
Ueda et al. (2013) 
de la Rubia Orti (2018) 
Ihara et al. (2018) 
Holden et al. (2019) 
Sleep improvement 
programs 
Programs designed to improve overall sleep 
and/or sleep hygiene practices among people 
with ADRD 
Bright light therapy 
Manual-based sleep education program 
for family caregivers  
Forbes et al (2015) 




Programs designed to provide support to 
diagnosed individuals with ADRD and their 
caregivers through interdisciplinary collaboration 
through hospitals and other organizational 
settings. (Trivedi et al., 2018). 
Collaborative care planning 
Interdisciplinary transitional care programs  
Case management programs 
Callahan et al., 2006  
Chien & Lee, 2008  
Lam et al., 2010 
Spijker et al., 2011 
(Studies are included in Trivedi et al. 
2018 review) 
*The studies listed here are only meant to provide examples of studies that evaluated the different types of non-pharmacologic interventions. This list is not 






Acutherapy is a specific type of sensory stimulation therapy that is rooted in 
Traditional Chinese Medicine that is being increasingly used in bio-medical based 
healthcare systems (García-Escamilla et al., 2015). Acutherapy is unique from other 
touch based sensory stimulation therapies, including massage and therapeutic touch, 
as it involves the stimulation of multiple, targeted acupoints across the body, as 
opposed to broad area pressure application (Smith et al., 2013). Acupoints can be 
targeted using manual hand pressure, threadlike needles, massage tools, electrical 
stimulation, or low-grade lasers. Acutherapy is an umbrella term that includes several 
techniques including needle acupuncture, acupressure, and laser acutherapy 
(Kaptchuk, 2002; Smith et al., 2013).  
Weighted Blankets  
Weighted blankets are comparable to traditional comforters but are filled with 
weighted pellets and typically weigh between 10-15 pounds. They are a safe, non-
invasive form of deep pressure tactile, or touch stimulation therapy and are a tool to 
apply stimulating pressure to broad areas of the body (Eron, 2020). Weighted blankets 
are commonly used in hospital and long-term care settings, but there is no 
standardization for use across clinical settings. This lack of standardization may be due 
to limited research on weighted blankets in general which is needed to support 
evidence-based guidelines. 
Hypothesized Mechanisms of Action. This conceptual framework hypothesizes 
two mechanisms by which sensory stimulation therapies may decrease BPSD. One 
mechanism is by decreasing stress in the PLWD, the second is by directly improving or 
maintaining cognitive function. Described below is the research in support of acutherapy 
and weighted blankets in reducing stress, as well as acutherapy for maintaining, and in 
some cases improving cognitive function 
Acutherapy and Stress. Acutherapy has been tested with demonstrated 
improvement in signs and symptoms of many physiologic and psychologic stress-
related conditions in non-cognitively impaired individuals. Examples of stress-related 
physiologic conditions improved by acutherapy include gastrointestinal motility 





Cho et al., 2009; Flachskampf et al., 2007; Linde et al., 2016; Melchart et al., 1999; 
Sparrow & Golianu, 2014; Yin & Chen, 2010). Stress-related psychologic conditions that 
have demonstrated improvements include post-traumatic stress disorder, insomnia, 
depression, and anxiety (Cao, Pan, Li, & Liu, 2009; Kim et al., 2013; Pilkington et al., 
2007; Smith et al., 2018; Sok et al., 2003). Needle acupuncture specifically has 
demonstrated significant reductions in depression, anxiety, and stress related 
symptoms among older adults (Pavão et al., 2010).  
Weighted Blankets and Stress. Research demonstrates that broad, deep pressure 
touch stimulation increases the arousal of the parasympathetic nervous system, while 
also reducing sympathetic arousal (Chen et al., 2016; Reynolds et al., 2015). The 
increase in parasympathetic arousal is hypothesized to have a calming effect, while the 
decrease in sympathetic arousal is associated with changes in physiological processes 
that dampen the body’s physiologic stress response (Chen et al., 2016; Mullen et al., 
2008; Reynolds et al., 2015). Daily use of weighted blankets has shown reductions in 
stress-related psychologic and physiologic symptoms among non-cognitively impaired 
older adults with mental health conditions (Champagne et al., 2015; Mullen et al., 2008). 
Regular nightly use of weighted blankets has demonstrated improvements in overall 
sleep maintenance, depression, anxiety and reduction in daytime fatigue in non-
cognitively impaired adults with a variety of mental health conditions (e.g., insomnia, 
major depressive, generalized anxiety, attention deficit hyperactivity, and bipolar 
disorders) (Ekholm et al., 2020). As there is a strong association between stress and 
sleep disturbances among older adults with ADRD (Porter, 2015; Webster, 2019), the 
effects of weighted blankets on sleep outcomes are important to hypothesizing about 
how they may improve BPSD among PLWD. 
Sensory Stimulation Therapies and Stress. The research in support of the 
positive effects of acutherapy and weighted blankets on stress-related psychologic 
conditions, particularly on depression and anxiety, is important to support the 
relationship between sensory stimulation therapies and BPSD in this model. Prior 
research show that a strong association exists between ADRD and depression, while 
depression is both a risk factor and a symptom of ADRD (Snowden et al., 2015; Enache 





depression and anxiety among individuals with ADRD (Qazi et al., 2017; Sibley et al., 
2021).  
Stress induced chronic inflammation is proposed to play an important role in the 
development of depression, anxiety and ADRD (Bisht et al., 2018; Dafsari & Jessen, 
2020; Hermida et al., 2012; Salim et al., 2012), which explains the association between 
physiologic stress-related chronic inflammatory diseases, such as cardiovascular 
diseases with ADRD (Cunningham & Hennessy, 2015; Newman et al., 2005). Prior 
research supports that acutherapy and deep pressure therapies have anti-inflammatory 
effects at the cellular level (Chen et al., 2016; Kavoussi & Ross, 2007; McDonald et al., 
2015), which is the hypothesized mechanism by which sensory stimulation therapies 
affects symptoms experienced by non-cognitively impaired individuals with depression 
and anxiety (Lu et al., 2016; Pilkington, 2013; Sun et al., 2010).  
Given the strong associations between depression and ADRD, along with the high 
degree of potential overlap of depressive, anxious and ADRD-related symptoms, the 
research in support of the effects of acutherapy and weighted blankets on depression 
and anxiety in non-cognitively impaired people is highly relevant. These relationships 
are significant to hypothesizing the potential effects on symptoms experienced by 
PLWD. This model posits that mechanisms similar to that of other psychologic diseases 
(e.g., depression and anxiety), sensory stimulation therapies can improve symptoms of 
ADRD through the stress and inflammatory process. In this model, the PLST framework 
is used to encompass the stress process, as it has been tested and is widely used in 
ADRD related intervention research.  
Two acutherapy intervention studies have evaluated stress as an outcome in older 
adults with ADRD after receiving acupressure therapy, both showed statistically 
significant reductions (p<0.05) in cortisol levels (a biomarker for stress) during and after 
the therapy intervention periods (Kwan et al., 2016, 2017). These studies also 
demonstrated reductions in the specific BPSD of agitation. These findings, along with 
the PLST framework and research on acutherapy and deep pressure therapies for 
stress-related psychologic conditions, support the relationship between sensory 
stimulation therapies, the Progressively Lowered Stress Threshold (PLST), and BPSD. 





2 and 3) of this dissertation, stress remains an important component in the model and 
represents a potential area of future research to explicate the mechanism by which 
sensory stimulation therapies such as acutherapy and weighted blankets may reduce 
BPSD. 
Cognitive Function and BPSD. A second hypothesized mechanism of acutherapy 
on BPSD is by directly improving or maintaining cognitive function. As illustrated in this 
model, interventions such as acutherapy that potentially improve or maintain cognitive 
function in PLWD may also act through other neurochemical and neuropathological 
processes that ultimately reduce BPSD (Casanova et al., 2011). 
Acutherapy and Cognitive Function. Declining cognitive function has been 
consistently linked to increasing BPSD frequency and severity (Lövheim et al., 2008; 
Majer et al., 2019; Thompson et al., 2010). Meanwhile, non-pharmacologic intervention 
research, including acutherapy studies, have demonstrated improvements in cognitive 
function in people with ADRD specifically (Zhou et al., 2015). A study examining needle 
acupuncture in individuals with ADRD used functional magnetic resonance imaging to 
explore the physiologic mechanism of acupuncture for treating cognitive impairment in 
individuals with Alzheimer’s disease and mild cognitive impairment (MCI). Results 
showed that during and immediately after acupuncture therapy sessions, individuals 
with MCI and Alzheimer’s disease demonstrated activation of multiple regions of the 
brain, specifically the frontal and temporal lobes, which are responsible for recognition, 
memory, and cognition (Wang et al., 2012). Other acutherapy studies have 
demonstrated significant improvements in both cognitive function and BPSD (Jia et al., 
2017; Kwok et al., 2013; Rodríguez-Mansilla et al., 2015; Shi et al., 2015; Wang, Qin, & 
Yu, 2014). This research provides support for the relationship between acutherapy and 
cognitive function, as well as the direct relationship between cognitive function and 
BPSD. 
Caregiver Well-Being and Care Recipient Well-Being 
Family caregivers play a critical role in providing care for PLWD in the community, 
but ADRD caregiving can come at a significant cost. BPSD have consistently been 
shown to be a major factor related to increased caregiver burden (Campbell et al., 2008; 





(Son et al., 2007), and decreased quality of life of caregivers and care recipients with 
ADRD (Brodaty & Donkin, 2009; Hurt et al., 2008). Caregiver well-being is a concept in 
this model used to encompass many dimensions related to the overall health, basic 
needs, and functional ability. Caregiver well-being is conceptualized as a broad, 
multifaceted concept composed of dynamic relationships and interactions between 
caregiver physical health, mental health, assets, and resources (George & Gwyther, 
1986). 
There is an interdependent, dynamic relationship between the well-being of 
individuals with ADRD and their family caregivers (Harris et al., 2020; Bom et al., 2019; 
Kershaw et al., 2019; Graham & Bassett, 2006; Norton et al., 2009; Stall et al., 2019). 
Increased caregiver distress is associated with several negative care recipient specific 
outcomes, such as early institutionalization, worsening cognition, mood and quality of 
life, increased healthcare utilization and costs (Stall et al., 2019). Meanwhile, care 
recipient specific factors such as functional ability and degree of symptom severity are 
associated with overall caregiver well-being (Kang et al., 2014; Miyamoto et al., 2010). 
For these reasons, the concept of caregiver well-being is included in this framework, 
bidirectionally associated with the well-being of the care recipient with ADRD and 
unidirectionally linked to BPSD.  
The lack of a conceptual and theoretical framework on sensory stimulation therapy 
for ADRD and BPSD limits the understanding of key concepts and relationships, thus 
restricting the development and applicability of these interventions in research and 
practice. This conceptual framework was developed for this dissertation research to link 
the current research on sensory stimulation therapies with prior theoretical models that 
advance the understanding of BPSD. As this framework identifies and delineates 
concepts and hypothesized relationships, it was used in this dissertation and will be 
used in future research to develop sensory stimulation therapy interventions for BPSD. 
This model also prioritizes family caregivers, who act as key stakeholders in 
understanding and advancing care for PLWD in the community, which promotes the 
applicability and usefulness of this research to community-based settings (White et al., 





key components of the framework were captured in the weighted blanket intervention 
feasibility and acceptability study (Paper 3) of this dissertation research. 
Specific Aims 
To achieve the overall purpose of this dissertation, the following aims were used to 
guide this research. 
Aim 1 
Identify, examine, and synthesize the state of the science relating to the effects of 
acutherapy on BPSD. (Paper 1) 
Aim 2 
Explore the perspectives and experiences of family caregivers of community dwelling 
older adults with ADRD regarding BPSD and use of non-pharmacologic interventions for 
BPSD management. (Paper 2) 
Aim 3 
Explore the perspectives and experiences of family caregivers of community dwelling 
older adult family members with ADRD regarding changes in their caregiving 
experiences, BPSD displayed by their family member with ADRD, and BPSD 
management strategies used during the COVID-19 pandemic. (Paper 2) 
Aim 4 
Explore the initial perceptions of family caregivers regarding weighted blankets as an in-
home care strategy for community dwelling older adults with ADRD following a brief 
description and visual presentation of weighted blankets. (Paper 3) 
Aim 5 
Examine the feasibility and acceptability of a virtually delivered, in-home weighted 
blanket intervention for older adults with ADRD living in the community as perceived by 
the family caregiver and the person with ADRD. (Paper 3) 
Aim 6 
Examine the feasibility of collecting outcome measures of BPSD, cognitive function, and 
quality of life of care recipients with ADRD, and well-being and self-reported health 
status of family caregivers. (Paper 3) 





Chapter 2 presents the first paper of this dissertation titled, Acupuncture and 
Acupressure for Dementia Behavioral and Psychological Symptoms: A Scoping Review. 
A scoping review methodology was used to identify, examine, and synthesize the state 
of the science on acutherapy and its effects on behavioral and psychological symptoms 
among older adults with ADRD (Aim 1). Findings of this review were first published in 
the Western Journal of Nursing Research in December 2019 (Harris, Titler, & Struble, 
2019). 
Chapter 3 paper 2 of this dissertation titled, Perceptions of Family Caregivers of 
Older Adults Living with Dementia Regarding Behavioral and Psychological Symptoms 
of Dementia and the Impact of the COVID-19 Pandemic. This study used a qualitative, 
exploratory approach using virtual semi-structured interviews with family caregivers who 
lived with older adults with ADRD. The purpose of these interviews was to explore 
caregivers’ perceptions and experiences regarding BPSD experienced by their relatives 
with ADRD, non-pharmacological strategies they used to address these symptoms and 
how helpful these strategies were to better manage challenging symptoms (Aim 2). 
Furthermore, interviews explored how the COVID-19 pandemic affected caregivers’ 
experiences in caring for their family member with ADRD, the BPSD their family 
member experienced, and strategies they used to manage BPSD (Aim 3). 
Chapter 4 is the third paper of this dissertation titled, Examining the Feasibility and 
Acceptability of a Virtually Delivered In-Home Weighted Blanket Intervention for Older 
Adults Living with Dementia and their Family Caregivers. This study used two designs, 
the first being the same qualitative approach that was used in paper 2 with the aim of 
exploring the initial perceptions of family caregivers regarding weighted blankets as an 
in-home care strategy for community dwelling older adults with ADRD following a brief 
description and visual presentation of weighted blankets (Aim 4). A prospective, within 
subjects, pre-post design was used to examine the feasibility and acceptability of a 
virtually delivered, in-home weighted blanket intervention for older adults with ADRD 
living in the community as perceived by the family caregiver and the person with ADRD 
(Aim 5). This feasibility and acceptability study also examined the feasibility of collecting 
outcomes of BPSD, cognitive function, and quality of life of care recipients with ADRD, 





Chapter 5 concludes this dissertation by summarizing and synthesizing the findings 
across all 3 papers (Chapter 2, 3 and 4) by linking the findings back to the conceptual 
framework. This chapter also presents the significance of the overall findings of this 






























Acupuncture and Acupressure for Dementia Behavioral and Psychological 
Symptoms: A Scoping Review 
 
Introduction 
The projected number of people diagnosed with Alzheimer’s disease or related 
dementias (ADRD) is anticipated to reach 92 million by 2030 and jump to 152 million by 
2050 (World Health Organization, 2020). Behavioral and psychological symptoms of 
dementia (BPSD) affect virtually all of people with ADRD (Lyketsos et al., 2002; 
Margallo-Lana et al., 2001) and have negative effects on those diagnosed, their 
families, clinicians, and society. Pharmacologic treatments are often ineffective at 
managing BPSD and can be harmful to older adults with ADRD (Jeste et al., 2008; 
Maust et al., 2015), thus practice guidelines encourage the use of non-pharmacologic 
interventions as first line treatment of BPSD.  
Acupuncture and acupressure, collectively referred to as acutherapy are non-
pharmacologic interventions that have demonstrated to be safe and have the potential 
to improve cognitive function among older adults with ADRD (Peng et al., 2007; Zhou et 
al., 2015). Additional research is needed to examine the efficacy for improving 
outcomes besides cognitive function among people living with dementia (PLWD). With 
the significant individual, family, and societal level costs associated with BPSD, there is 
a need to understand the extent and nature of the effects that acutherapy has on these 





Background and Significance 
Behavioral and Psychological Symptoms of Dementia 
BPSD are defined as signs and symptoms of disturbed perception, thought content, 
mood, or behavior that frequently occur in PLWD (Finkel et al., 1997). Examples of 
BPSD include anxiety, sleep disturbance, depressed mood, hallucinations and 
delusions, aggression, restlessness, agitation, wandering, culturally inappropriate 
behaviors, screaming, wandering, sexual disinhibition, hoarding, cursing, and 
shadowing (Finkel et al., 1997; Kar, 2009).    
Virtually all people diagnosed with dementia are likely to experience at least one 
specific behavioral or psychological symptom during the disease. Specific symptoms 
are often episodic in nature, while BPSD as a whole are present throughout the lifetime 
of the diagnosis (Aalten et al 2005; Steinberg et al., 2004). The causes of BPSD are 
diverse, complex, and multifactorial. Some individuals with ADRD may be more at risk 
than others to experience certain types and degrees of severity of BPSD.  Research 
has shown that women may be more at risk for depressive symptoms (Buchanan et al., 
2004; Lövheim et al., 2009; Steinberg et al., 2006), while men may be more at risk for 
aggressive type behaviors (Buchanan et al., 2004; Hall & O'Connor, 2004; Lövheim et 
al., 2009). BPSD are most common in the middle stages of the disease, with an 
estimated prevalence of 61%-88% (Lövheim et al., 2008; Steffens et al., 2005). Specific 
BPSD have been shown to vary depending on dementia type, for example, depressive 
and anxious type symptoms have consistently shown to be more prevalent among 
individuals with vascular type dementia compared to Alzheimer’s dementia (Cerejeira et 
al., 2012; Steinberg et al., 2006). Worse general health and increased comorbidities are 
associated with increased risk for many BPSD, including agitation/aggression, aberrant 
motor behavior, disinhibition, and irritability (Steinberg et al., 2006).  
BPSD are a leading factor in worsening caregiver burden (Campbell et al., 2008), 
and they negatively impact the quality of life of PLWD, as well as their family caregivers 
(Banerjee et al., 2006; Hurt et al., 2008). Similarly, these symptoms are associated with 
increased stress and burden among care staff in geriatric-acute care and nursing home 
settings (Cocco et al., 2003). BPSD can ultimately lead to early institutionalization, or 





al., 2009) BPSD are also incredibly costly to society, as they account for up to 30% of 
the $305 billion in total health costs for ADRD in the United States (Alzheimer's 
Association, 2021; Schnaider et al., 2002).  
Pharmacologic treatments for BPSD have been shown to be ineffective at managing 
BPSD and in many cases, dangerous to PLWD. For example, antipsychotics continue 
to be used as a primary treatment for severe agitation and psychosis in dementia; 
however, these medications have been shown to have limited efficacy and have been 
linked to increased mortality rates in this population (Maust et al., 2015). Current FDA 
black box warnings caution against the use of all antipsychotics in older adults with 
dementia due to the increased risk of death (Jeste et al., 2008). Anti-anxiety 
medications such as benzodiazepines, which are also commonly used for BPSD 
management, are associated with worsening cognitive function and increased falls and 
fractures in older adults (Defrancesco et al., 2015; Van Strien et al., 2013). Meanwhile, 
use of anti-depressant medications have been linked to increased risk for suicide in this 
population (Seyfried et al., 2011).  
Due to the dangers associated with psychotropic medications in older adults with 
ADRD, recent practice guidelines and recommendations encourage the use of non-
pharmacologic interventions for BPSD (Austrom et al., 2018; Reus et al., 2016). There 
is an urgent need for safe and effective non-pharmacologic treatments for BPSD to 
support families and clinicians to better manage these burdensome symptoms 
experienced by PLWD. Acupuncture and acupressure present as possible non-
pharmacologic care strategies for BPSD management. 
Acutherapy and Dementia 
Based in Traditional Chinese Medicine, acutherapy is a non-pharmacologic 
intervention that emerged in China as early as first century B.C. The traditional 
understanding of acutherapy is based on scientifically non-detectable energy pathways 
called meridians. Meridians are interconnected throughout the body and thousands of 
acupoints that are along these pathways can be stimulated using needles, manual hand 
pressure, and light or electrical stimulation to correct various disturbances in the 
harmony of the body (Kaptchuk, 2002). Given the non-invasive nature of acutherapy 





increasingly used in Western healthcare systems that embrace primarily bio-medical 
perspectives of health (García-Escamilla et al., 2015; Ma, 2007). It has been found to 
be a safe and effective treatment option for several symptoms and diseases such as 
chronic pain, migraines, depression, anxiety and weight loss (Amorim et al., 2018; Kim 
et al., 2018; Lee & Ernst, 2011; Wu et al., 2012).  
Functional magnetic resonance imaging (MRI) has advanced the understanding of 
how acutherapy provides symptom relief by demonstrating that through the stimulation 
of acupoints corresponding areas of the brain are effectively activated that relate to 
disease processes (Fang et al., 2004). Despite these technological advancements, the 
exact mechanism of action is still not fully understood. The stimulation of acupoints is 
hypothesized to have a therapeutic effect on symptoms and disease through a variety of 
neurologic, hormonal and endocrinologic mechanisms (Han, 2003; Kou et al., 2017; Li 
et al., 2013; Noguchi, 2010). MRI studies have been conducted examining needle 
acupuncture in individuals with ADRD. Findings showed that the acutherapy 
interventions activated primarily the frontal and temporal lobes of the brain, which are 
responsible for recognition, memory and cognition (Shan et al., 2018; Wang et al., 
2012). Given these findings, it is suggested that acutherapy may be beneficial for those 
with cognitive impairment; however, there remains no unified understanding of the 
mechanism of action of acutherapy for improving cognitive function, or for reducing 
BPSD in individuals with ADRD. The conceptual framework guiding this dissertation 
research hypothesizes that acutherapy may influence BPSD through the stress process, 
or by directly improving cognitive function (See Chapter 1, Figure 1.1, p. 6). 
Systematic reviews support that acupuncture is safe for people with ADRD with very 
few side effects and that participants often report high satisfaction with the treatments; 
however, the quality of the evidence identified was low and additional research was 
recommended (Peng et al., 2007; Zhou, et al., 2015). Despite these recommendations, 
research on acutherapy in people with ADRD in Western healthcare systems has 
stalled, and despite its high degree of safety and potential for improving cognitive 








Despite these encouraging findings, the effects of acupuncture and acupressure on 
BPSD specifically remain understudied. Prior to this review which was published online 
in the Western Journal of Nursing Research (WJNR) in December 2019 (Harris, Titler, 
Struble, 2019), no review existed on acutherapy for BPSD. The purpose of this review 
was to identify, examine and synthesize the science relating to the effects of 
acupuncture and acupressure therapy on BPSD. The research question guiding this 
review was, “What are the effects of acupuncture and acupressure therapy on the 
behavioral and psychological symptoms in persons with dementia?”.  
Methods 
This review was guided by the scoping review methodology outlined by the Joanna 
Briggs Institute Reviewers’ Manual (Peters et al., 2015), which is based on the scoping 
review frameworks of Arksey and O’Malley (2005) and Levac, Colquhoun, and O’Brien 
(2010).  
A scoping review framework uses a systematic approach to identify, examine, and 
summarize available evidence and to identify gaps in knowledge (Arksey & O’Malley, 
2005). Prior to this review, evidence available regarding acutherapies for managing 
BPSD was unknown. A scoping review is useful when the state of the science is 
emerging, as it allows for a broad view of the nature and range of evidence on the given 
topic area (Munn et al., 2018). Unlike a systematic review, a scoping review framework 
allows for greater breadth and inclusion of all pertinent research regarding acutherapy 
for BPSD, irrespective of quality (Peters et al., 2015). This approach also enables 
identification and examination of gaps in the evidence, which is useful to this emerging 
area of study.  
Eligibility Criteria 
Studies were included that consisted of participants with a diagnosis of ADRD. 
Alzheimer’s disease and vascular dementia are the two most common types of 
dementia and were expected to be the most prevalent dementia types in this review; 
however, some studies did not specify the type of dementia of study participants. As the 
characteristics of the participants and settings were similar across studies, studies were 





Studies were included that examined the use of acupuncture and/or acupressure 
therapy. The studies could use multi-modal interventions that included other types of 
treatments including pharmacologic and non-pharmacologic approaches, but a 
acupuncture or acupressure treatment had to be included. Because the aim of this 
review was to explore the effects of acupuncture or acupressure therapy on BPSD 
rather than cognitive function, at least one behavioral or psychological symptom needed 
to be included as an outcome measure in the studies to be included in this review. 
Studies evaluating activities of daily living (ADLs) as an outcome were also included, as 
BPSD are often marked by increased ADL dependence and poor hygiene (Kar, 2009). 
Studies that only evaluated cognitive function or no BPSD outcomes were excluded. 
Included studies had to be published in the English language. As acupuncture 
therapy is rooted in Traditional Chinese Medicine, studies could be conducted within or 
outside the United States. No exclusion criteria were applied to the setting of the 
studies, for example, they could be conducted in acute care, primary care and/or 
community settings.  
Gray literature such as dissertations, theses, conference reports and proceedings, 
and white papers were excluded. In addition, commentaries, opinion pieces and letters 
to the editor were also excluded as they provided little support relevant to the research 
question. Reviews and meta-analyses that did not include BPSD were also excluded. 
A broad range of study designs were included, due to the potential paucity in high 
quality research studies and unknown state of the science on acupuncture and 
acupressure therapy for BPSD in those with dementia. Studies were not excluded 
based on the date of publication, as to include studies that may add historical value to 
the review. 
Search Strategy 
An initial search was done using the MEDLINE database to briefly review the topic of 
interest, as to ensure no review had been done on the topic already. This was also done 
to gain a better understanding of keywords to be used in a more systematic search.  
A systematized search strategy was then created and conducted. University of 
Michigan Health Science Library informationalists were involved and provided expertise 





PubMed, CINAHL, Embase, PsycINFO and AgeLine. Search terms and keywords, 
along with how they were combined for the database searches are outlined in Table 2.1. 
BPSD were not included in the database search, as this concept involves a wide 
range of examples and could result in excluding relevant studies if a specific type of 
BPSD was not included in the database search. For this reason, the inclusion and 
exclusion criteria were applied to this concept during the review of titles/abstracts and of 
full text articles.  
Table 2.1 
Search Terms and Combinations 
Boolean operator Field Keywords 
 Title, abstract, medical 
subject headings (in 
PubMed), author defined 
keywords 
‘dementia’, ‘dementia, vascular’, ‘Alzheimer disease’ and 
keywords and synonyms of dementia such as ‘senile’, 
‘Alzheimers’, ‘Alzheimer’, ‘Alzheimer’s’, ‘dementia’ and 
‘amentia’ 
AND Title, abstract, medical 
subject headings (in 
PubMed), author defined 
keywords 
like ‘acupuncture’, ‘acupuncture therapy’, ‘acupuncture, 
ear’, ‘acupuncture points’ and ‘acupressure’ 
OR Title, abstract, medical 
subject headings (in 
PubMed), author defined 
keywords 
‘shiatsu’, ‘pharmacopuncture’, ‘acupuncture’, 
‘electroacupuncture’, ‘acupoints’, ‘meridians’, 
‘acupressure’, ‘acupotomy’, ‘auriculotherapy’, ‘intradermal 
needling’, ‘Zhi Ya’, ‘Chih Ya’ and ‘Tui Na’ ‘acutherapy’ 
 
Data Management 
Original database searches were conducted between October 2 through October 19, 
2018, then updated and conducted again in January 2020. All article citations were 
downloaded to EndNote X8. EndNote X8 was used to filter duplications. Review of titles 
and abstracts and full text articles was conducted by the primary reviewer (M. Harris). 
Studies that seemed uncertain regarding inclusion and exclusion criteria were 
discussed with authors L. Struble and M. Titler until a consensus was reached. Data 
was extracted pertaining to reference title, author, year, sample characteristics (size, 
dementia types, dementia severity), study location, study design, acutherapy 
intervention procedures, BPSD examined and other outcomes, adverse effects of 
interventions, and significant results relating to BPSD. These data were charted in an 
ongoing, iterative manner in tables, which were then shared and discussed among the 






Figure 2.1 provides a PRISMA diagram outlining the results of the search process. 
The total number of citations from the database search was 1178. EndNote X8 was 
used to filter duplications, which left a total of 836 citations to be reviewed by title and 
abstract. Common reasons for exclusion at the title and abstract screening phase were 
studies that evaluated alternative treatments but did not include acupuncture or 
acupressure therapy and studies that did include a BPSD outcome.  
Fifty-seven articles were then reviewed by full text. Articles were excluded for the 
same reasons as the title and abstract review, in addition, some articles were 
commentaries (n=6), one was a report on a not yet completed study, one was a 
conference abstract and several articles reported on the same study, but in different 
journals (n=11). Ultimately, 15 articles were included based on the inclusion and 
exclusion criteria. The final step of the search was a review of the references of the 
included studies, no new studies were found. 
Synthesis of the Extent and Nature of the Research on Acutherapy for BPSD 
The 15 studies identified through the database search are summarized in Tables 2.2 
and 2.3. The 6 studies in Table 2.2 examined the effects of acupuncture on BPSD in 
persons with ADRD (Jia et al., 2017; Kwok et al., 2013; Lombardo et al., 2001; Shi et 
al., 2015; Shi et al., 2012; Wang et al., 2014). The 9 studies in Table 2.3 includes those 
that tested the effectiveness of acupressure therapy on BPSD in persons with ADRD 
(Fung & Tsang, 2018; Kwan, Leung, & Lai, 2016, 2017; Lin et al., 2009; Rodríguez-
Mansilla et al., 2015; Simoncini et al., 2015; Sutherland et al., 1999; Yang et al., 2015; 
Yang et al., 2007). The publication years of the articles ranged from 1999-2018. The 
sample sizes of all the studies ranged from 10-186, with an average of 69 participants. 
Sample sizes of the acupuncture studies ranged from 10 to 186 with an average of 88, 





























Jia et al. 
(2017) 
79 China  
In the home 
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11 United States 
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Repeated measures 
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ADL function in 
acupuncture 
group 
Wang et al. 
(2014) 
55 China 
Inpatient and outpatient 
neurology units 
RCT, 2 arms (daily oral 









Combined daily dosage of 
donepezil with once-daily 
acupuncture treatments 
for 20 days 
Sessions duration: ~30 
minutes 
Not specified Cognitive 
impairment (MMSE) 
ADL’s (ADAS-ADL) 




ADL function in 
acupuncture 
group 
Note. ADLs activities of daily living, ADCS-ADL Alzheimer’s disease cooperative study activities of daily living scales, ADAS-Cog Alzheimer’s Disease Assessment 
Scale-Cognitive subscale, BPSD behavioral and psychological symptoms of dementia, CSDD Cornell scale for depression in dementia, DEMQOL Dementia 
Quality of Life Scale, EEG electroencephalogram, MMSE Mini-Mental Status Exam, NPI Neuropsychiatric Inventory, PMS Profile of Mood States PWD person with 
dementia, RCT randomized controlled trial 
*Auxiliary points could be added to the treatment based on the individual’s condition at the acupuncturist’s discretion. Treatments were individualized for each 














Table 2.3  
















Outcomes (Measurements) Significant Findings 
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(aroma-massage 
with acupressure + 
exercise vs. 
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Stress (Salivary cortisol 
levels) 
Reduced agitation 
and stress. Optimal 
dosage was 
determined to be 
2x/day for 2 weeks 
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Ease of care with ADLs 
(Ease of care inventory) 
Emotional expression 
(Apparent Affect rating scale) 
Need for restraint (Unit log) 
Number of family visits (Unit 
log) 
Reduced agitation 
and improved ease of 


















RCT, 3 arms (usual 
care vs. ear 
acupressure vs. 
massage therapy) 
Ear acupressure Continuous ear 
acupressure for 3 
months 
 
MA-TF1 Pain (DOLOPLUS2 scale) 
Depression (CSDD) 




anxiety and pain seen 
in acupressure group 
with greater 
improvement in pain 
and depression with 
ear acupressure 
compared to 
massage therapy  
Sutherland et 
al. (1999) 
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created by researchers) 
Pulse 
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stimulation of the 
HT7 acupoint 
applied for 8 
weeks 
HT7 Cognitive impairment 
(MMSE) 




ADLs (ADL scales) 
Disease stage 
QOL (Global health quality of 
life scale) 
Subjective sleep quality 




quality ADL, and 
sleep improved with 
acupressure therapy 
Yang et al. 
(2007) 
20 China 





2x per day for 5 
days per week 
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behaviors) 
Ease of care with ADLs 
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Reduced agitation 
and improved ease of 
care with ADLs with 
acupressure therapy 
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only vs. usual care) 
Note. ADL activities of daily living, ADAS-Cog Alzheimer’s Disease Assessment Scale-Cognitive subscale, BPSD behavioral and psychological symptoms of 
dementia, CCMAI Chinese version of Cohen-Mansfield Agitation Inventory, CMAI Cohen-Mansfield Agitation Inventory, CSDD Cornell Scale for Depression in 
Dementia, LTF long-term care facilities, MMSE Mini-Mental Status Exam, NPI Neuropsychiatric Inventory, PWD person with dementia, RCHs residential care 





Participants, Diagnoses and Cognitive Impairment Severity 
A total of 1,035 participants were included across the 15 studies. Four studies 
included participants with Alzheimer’s disease (Jia et al., 2017; Simoncini et al., 2015; 
Sutherland et al., 1999; Wang et al., 2014), one of which tested acupuncture (Jia et al., 
2017), the other three tested acupressure interventions. Two acupressure studies 
included participants with vascular type dementia (Shi et al., 2015; Shi et al., 2012) and 
the remainder of the studies did not specify the type of dementia. Fifty-seven percent of 
the participants were female, although two studies did not report the gender of 
participants (Simoncini et al., 2015; Sutherland et al., 1999). The age range of 
participants in all studies was 50-96. Across acupuncture studies specifically, a total of 
243 participants were included, while 792 were included across acupressure studies. 
Table 2.4 summarizes the baseline severity of cognitive impairment of study 
samples for the 12 studies that reported cognitive function and the cognitive measures 
used (Fung & Tsang, 2018; Jia et al., 2017; Kwan et al., 2016; Kwan et al., 2017; Kwok 
et al., 2013; Lin et al., 2009; Lombardo et al., 2001; Rodríguez-Mansilla et al., 2015; Shi 
et al., 2015; Shi et al., Simoncini et al., 2015; 2012; Wang et al., 2014). The Mini-Mental 
Status Exam (MMSE) and the Alzheimer’s Disease Assessment Scale-Cognitive 
subscale (ADAS-Cog) were the tools used to measure cognitive function across the 
studies with the majority (83%) using the MMSE. The overall cognitive impairment 
severity of study samples was determined based on standardized MMSE scores which 
range from 0-30, scores greater than 25 indicate no cognitive impairment, 19-23 mild 
cognitive impairment, 10-18 moderate cognitive impairment and < 9 severe cognitive 
impairment (Folstein et al., 1983). The ADAS-Cog subscale scores range from 0-70, 
with higher scores indicative of greater impairment (Rosen et al., 1984).  
The degree of cognitive impairment severity ranged from mild to severe, with most 
samples having moderate severity (58%) (Table 2.4). Across the 6 acupuncture studies, 
one had a sample with mild impairment (Lombardo et al., 2001), and 5 with moderate 
cognitive impairment (Table 2.4). Across the 6 acupressure studies that reported 
baseline cognitive impairment scores, 2 had samples with overall moderate cognitive 
impairment, 3 were severe, and 1 had a sample that included participants with 





Table 2.4  
Cognitive Measures and Cognitive Impairment Severity of Study Samples in Acutherapy Intervention Studies with BPSD Outcomes 
Author (Year) Measurement Tool Baseline CF 
Mean (SD) 
Sample (n) Cognitive Impairment Severity  
 Fung et al. (2018)  
 
Chinese version MMSE 14.6 (1.90) Aroma-message with acupressure + 
exercise group (20) 
Moderate 
13.85 (1.93) Aroma-message with acupressure + 
cognitive training group (20) 
⚫ Jia et al. (2017)  ADAS-Cog 29.38 (9.43) Acupuncture group (43) Moderate  
 Kwan et al. (2016)  
 
MMSE 6.61 (6.32) Total study sample, excluding 1 
participant who declined (23) 
Severe 
 Kwan et al. (2017)  
  
MMSE 7.4 (5.8) Acupuncture group (39) Severe 
⚫ Kwok et al. (2013)  Chinese version ADAS-
Cog 
27.28 (10.93) Total study sample (19) Moderate 
 Lin et al. (2009)  
 
MMSE 6.9 (6.1) Sequence 1 Acupressure-Presence-
Montessori (42) 
Severe 
7.1 (6.5) Sequence 2 Montessori-Acupressure-
Presence (39) 
8.0 (6.1) Sequence 3 Presence-Montessori-
Acupressure (52) 
⚫ Lombardo et al.  (2001)  MMSE 21.9 (5.9) Total study sample (11) Mild  
 Rodríguez-Mansilla et al. 
(2015)  
 
MMSE Mean scores 
not reported 
Ear acupressure group (40) 50% of participants in acupressure 
group had moderate dementia, 50% 
had severe dementia 
⚫ Shi et al. (2012)  MMSE 18.24 (0.91) Total study sample (16) Moderate 
⚫ Shi et al. (2015)  MMSE 18.27 (4.08) Randomized group (22) 
Non-randomized group (19) 
Moderate 
17.74 (3.33) Non-randomized group (19) 
 Simoncini et al. (2015)  MMSE 18.0 (4.6) Total study sample (129) Moderate 
⚫ Wang et al. (2014)  MMSE 18.4 (2.9) Combined group (27) Moderate 







Locations, Settings and Designs 
Most of the studies were conducted in China (n = 11). (Fung & Tsang, 2018; Jia et 
al., 2017; Kwan et al., 2016, 2017; Kwok et al., 2013; Lin et al., 2009; Shi et al., 2015; 
Shi et al., 2012; Wang et al., 2014; Yang et al., 2015; Yang et al., 2007). Approximately 
83% of acupuncture and 67% of acupressure studies took place in China. One 
acupressure study was conducted in Spain (Rodríguez-Mansilla et al., 2015). Only one 
acupuncture study was conducted in the United States, and it was of small sample size 
with only 11 participants (Lombardo et al., 2001). Two studies did not specify the 
geographic location (Simoncini et al., 2015; Sutherland et al., 1999). 
The majority of the studies took place in settings such as nursing homes, specialized 
dementia and residential care homes, and long-term care facilities (n=10) (Fung & 
Tsang, 2018; Kwan et al., 2016, 2017; Kwok et al., 2013; Lin et al., 2009; Rodríguez-
Mansilla et al., 2015; Simoncini et al., 2015; Sutherland et al., 1999; Yang et al., 2015; 
Yang et al., 2007). Two acupuncture studies took place in a hospital setting (Shi et al., 
2015; Shi et al., 2012). One acupuncture study was conducted in the home (Jia et al., 
2017), and one included participants from an inpatient and outpatient neurology 
department (Wang et al., 2014). One acupuncture study did not specify the setting 
where the study was conducted (Lombardo et al., 2001). The majority (~89%) of 
acupressure studies took place in long-term care settings (Table 2.3). 
Most of the studies used a randomized controlled trial design with 2 or 3 arms (n=8) 
(Fung & Tsang, 2018; Jia et al., 2017; Kwan et al., 2017; Lin et al., 2009; Rodríguez-
Mansilla et al., 2015; Shi et al., 2015; Wang et al., 2014; Yang et al., 2015). Four of 
these studies were double-blinded  (Kwan et al., 2017; Rodríguez-Mansilla et al., 2015; 
Wang et al., 2014; Yang et al., 2015). Six studies used single group designs such as 
repeated measures and longitudinal prospective designs (Kwan et al., 2016; Kwok et 
al., 2013; Lombardo et al., 2001; Shi et al., 2012; Simoncini et al., 2015; Yang et al., 
2007). One study used a quasi-experimental design with purposive sampling and 
random assignment of participants to the experimental and control groups (Sutherland 
et al., 1999). Half of the acupuncture studies were RCTs, while the other half were 
single group designs with repeated measures (Table 2.2). Over 55% (5 of 9) of the 
acupressure studies were RCTs (Table 2.3). 




Delivery of Acutherapy Interventions 
Acupuncture Interventions 
Intervention delivery procedures varied widely across the 15 studies (Table 2.2 and 
2.3). Of the 6 acupuncture studies, 2 studies combined acupuncture therapy with 
medication (donepezil) for improving memory in dementia (Jia et al., 2017; Wang et al., 
2014). Intervention period durations ranged from 3 weeks to 12 weeks, with 
acupuncture treatment session frequencies ranging from 2 to 3 times per week. 
Duration of treatments sessions was approximately 30 minutes for all studies, except 
one which did not report the average session duration (Jia et al., 2017).  
Acupoints used across studies varied, with one study not reporting specific 
acupoints  (Wang et al., 2014). The only common acupoint targeted across the 5 
studies was ST36, which is located below the knee cap and is commonly used to treat 
gastrointestinal discomfort, nausea, vomiting, stress and fatigue (Chao et al., 2013). 
Three studies reported using auxiliary points, which could be added to the treatment 
based on the individual’s condition at the acupuncturist’s discretion. These intervention 
sessions were individualized for each person for each session (Jia et al., 2017; Shi et 
al., 2015; Shi et al., 2012). All treatments were delivered by professional acupuncturists 
(Jia et al., 2017; Kwok et al., 2013; Lombardo et al., 2001; Rodríguez-Mansilla et al., 
2015; Shi et al., 2015; Shi et al., 2012).  
Acupressure Interventions 
Of the 9 acupressure studies, 3 studies used multi- modal treatments that involved 
acupressure therapy in combination with another alternative treatment, such as 
massage, Montessori-based activities, and aromatherapy. (Fung & Tsang, 2018; Lin et 
al., 2009; Yang et al., 2015). Durations of the acupressure intervention periods ranged 
from 1 week to 3 months, with treatment session frequencies ranging from 2 times per 
week to 2 times per day. Two studies used acupressure ear seeds to apply continuous 
pressure to acupoints for 2 (Simoncini et al., 2015), and 3 months (Rodríguez-Mansilla 
et al., 2015). Only 1 study examined optimal dosage of acupressure for BPSD by 
evaluating what dosage and frequency yielded the most significant effect on agitation in 
PLWD. The optimal dosage of acupressure therapy for treating agitation was 
determined to be twice a day for 2 weeks (Kwan et al., 2016). The findings of this pilot 




study were then used in a larger RCT testing a twice daily, 2 week acupressure 
intervention in individuals with ADRD living in residential care homes (Kwan et al., 
2017). 
Acupoints stimulated across acupressure intervention treatments varied, while one 
study did not report the specific acupoints used (Sutherland et al., 1999). Common 
acupoints stimulated across the studies were HT7 and GB 20 (Fung & Tsang, 2018; R. 
Kwan et al., 2016; Kwan et al., 2017; Lin et al., 2009; Yang et al., 2015; Yang et al., 
2007). Four of the studies included acupressure interventions delivered by non-
professional and non-healthcare individuals trained in acupressure (Fung & Tsang, 
2018; Kwan et al., 2016; Kwan et al., 2017; Lin et al., 2009). One study evaluated nurse 
delivered acupressure therapy (Simoncini et al., 2015). 
Effects of Acutherapy Interventions on BPSD and Measurement Tools Used 
Table 2.5 summarizes the BPSD outcomes evaluated in the 15 studies and indicates 
those for which there was significant treatment effect. Agitation and activities of daily 
living (ADL) function were the most commonly measured outcomes across acutherapy 
studies. ADL function was an outcome of interest in this review, as BPSD are often 
marked by increased ADL dependence and poor hygiene (Kar, 2009). Four studies 
included multiple BPSD outcome measures (Fung & Tsang, 2018; Jia et al., 2017; 
Lombardo et al., 2001; Simoncini et al., 2015). 
Eight studies included ADL function as an outcome variable (n=4 acupuncture 
studies, n=4 acupressure studies) (Fung & Tsang, 2018; Jia et al., 2017; Lin et al., 
2009; Shi et al., 2015; Shi et al., 2012; Simoncini et al., 2015; Wang et al., 2014; Yang 
et al., 2007). Six of these studies (n=2 acupuncture, n=4 acupressure) showed 
statistically significant improvement in ADL function scores post-intervention (Fung & 
Tsang, 2018; Lin et al., 2009; Shi et al., 2015; Simoncini et al., 2015; Wang et al., 2014; 
Yang et al., 2007). The ADCS-ADL and Barthel Index were used to measure ADLs, 
both instruments have been validated and demonstrated good reliability in older adults 









Behavioral and Psychological Symptoms of Dementia Evaluated Across Acupuncture and Acupressure Studies 
and Those that Demonstrated Significant Treatment Effects  
BPSD Outcomes Number of Studies that 
Evaluated Outcome 
(N=15) 
Number of Studies with Statistically Significant 
Improvement in Outcomes (%) 
ADL function 8 6  
(75%) 
Agitation 6 6  
(100%) 
Anxiety 3 2  
(67%) 
Depression 2 2  
(100%) 
Mood 1 1  
(100%) 
Neuropsychiatric symptoms 3 2  
(67%) 
Sleep disturbances 2 2  
(100%) 
Total 25 21  
(84%) 
Note. ADL activities of daily living, BPSD behavioral and psychological symptoms of dementia 
 
Six acupressure studies included agitation as an outcome measure and all 
demonstrated significant improvements in agitation scores after delivery of the 
acupressure therapies (Fung & Tsang, 2018; Kwan et al., 2016, 2017; Lin et al., 2009; 
Yang et al., 2015; Yang et al., 2007). The Cohen-Mansfield Agitation Inventory was 
most commonly used to measure agitation across studies, which has demonstrated 
high reliability in people with ADRD (Cohen-Mansfield, 1986).  
Three studies evaluated anxiety as an outcome (n=1 acupuncture, n=2 acupressure) 
(Lombardo et al., 2001; Rodríguez-Mansilla et al., 2015; Simoncini et al., 2015) The 
acupressure study by Simoncini et al. (2015) was the only one that did not demonstrate 
improvement in anxiety, which was attributed to many participants having low anxiety at 
baseline (Simoncini et al., 2015). The Spielberger State‐Trait Anxiety Inventory was 
used in two studies; it is known to have a demonstrated bias of increased anxiety for 
geriatric adults, which may be confounded by a decreased well-being in this population 
(Kvaal et al., 2001). The Campbell scale was used in one study (Rodríguez-Mansilla et 
al., 2015); the validity and reliability of this measure in the geriatric or dementia 
population is unknown. 




The outcome of depression was measured in two studies (n=1 acupuncture, n=1 
acupressure) (Lombardo et al., 2001; Rodríguez-Mansilla et al., 2015), both 
demonstrated significant improvement in depression scores after the acupuncture or 
acupressure intervention. The Cornell Scale for Depression in Dementia was used to 
measure depression – a tool that is commonly used in people with ADRD with good 
reliability and validity for this population (Alexopoulos et al., 1988). 
Mood was an uncommon outcome measure and was only examined in one 
acupuncture study, which demonstrated significant improvement following the 
intervention period. Mood was measured using the Profile of Mood States (POMS) 
instrument (Lombardo et al., 2001). The validity and reliability of this tool has been 
established in an older adult sample; however, this sample did not include people with 
cognitive impairment (Kaye et al., 1988). 
The broad cluster of neuropsychiatric symptoms was examined in three studies (n=1 
acupuncture, n=2 acupressure) (Fung & Tsang, 2018; Jia et al., 2017; Simoncini et al., 
2015). The acupuncture study by Jia et al. was the only study to not demonstrate 
significant improvement in this outcome; however, it did demonstrate significant 
improvement in cognitive function after the intervention (2017). The Neuropsychiatric 
Inventory was used to measure neuropsychiatric symptoms in all three studies 
(Cummings et al., 1994).  
Finally, sleep disturbance was included as an outcome in two studies (n=1 
acupuncture, n=1 acupressure) (Kwok et al., 2013; Simoncini et al., 2015). Both studies 
demonstrated improvement in sleep at post-intervention. Wrist actigraphy was used in 
one study (Kwok et al., 2013), while the Pittsburgh Sleep Quality Index (PSQI) was 
used in the other (Simoncini et al., 2015). The PSQI has been used in a nursing home 
population and showed to have good reliability scores; however, the sample included 
only residents with normal cognition (Gentili, Werner, Kuchibhatla, & Edinger, 1995). No 
information was found on the reliability and validity of the PSQI in people with ADRD. 
Six studies included physiologic outcome measures, 2 were acupuncture 
intervention studies (Kwok et al., 2013; Shi et al., 2012), and four were acupressure 
(Kwan et al., 2016, 2017; Rodríguez-Mansilla et al., 2015; Sutherland et al., 1999). 
Kwok et al. included wrist actigraphy to measure sleep and rest cycles (2013), the 




acupressure study by Rodríguez-Mansilla et al. (2015) included pain as an outcome, 
while the acupressure study by Sutherland et al. (1999) included pulse and respirations.  
The 2012 study by Shi et al. included urine samples to detect an oxidative marker 
indicative of DNA damage, which significantly decreased immediately after participants 
received the acupuncture treatments. Kwan et al. (2016, 2017) used salivary cortisol 
samples to evaluate stress. The results of both studies by Kwan et al. indicated the 
acupressure treatment groups had significant reductions in salivary cortisol levels, 
suggesting a reduction in stress. Together, these three studies support the relationship 
between acutherapy, and the stress process outlined in the conceptual framework 
guiding this research (Chapter 1, Figure 1.1, p. 6). 
Across all acutherapy studies focused on BPSD outcomes, acutherapy interventions 
were most effective for reducing agitation and depression among individuals with 
ADRD. Needle acupuncture demonstrated significant treatment effects on ADL function, 
as well as other non-BPSD related outcomes such as cognitive function and quality of 
life (Table 2.2). Acupressure interventions demonstrated significant improvements in 
agitation scores in all 6 studies that included agitation as an outcome, and in both 
studies that examined the broad cluster of neuropsychiatric symptoms as an outcome 
(Table 2.3).  
Evaluations of Intervention Acceptability 
Four studies reported findings relating to intervention acceptability, 2 of which were 
acupuncture studies (Kwok et al., 2013; Lombardo et al., 2001), and 2 tested 
acupressure therapy (Kwan et al., 2016, 2017). Two acupressure studies and one 
acupuncture study evaluated completion rates, which ranged from 79%-91% (Kwan et 
al., 2016,  2017; Kwok et al., 2013). The acupuncture study by Kwok et al. (2013) also 
tracked refusal to participate rates, of which there were no reported refusals, although 
this study did use a convenience sampling approach. The acupuncture study by 
Lombardo et al. (2001) used a participant satisfaction questionnaire and reported that 
82% of participants reported being satisfied with the acupuncture treatments; however, 
this study did not describe the specific questions in the questionnaire, the data 
collection methods, or how data was analyzed. This study was also a small sample, with 
only 11 participants. 





No adverse effects were reported across the 15 studies. One acupuncture study 
reported that 10.8% of participants experienced punctate hemorrhage when 
acupuncture needles were withdrawn (bleeding stopped within 5-10 seconds of holding 
dry, sterile cotton to the sites) (Jia et al., 2017). Another acupuncture study stated that 
25% of participants reported mild discomfort at the acupoint sites during treatments and 
20% experienced mild bruising (Shi et al., 2015). These side effects were reported as 
non-significant in both studies. 
Discussion 
Summary of Findings 
The results of this review suggest acupuncture and acupressure therapy have the 
potential to improve BPSD. All 15 of the studies reported high degrees of safety and 
overall satisfaction of the acutherapy intervention treatments in individuals with ADRD. 
Thirteen of the studies demonstrated statistically significant (p<0.05) improvements in at 
least one BPSD outcome. Two acupuncture studies did not demonstrate a treatment 
effect for BPSD measures but did demonstrate significant improvements in other 
important outcomes, including cognitive function and quality of life (Jia et al., 2017; Shi 
et al., 2012). There is an ongoing need for safe and effective non-pharmacologic 
treatment options for BPSD for individuals in all stages of the disease. Findings relating 
to cognitive impairment severity across studies suggest that these therapies are feasible 
and safe for individuals with mild, moderate, and severe cognitive impairment. The 
significant findings suggest that acutherapy may be a reasonable option for BPSD 
management, but additional research is needed to support its efficacy. Acupuncture and 
acupressure offer an area for future research for treating BPSD. 
Limitations 
Findings of this scoping review should be interpreted in light of some limitations. 
First, studies were excluded that were not in English, as reviewers were only proficient 
in English. This may have led to the exclusion of potentially relevant studies as 
acutherapy is rooted in Traditional Chinese Medicine; however, no studies that were 
reviewed by full text were excluded for this reason, and many abstracts that were 
originally published in another language were translated to English. Despite this, it is 




possible that relevant studies were missed due to this criterion. Second, this review did 
not exclude studies based on quality, as it was unclear what the state of the science 
would be prior to the review. Given this limitation, many studies included were found to 
be methodologically flawed and findings related to efficacy for BPSD should be 
interpreted with caution. Finally, for feasibility this review excluded gray literature 
including dissertations/theses, conference proceedings, and white papers, which may 
have excluded new research focused on this topic; however, the original database 
search was conducted in 2018 and again in 2020 and no new studies were found. As 
research on acutherapy for BPSD continues to emerge, it will be important to 
cumulatively review the quality of studies and their effects on BPSD. 
Gaps Identified and Recommendations 
Despite these limitations the findings of this review are encouraging, but due to 
variations in study designs and measures, as well as incomplete explanations of 
intervention procedures (such as use of specific acupoints, acutherapy dose, and who 
carried out the interventions) it is difficult to determine exact conclusions about the 
efficacy of these therapies. Given the methodological flaws in these studies including 
the limited theoretical basis for the interventions and symptoms, differences in 
measures, variations in study designs and intervention dosage, and overall limitations in 
internal and external validity, there remains a gap in the knowledge and quality of 
evidence needed to use acupuncture and acupressure for BPSD.  
There is a need for additional research to evaluate the use of acupuncture and 
acupressure, specifically in countries with a Westernized approach to medical care 
where acutherapy is not as widely used. The majority of the studies were conducted in 
China, as acutherapy is rooted in Traditional Chinese Medicine; however, acupuncture 
and acupressure have the potential to expand treatment for many diagnoses and 
symptoms in Western society. Therefore, additional studies conducted in Western 
healthcare systems are needed to support the generalizability of acupuncture and 
acupressure treatments for BPSD.  
Despite the significant impact that BPSD have on home-dwelling individuals with 
dementia and their family caregivers, most of the studies (n=10/15) were conducted in 
long-term care facilities. Additional research is needed to evaluate the feasibility of 




applying these interventions in the home. To promote the uptake of acutherapies in real 
world settings, future research should evaluate intervention acceptability in addition to 
testing the effectiveness of the intervention. By evaluating acceptability, researchers will 
better understand how the targeted population perceive it and respond to it, which may 
help promote broader implementation and sustained use. As family caregivers play a 
pivotal role in directing care for their relatives with ADRD, it is important for future 
research to evaluate the acceptability of acutherapy from their perspectives and explore 
their perceptions regarding the use of acutherapy as a potential care strategy for BPSD. 
Acupuncture is often performed by licensed acupuncturists and state level 
regulations may require acupuncturists to work under the supervision of a medical 
doctor, which can be a limitation for applying this intervention in the home. Alternatively, 
this review supports that acupressure can feasibly be performed by a non-professional 
given adequate training. Acupressure presents as an opportunity to support informal 
caregivers (such as family members and friends) in having complementary treatment 
options for better managing BPSD.  
Another option to promote delivery and uptake may be the use of a new, less 
invasive, virtually pain-free acutherapy technique called laser acutherapy which does 
not require interventionists to work under the supervision of licensed physicians. Only 
one study led by Dr. Laura Struble PhD, GNP-BC at the University of Michigan School 
of Nursing is focused on laser acutherapy use in PLWD. This pilot study was being 
conducted in assisted living and memory care settings to examine the effects of a 6-
week laser acutherapy protocol on BPSD (agitation specifically), cognitive function and 
activities of daily living in individuals with ADRD. The study was paused due to the 
COVID-19 pandemic in March 2020. Further examination of laser acutherapy and its 
effects on BPSD will be needed when in-person intervention research with vulnerable 
older adults continues, as they are likely in even greater need of effective symptom 
management strategies as a result of the pandemic (Keng et al., 2020). 
Many national and state level entities exist to educate healthcare professionals, 
family members, friends and those diagnosed with dementia regarding BPSD 
management techniques. These organizations can empower healthcare professionals 
and families with knowledge regarding non-pharmacologic care strategies in times when 




other, more traditional approaches, such as psychotropic medications fail, or when they 
cause more harm than healing. Organizations such as the Alzheimer’s Association and 
the Alzheimer’s Foundation of America present significant opportunities to promote 
education for informal and formal caregivers alike regarding alternative and 
complementary approaches to dementia symptom management. 
The policy implications of this work are based on the fact that national programs, 
such as Medicare, currently cover pharmacologic interventions for ADRD care; 
however, there is limited or conditional coverage for non-pharmacologic therapies. As 
the research in support of non-pharmacologic treatments continues to grow and as the 
research builds relating to their efficacy in reducing BPSD, there will be a need for 
policy makers to advocate for coverage for non-pharmacologic treatments and 
incentives for community support services and clinicians to provide them. 
Conclusion 
BPSD ultimately threaten a person’s ability to remain in the home, resulting in 
negative effects on society due to increased healthcare utilization and cost. Due to the 
increased susceptibility to adverse effects of pharmacologic treatments in this 
population, there is an ever-increasing need to prioritize non-pharmacologic care 
strategies in the management of BPSD. This review evaluated the current research 
relevant to acupuncture and acupressure treatments for BPSD. Fifteen studies were 
included in the final review and findings tended to be in support of acupuncture and 
acupressure for symptoms such as agitation, anxiety, ADL function, sleep, mood, 
depression, and neuropsychological disturbances. Limitations in study designs, 
intervention procedures and outcome measures limit the interpretations regarding 
efficacy of acupuncture and acupressure for BPSD.  Additionally, concerns relating to 
generalizability limit the ability to make broad statements in support of the use of 
acutherapy in practice. As BPSD continue to have devastating effects on PLWD, their 
families, and society, there is an overwhelming need to examine the efficacy of non-
pharmacologic interventions that demonstrate potential such as acutherapy.






Perceptions of Family Caregivers of Older Adults Living with Dementia Regarding 
Behavioral and Psychological Symptoms of Dementia and the Impact of the 
COVID-19 Pandemic 
 
Background and Significance 
More than 16 million Americans provide over 18 billion hours of informal, unpaid 
care to older adults living with Alzheimer’s disease or related dementias (ADRD); the 
majority of care being for a family member living in the community (AARP and National 
Alliance for Caregiving, 2020). ADRD are chronically debilitating, progressive diseases 
that affect not only cognitive function, but also physical, psychological, behavioral, and 
social function (National Institute on Aging, 2019). Care demands are high for those with 
ADRD given the many effects on health (McLaughlin et al., 2010), which present 
substantial physical and emotional health risks for family caregivers (Schulz & Martire, 
2004; Stall et al., 2019). 
Older adults with ADRD often experience, interpret, and respond to situations and 
the environment differently from people without cognitive impairment (Hall & Buckwalter, 
1987). This change in perception can increase the person’s susceptibility to an array of 
behavioral and psychological symptoms, such as anxiety, frustration, anger, depression, 
delusions, paranoia, hallucinations, apathy, irritability, and mood lability. These 
symptoms can manifest as a spectrum of behaviors such as restlessness, agitation, 
aggression, resistance to care, tearfulness, paranoid behaviors, suspiciousness, 
inappropriate or irrational behaviors, sleep disturbances, isolation, repetitive actions, 
and mood changes (Kales et al., 2015; McShane, 2000). Clinicians and researchers 
term these symptoms and behaviors as behavioral and psychological symptoms of 
dementia (BPSD), which affect 98% of people living with ADRD (Cerejeira et al., 2012; 
Steinberg et al., 2008). 




The occurrence of BPSD cannot be explained by cognitive impairment alone but is 
theorized to be multifactorial and dependent on dynamic interactions between many 
behavioral, biological, pathological, environmental, and individual level factors 
(Eriksson, 2000; Garand, Buckwalter, & Hall, 2000; Hall & Buckwalter, 1987; Kales, 
Gitlin, & Lyketsos, 2015; Smith et al., 2004). BPSD are prevalent throughout the 
disease process and are a significant predictor of increasing caregiver burden and 
distress (Allen et al., 2017; Ornstein & Gaugler, 2012). More severe BPSD leading to 
increased caregiver distress are also associated with earlier rates of institutionalization 
(or placement in long term care settings), increased risk of elder abuse, and increased 
healthcare utilization and costs (Stall et al., 2019). 
Family caregivers of those with ADRD often have an increased amount, intensity, 
and complexity of caregiving demands, even when compared to caregivers of people 
with other chronic conditions (AARP and National Alliance for Caregiving, 2020; Kasper 
et al., 2015). The experiences of ADRD family caregivers are highly variable across 
different types and severities of ADRD (Liu et al., 2017; Mioshi et al., 2013). These 
findings suggest that ADRD family caregivers are experiencing unique challenges when 
it comes to providing care and coping with a loved ones’ progressive health decline. 
Despite their distinct caregiving experiences, prior research has demonstrated that the 
insights, perceptions, and unique needs of ADRD family caregivers are often not 
prioritized when it comes to ADRD symptom management research (Feast et al., 2016). 
Similarly, in clinical practice, care planning for those with ADRD often fails to 
encompass the unique needs of family caregivers, even though they are primarily 
responsible for the daily care of people living with ADRD in the community (Prorok et 
al., 2013). While the experiences of clinicians and formal caregivers have been 
explored, there is a need to better understand the broader experiences of family 
caregivers with symptoms experienced by their relatives with ADRD and their 
experiences with managing these symptoms in the home (Appleton & Pereira, 2017; 
Cohen-Mansfield et al., 2012). 
The COVID-19 pandemic that began in the Spring of 2020 has increased the stress 
experienced by many family caregivers (Cohen et al., 2020). Due to restrictions and 
modifications to standard care practices and support programs during the pandemic, 




family caregivers may be experiencing increasing challenges to managing symptoms 
experienced by their loved ones with ADRD. These already vulnerable older adults with 
ADRD and their family caregivers have limited access to resources that they previously 
relied on to manage challenging symptoms at home (e.g., in-person consultations with 
clinicians, adult daycare programs, social support programs) (Brown et al., 2020; 
Greenberg et al., 2020). Public health restrictions may directly affect how their loved 
one manages the ADRD (e.g., physical activity, social activities) and their own ability to 
act as caregivers (e.g., limited support from other informal caregivers, limited 
experience in accessing home-based services). Families may also face new challenges 
related to the disease process of COVID-19, as those who experienced severe BPSD 
prior to the pandemic are likely to be at an increased risk of contracting the coronavirus 
and of experiencing more severe symptoms (Keng et al., 2020). Qualitative exploration 
during this time is key to understanding the impact of this global crisis on the health and 
wellness of vulnerable populations, such as those with ADRD and their families (Leach 
et al., 2020; Teti et al., 2020). 
The aims of this exploratory study were driven by the need for additional research to 
better understand the broader experiences of family caregivers and BPSD as 
experienced and managed by people with ADRD and their caregivers. It also addresses 
how their experiences have changed as a result of the COVID-19 pandemic.  
Specific Aims and Research Questions 
This study was guided by 2 specific aims with 6 corresponding research questions 
which were: 
Specific Aim 1 
To explore the perspectives and experiences of family caregivers of community 
dwelling older adults with ADRD regarding BPSD and use of non-pharmacologic 
interventions for BPSD management. 
Research Question 1  
How do family caregivers living with older adult family members with ADRD describe 
their experience as caregivers? 
Research Question 2 




What is the nature and extent of the impact of BPSD on family caregivers of 
community dwelling older adults with ADRD living in the community?   
Research Question 3  
How do family caregivers manage (or attempt to manage) these symptoms and 
behaviors in the home setting and to what extent have the strategies used been helpful?  
Specific Aim 2 
To explore the perspectives and experiences of family caregivers of community 
dwelling older adult family members with ADRD regarding changes in their caregiving 
experiences, BPSD displayed by their family member with ADRD, and BPSD 
management strategies used during the COVID-19 pandemic. 
Research Question 4  
How do family caregivers living with people with ADRD describe their experience as 
caregivers during this time of COVID-19? 
Research Question 5 
What is the extent and nature of the impact of the COVID 19 pandemic on BPSD of 
community dwelling older adults with ADRD and how has this impacted family 
caregivers?   
Research Question 6 
To what extent have strategies used to manage BPSD in the home been affected 
during this time of COVID-19? 
An additional research question for Aim 1 of this study was, “Following a brief 
description and visual presentation of weighted blankets, what are the perceptions of 
family caregivers regarding the use of weighted blankets to help manage BPSD of 
community dwelling older adults with ADRD?”. The findings relevant to this question are 
presented in Paper 3 of this dissertation. 
Methods 
Study Design 
A qualitative, exploratory approach was used for this study. Semi-structured 
interviews using Zoom virtual conferencing system were conducted with family 
caregivers of older adults with ADRD living at home. Semi-structured interviews were 
designed to elicit family caregivers’ perceptions and experiences regarding behavioral 




and psychological symptoms exhibited by their family member with ADRD, non-
pharmacological strategies they used to address these symptoms and how helpful 
these strategies were to better manage challenging symptoms. Furthermore, interviews 
explored how the COVID-19 pandemic affected caregivers’ experiences in caring for 
their family member with ADRD, the BPSD experienced by their family member, and 
strategies they used to manage BPSD.   
Semi-structured interviews were selected because they allow for open-ended 
responses and in-depth exploration of topics that may be too sensitive to discuss in a 
group setting (Newcomer et al., 2015). Virtual, video conference-based interviews were 
used as they are a feasible, acceptable, and increasingly used technique for collecting 
qualitative data (Archibald et al., 2019; Nehls et al., 2015). Given COVID-19 related 
research restrictions, this approach protected both the participants and the interviewer 
by limiting exposure through direct, in-person contact, which is required for traditional 
face-to-face interviews. 
Study Sample 
Family caregivers living at home with an individual with ADRD were invited to 
participate in virtual semi-structured interviews. The total sample size included 21 family 
caregivers of 20 older adults with ADRD. Two caregivers participated in the interview 
together as a couple, for a total of 20 interviews.  
Family caregivers were selected as the population of interest, as over 70% of 
individuals with ADRD reside in the community setting and receive most of their care 
from informal caregivers, such as family members and friends (Lepore et al., 2017; 
Spillman et al., 2014). Across studies, a wide range of definitions have been used to 
define informal and family caregivers for eligibility to participate in community-based 
studies involving caregivers of individuals with ADRD. There is no consistent definition. 
This study aimed to gain insight into the perceptions and experiences of family 
caregivers who act as the primary or key member of the diagnosed individual’s care 
network. Thus, this study defined family caregivers as any relative, partner or other 
family member who provides a broad range of assistance for an older adult with ADRD 
and lived in the same household (Family Caregiver Alliance, 2014). 
Eligibility Criteria. The following criteria were used to identify eligible caregivers. 





1) 21 years of age or older and identify themselves as a primary caregiver of an 
older adult (60 years of age or older) with ADRD who lives in the same household 
2) has access and ability to use a telephone, smart phone, tablet (with internet 
access), or computer (with internet access and a microphone) 
Exclusion criteria:  
1) less than 21 years of age 
2) unable to read or speak English 
3) has a hearing or visual impairment that limits their ability to participate in the study  
Having a family member with a specific type of ADRD (e.g., Alzheimer’s disease, 
vascular dementia) was not a criterion for inclusion for caregiver participants. This was 
decided for several reasons. First, distinguishing between types of dementia can be 
difficult and requires advanced testing (e.g., PET imaging, CSF biomarker analysis) that 
individuals in earlier stages of disease living in the community may not have received. 
Second, diagnoses made without advanced testing may not always be accurate. Third, 
people with ADRD do not always receive a specific type of diagnosis from physicians 
(Alzheimer’s Association, 2021). Not specifying an ADRD type for inclusion allowed for 
a broader, more inclusive eligibility criteria by not excluding individuals who may not 
have access to advanced diagnostic testing. Individuals were not excluded based on 
their relationship to the person with dementia, which means that spousal, sibling, child, 
and other family members were invited to participate, if they lived with a person 
diagnosed with ADRD and identified themselves as being a primary, nonpaid caregiver.   
Recruitment 
Family caregivers were recruited through two entities, the Alzheimer’s Association of 
Michigan and the Michigan Alzheimer’s Disease Research Center (MADRC). Study 
information and flyers were shared with potential participants at virtual support groups, 
educational events, organizational newsletters, websites, and by word of mouth. 
Interested individuals contacted the PI (Harris) directly, at which time the PI used an 
eligibility determination form that included the criteria listed above to confirm eligibility. 
Of the 25 caregivers that were screened, 21 were eligible for participation and enrolled. 
Of the 21 participants, 13 were referred to the study through the Alzheimer’s 




Association, and 8 were through the MADRC. The 4 individuals that were excluded did 
not live in the same household as their family member with ADRD. Recruitment began 
in mid-October and concluded in mid-November 2020.  
Consent  
Prior to scheduled interviews, all participants were provided with the study consent 
form electronically and reviewed the form with the PI by phone or Zoom. Participants 
signed the form electronically using secure, HIPAA compliant SignNow software 
(SignNow, 2021). 
Instrumentation 
A semi-structured interview guide was used to elicit information from family 
caregivers about:  
▪ their experiences with behavioral and psychological symptoms experienced 
by their family members 
▪ how distressing these symptoms were to them 
▪ how they managed these symptoms 
▪ their opinions about approaches they had tried for symptom management and 
▪ how their experiences were affected by the COVID-19 pandemic.  
The initial guide was presented individually to 3 people who identified as current or 
past family caregivers of individuals with ADRD to gain their feedback regarding the 
content, flow, cohesion of the guide and recommendations for modifications. In general, 
the 3 individuals found all the questions to be distinct, important, and well-stated, but 
they made suggestions on the order of the questions. Edits were made to the guide 
based on this feedback. In response to the progression of the global pandemic and 
resultant public health response, additional items related to the pandemic were added to 
finalize the guide (Appendix A). 
Data Collection Procedures 
Prior to beginning the recorded interview, participants were asked to answer 
questions relating to their demographics and caregiving status: age, race, ethnicity, 
gender, education level, marital status, duration of being a caregiver and their 
relationship to the family member with ADRD. This information was entered and stored 




in REDCap (Research Electronic Data Capture), a secure web database electronic data 
capture platform hosted by the University of Michigan (Harris et al., 2009). 
Semi-structured interviews were digitally recorded using the audio recording function 
on Zoom. Interviews were stored in a secure Shared Account folder using a designated 
institutional Box.com account. Interviews lasted from 35 to 90 minutes with an average 
of 60 minutes. The PI led the interviews, using the semi-structured guide (Appendix A). 
Participants were recruited and interviewed until data saturation was reached. 
Data Analysis 
Descriptive statistics (frequencies, percentiles, means, standard deviations (SDs)) 
were used to analyze demographic data of the 21 caregivers. 
To analyze interview data, audio recordings were transcribed verbatim using a 
transcription service. Two individuals checked transcriptions for accuracy. One interview 
included two primary family caregivers that participated together as a couple, in this 
case the unit of analysis was the transcript as a whole. All transcripts were analyzed 
inductively and iteratively using content analysis and constant comparative methods by 
a 3-member coding team (Glaser & Strauss, 1967; Strauss & Corbin, 1990). Three 
coders read the first 5 transcripts independently and identified minor themes that 
emerged from each of the transcripts. The minor themes were compared among the 3 
and discussed until consensus was reached about the minor themes. Two coders then 
independently identified minor themes that emerged from the next 5 transcripts and 
discussed until consensus was reached about the minor themes from the first 10 
transcripts. One coder (Harris) reviewed the final 10 transcripts and identified minor 
themes, which were discussed with the analytic team to finalize the minor themes 
across all transcripts. 
Considering the minor themes within and across the interviews, 2 coders then 
independently grouped the minor themes that conceptually clustered together into major 
themes. Analysists met over a series of meetings to compare and reach consensus 
regarding minor theme clusters and names of major themes. Discrepancies were 
resolved through consensus. Steps were taken to maintain rigor and reduce bias in the 
analysis by cross-checking transcripts with recordings, verifying emerging themes with 
review of transcripts by a 3-member coding team, maintaining records of the iterations 




of the coding process, and by using direct quotes from participants to describe and 
define themes (Mays & Pope, 1995). 
Findings 
Participant Characteristics 
Of the 21 participants, the majority were female (n=17; 81%) and non-Hispanic white 
(n=20; 95%). The average age was 66.2 years (SD=8.7). Nineteen participants reported 
education levels of some college or above. Most of the participants were caring for a 
spouse (n=17), while 4 were caring for a parent with ADRD. 
On average, participants reported being the primary caregiver for approximately 3 
years and reported providing 84 hours (SD=55.9) of care a week to their relative with 
ADRD. Relatives were diagnosed with Alzheimer’s disease (n=9), vascular dementia 
(n=1), mixed-type dementia (n=2), frontotemporal dementia (n=1), Lewy body dementia 
(n=7), posterior cortical atrophy (n=1). 
Minor and Major Themes 
Minor themes that emerged from the data clustered into 10 major themes including: 
1) Emotional and psychological experiences of the caregiver, 2) Emotional and 
psychological experiences and responses of the person with ADRD, 3) Cognition of the 
person with ADRD, 4) Loss, 5) Anticipation, 6) Reliance, 7) Learning to caregive, 8) 
Rewarding, 9) Caregiver perspectives, 10) Care strategies (Table 3.1). 
Major and minor themes are presented in Table 3.1 and in the narrative below, along 
with illustrative examples from the data. Major themes are indicated as bolded, italicized 
headings and minor themes are underlined in the narrative. Minor themes highlighted in 
dark gray in Table 3.1 relate to the pandemic specifically and address Specific Aim 2 of 
this study.  





Themes and Quotations from Family Caregivers of Those with ADRD Living at Home 
Major Theme: Emotional and Psychological Experiences of Caregiver 
Minor Themes*                                                                                       Example Quotations 
Loneliness related to dementia It’s just challenging the whole day especially when you’re stuck in a house, it’s raining, no support anywhere in sight for the 
next 24 hours. 
Frustration Sometimes it can be a frustrating day. She can be accusatory so I would try to retaliate “Damn it. I didn’t say that. That’s not 
what I said”. 
Stress Juggling six balls in the air with details. This for me right now is the stress of the constant unending flow of details to attend 
to be it car insurance, be it healthcare changing over, be it a credit card getting hacked, be it whatever comes up which 
there are many, many things and, uh, I keep getting them. 
Fatigue I’m also more willing to order food in than I ever used to. I just have so much more on my plate and I just get exhausted. I’ ll 
say “Let’s go get some food from somewhere and bring it home”. 
Feelings of being judged I’m not going to, you know, deal with someone’s opinion negatively about my wife, so I’m not going to take her anywhere 
and put her on display, you know. I don’t know how she’s going to be. 
Reflection on early stages of 
dementia 
Well, I didn’t see any of these things as Alzheimer’s. I mean I had worked in the aging field all my life and I didn’t see any of 
the signs of Alzheimer’s, you know, cutting the wrong piece of wood, not getting along with your coworkers. I totally missed 
it. 
Feelings of isolation related to 
pandemic 
We just can’t engage in life anymore. We’re just huddled hiding in our house from this disease, trying to survive it as best 
we can.” 
Neutral feelings about pandemic Yeah, so COVID-19… so one thing I’m saying and before that… a lot of people have found this profound change in their 
lives because of COVID, but we have been living that life for the last almost three or four years since the diagnosis. 
Major Theme: Emotional and Psychological Experiences and Responses of Person with ADRD 
Minor Themes*                                                                                       Example Quotations 
Loneliness related to dementia People with dementia are still socially isolated, COVID aside. You know, they’re still going to be home wishing there were 
people they could interact with. 
Frustration He is not angry like he used to be. He’s rarely bubbling. He stays in the low frustration. I mean he doesn’t stay there all the 
time but when he goes up, it’s mild frustration. It doesn’t go to the boiling point, and it doesn’t go over. 
Anger/agitation He was so angry and having these terrible fits of anger, and um, was pushing me. He was throwing things and storm out of 
the house. Um, it was very difficult especially at night he would do these things. I understand he would wake up not knowing 
where he is and be scared and it would go into anger. But it was very hard for me and I would get mad back at him. “Don’t 
you push me” and all this kind of stuff, which I think I have a right to say but also didn’t have, you know. 
 
He’s so focused. He has to be angry, angry, angry and work it out and then it’s done. Like he can’t stop midway. And so, I’m 
not sure he can stop midway. 
Anxiety Anxiety has been part of his life for his whole life. He’s learned ways of dealing with it. He was more effective at it before he 
started getting dementia. 
Delusions He’ll recreate whatever story he needs to help him understand it. So if I’m telling him he can’t do something, uh, he’ll say 
“Well, when you go home and my wife comes here to take care of me, I’ll see if I can get her to do it.” Um, so he simply 
creates a second one of me that’s kinder and gentler to him. 
Hallucinations One of the hallucinations he had was probably a few years ago now was he saw a gorilla in our den, and I kid him and 
always say “I hope it was a hallucination or we have a much bigger problem.” 
 




He’ll say “Where did he go?” (giggle). And I’d say “Who?” He’d say “You know, the guy that was across the table from us.” 
Um, and sometimes he won’t tell me but it’s clear that he’s thought someone was there. 
Paranoia Back in November was the first time I was aware of how paranoid he was and how he was able to recreate a reality that 
had nothing to do with my reality 
Depression She’s very emotional, depressed. I think she has a realization that the prognosis is not good. 
Lack of interest There’s a number of things we used to do that we don’t do anymore because she just doesn’t seem to have an interest in 
them. 
Lack of filter (acting in a way that is 
socially inappropriate in certain 
situations) 
Sometimes when we go out though she says things that are just really inappropriate in kind of a loud voice like if someone’s 
really tall or if someone’s kind of heavy or if someone has a lot of tattoos, you know, she’ll just make a comment and it’s not 
quiet and it’s really embarrassing. And I don’t know if people hear it or if they just ignore it or what, and I’m never sure what 
to do, um, except that I whisper to her, you know, like “please, let’s not talk about that right now. 
Repetitive behaviors Like when he washes his hands, it’s just like… Well, you know, probably with the COVID thing, you’re supposed to wash 
your hands for 20 seconds and that feels like forever counting to 20. Now, stand there and watch him do it for three minutes 
Hiding things I can’t leave papers around, bills because they’ll disappear, he will grab them and hide them, so as soon as I see anything, I 
snatch it up. 
 
He likes to hide stuff and tuck things away. So, he tends to lose things and can’t remember where he put it. He’s always 
been like that like hiding his money. But now he can’t figure out what he did with it. 
Sleep disturbances He’s been dozing off at the table at meals for quite a long time which I just attributed to he’s not sleeping well. I’m beginning 
to recognize it’s really a common symptom of Lewy body. 
 
He gets tired very easily now. He can sleep 11 hours at night and still take a 2 hour nap in the afternoon 
Feelings of isolation related to 
pandemic 
He always wanted a crowd of people around. But, of course, I learned to enjoy that and now it’s very hard because he still 
wants to invite everybody over and I have to keep explaining to him because he doesn’t remember what the COVID thing is.  
Major Theme: Cognition of Person with ADRD 
Minor Themes*                                                                                       Example Quotations 
Decreased awareness in general He doesn’t recognize his house anymore where he lived for over 20 years. He doesn’t know he’s in (stated city name). He’s 
lived in my house for a year. Every day he asks me where’s the bathroom still. 
Impaired decision making He was driving during a whiteout and he started driving on the wrong side of the road. I think he had his brights on, which is 
not a problem for you. It’s a problem for the other drivers. And he said “Well, it doesn’t matter. It doesn’t matter that it’s 
bothering them but I’ve got to be able to see.’ That was not characteristic of him. I mean the whiteout yes but ordinarily, he 
would stop and say ‘I can’t see anything and this is really dangerous driving. I’m going to have to pull over or something.’ 
instead of saying ‘Well, it doesn’t matter if this bothers anybody else’ and just want to keep going. 
Impaired comprehension About nine years ago we were at my son’s who lives in California and we have some other friends out there, and I wasn’t 
there so I heard about this, but they apparently… somebody took out a new game, like some kind of card game, and 
wanted to play. And he could not get the rules and instead he just made fun of it. He made it into a big joke. And it was 
significant enough that people told me about it when I got back that evening. 
Pandemic impact on dementia 
progression 
His cognitive decline was he was hanging in there and since we started quarantining, he has just plummeted in many ways, 
physically and cognitively. 
Impaired awareness of pandemic  I don’t really think he understands what’s going on. He just understands that it’s affecting him by him not being able to do 
the things that he likes to do. 
Major Theme: Loss 
Minor Themes*                                                                                       Example Quotations 




Loss of independence (caregiver) Well, I would say that it limits my ability to do things for myself and that, uh, you know, I just can’t run up to the store and 
leave him home. I can’t. I’m afraid he’ll wander if I do that. So, it just really limits your personal freedom to care for an 
Alzheimer patient. 
Loss of independence (relative with 
ADRD) 
You know, it just changes everything and we’re really not equals in our marriage anymore. He’s not capable of being 
independent. 
Loss of socialization (caregiver) And friends, um, having someone with dementia is very socially isolating so we had a pretty good circle of friends or several 
circles of friends, and for the most part, they’ve dropped away except there’s really one family and maybe my own family. 
Loss of socialization (relative with 
ADRD) 
I am a little PO’d that nobody reaches out to him, you know. That makes me sad. So then what does that do in terms of the 
impact of his day? He waits. He waits for me. He waits, he waits, he waits because people living with dementia frequently 
have a hard time initiating new things, activities. And so, if I’m busy working, he sits. 
 
It’s not like she has a cold. You’re not going to get it. I know we’re concerned about the COVID thing but, you know, prior to 
COVID you could hug her. You’re not going to get Alzheimer’s. I don’t know why certain people aren’t around. 
Loss of sense of self in relative with 
ADRD 
He redesigned the Hubble telescope for NASA. I mean he is a smart, smart, smart, smart man and was well received in 
doing what he did in his life. And to then be reduced and I used that word… I wouldn’t use it if he was here, but it’s very 
frustrating for him, and it’s frustrating for me too. 
Loss of pre-dementia relationship 
dynamics 
As the child, it’s not always easy to say, you know, “You shouldn’t be buying that” or “You shouldn’t be acting like that” or 
“You shouldn’t”… so taking more of like a parent/guardian role and speaking up is hard. 
 
Because in a relationship it’s 50/50. Yeah, I’ll cut the grass. You cook the dinner. I’ll wash the car. You go shopping, or vice 
versa, but you can’t delegate nothing no more. You are it, and you get bitter sometimes because you’re tired. 
 
Loss of pre-dementia relationship 
roles 
And he was very good about noticing what needed to be done and making sure it was repaired. It was kind of his territory 
so I didn’t… I could kind of ignore a lot of stuff because he would take care of it, and I can’t ignore anything now. 
 
We used to be two chiefs in this family. We both wanted to do things our own way and so we would, um, you know 
squabble about a lot of things about who’s deciding and who’s going to do it their way. So, I’m the only one making the 
decisions now. 
Loss of socialization due to 
pandemic (caregiver) 
I miss going out with my friends. I miss my, you know… not that I went out that much but I just hold back now because I 
cannot afford to bring that back into the home, you know. 
Loss of socialization due to 
pandemic (person with ADRD) 
So, she doesn’t really remember that kind of stuff, but I know that she realizes that she’s had fewer visitors than she did 
before COVID. 
Loss of activities and outings due 
to pandemic 
Pumping gas, ordering food at a restaurant, you know, being in a used clothing store, you know, looking for fun T-shirts, you 
know, returning things, picking up prescriptions. I just tried to keep him engaged in actual life in addition to his groups. Well, 
I can’t keep him engaged in life anymore. He just watches TV.  
 
I think it has bothered him the fact that we have not been able to attend church services. I think that has really bothered him 
a great deal, but I refuse and he refuses to go and did during that time and even continuing not going because we both are 
fearful of getting it and we both know one or the other cannot get it because that would be a nightmare. 
Loss of dementia related support 
programs due to pandemic 
I was setting him up for an adult daycare program just as this thing started and they all closed. It would have been great for 
me and for him to have that, you know, and who knows if we’ll ever be able to do it because it seems to me… I’m not too 
knowledgeable about these things, but he seems to be progressing pretty quickly so he may not be able to use one of these 
programs by the time they open. 
 




What minimal support we had, you know, we can’t go to Alzheimer’s meetings, right. We can Zoom but she can’t Zoom 
because why? Because she can’t see, she can’t hear. It leads to frustration for her so I don’t participate in that. So, there’s 
whatever little support is nil. 
Loss of access to resources due to 
pandemic 
I go to Costco and try and buy Depends. In the beginning, I wanted to buy a whole bunch of boxes so I don’t have to go out 
a lot. They limit you to two, which it’s just stressful to be out there worrying about catching it, bringing it home, dying from it 
Major Theme: Anticipation 
Minor Themes*                                                                                       Example Quotations 
Of disease progression So, what I’m seeing now is a little anger, a little depression. It’s a little. It’s not a lot and it’s not out of control by any means, 
but um, you know, that just causes concern. Where are we going here, you know? Is this it or is this going to get worse? 
 
Knowing that it’s going to get continually worse is the hardest part for me. 
Long term care planning He’s on the waiting list for the Veteran’s Home so if it happens one year from now or five years from now, I know he’s going 
to have a place to go.” 
End of life planning I’m going to love him to death both in terms of loving him beyond belief and then loving him until he dies, and I want him to 
die here at home. 
 
Our legal affairs and our financial affairs are all in order but uh. So, we’re always looking forward to make the care easier at 
the end. 
Of unexpected changes It has slowly but surely taken over our lives. We were at a point where we were really starting to talk about, you know, what 
life would be like when we retire and we have grown children so we’re super proud of them and visit them whenever we can 
and they come home whenever they can. It really stopped that momentum kind of forever, um, because we don’t really 
know what the future holds. I mean I can sort of predict and it’s not pretty so it stopped… it really stopped our lives in a slow 
progression. 
 
It’s like not just advanced care planning. It’s about how to live your life the fullest today. Today’s today but what’s going to 
happen tomorrow because you know there’s going to be changes. So, how will we talk about that change before it actually 
happens. 
Of pandemic effects on dementia 
progression 
But even now, I wonder what it’s going to be like when COVID goes away and he hasn’t drove as much and he hasn’t been 
as social at church, and he hasn’t done his choir. And like for right now he’s bored and he’s not very motivated but what’s 
going to happen… I don’t think that’s going to go away. I just think it’s going to get worse. 
Of caregiver or relative with ADRD 
getting COVID-19 
If one of us got COVID, we would never survive that. So, I’ve made a decision that if I get COVID, it’s in my daughters’ 
hands and that I will model for them how I want him cared for and, hopefully, they can do that because no one is going to 
take better care of him than me. 
 
I have to tell him, we cannot do any of these things because that’s the quickest way to attract and bring that home with us 
and we cannot do it because we would not have a caregiver. If I come down with it, who would care for you? 
Pandemic effects on care planning First of all, you can’t plan anything. There’s nothing you can plan under COVID. There’s nothing. You can’t plan for the 
future. You can’t even usually plan for the day. 
 
That whole plan I had of caring for him so that he didn’t have to go into memory care I could handle it, you know with help, 
has all changed. 
Major Theme: Reliance 
Minor Themes*                                                                                       Example Quotations 




Of relative with ADRD on caregiver 
to address physical needs 
He’ll have a bite of something and then he won’t have any more and I will sit there and start feeding him bites. I mean even 
six months ago he would have… the fact that I’m feeding him, he would never do that before. 
Of relative with ADRD on caregiver 
to manage new responsibilities 
He’s a runner. He used to be on the city track club board. He was a major player in organizing like community events and 
those were his friends and now I do the communication with those friends if they want to get together to run, and he’s off all 
those responsibilities. 
 
When he was in a major role, um, I became his advocate to help explain the things that he could do still. So, I would say 
he’s still involved in service projects and I might be his interpret… I call it his cognitive interpreter. So, I will kind of say he’s 
really good at this or, um, I may reword something because I know he may not have understood what they’re asking him to 
do but it might be a two-step and I may break it down to a one-step. 
Of relative with ADRD on caregiver 
to maintain safety 
I can leave him alone yet for periods of time, but I certainly wouldn’t go away for the whole day. If I were gone away most of 
the day, he might venture into trying things or doing things that aren’t the best choices for him and there would be more of a 
chance he’d get hurt. 
 
Well, I’ve got to be very vigilant because no matter what I do she will fall somewhere along the line so I don’t want that to 
happen. You cannot take your eyes off her. So, a fall I think is inevitable as hard as I work to prevent that. Then it’s the 
beginning of the end, right? So, you fall, god forbid you break a bone, you’re admitted, you know a urinary tract infection, 
you know, pneumonia, bedsores, sepsis, septic shock, you know, so. 
 
I can’t leave him with the grandchildren if we’re in a babysitting situation or even if we’re there visiting if he wants to go 
outside with the children, I’ve got to be aware of what’s going on. So, him not being able to be responsible for children is a 
challenge too. 
Of others on caregiver (multiple 
caregiving demands) 
We had a neighbor die this summer and his birthday is today. He would have been 71 and his wife is at the same kind of 
stage that my husband.  She couldn’t take him to the hospital so I had to and I became her cognitive interpreter talking 
through palliative care and when to take him off the vent and everything and involving the family. So, that’s kind of where I 
learned and I said “I’m her cognitive interpreter and I’m a nurse” so I could help explain, breakdown what was going on with 
him, so. That was another caring role I took on this year. 
Of relative with ADRD on caregiver 
to maintain COVID-19 precautions  
Caregiving during the pandemic… well, one of the things to be more watchful about are these changes in routines about 
things to do safely like wear a mask, wash your hands, etc., maintain social distance. I had to be constantly vigilant with him 
about doing that and actually we had one experience where he didn’t which caused me to pretty much have a total 
meltdown because I hadn’t realized his forgetfulness about wearing a mask or maintaining social distance. Of course, I 
knew that put him at risk and if he’s at risk, I’m at risk because we live together. Um, but that was a real game changer for 
me in that I didn’t… hadn’t appreciated the additional risk we were at. I don’t think that event changed our level of risk it just 
changed my appreciation for the risk that his condition would cause to us. 
Major Theme: Learning to Caregive 
Minor Themes*                                                                                       Example Quotations 
Experiential learning Well, for me, it’s learning by fire and I guess at first it’s kind of uncomfortable talking about the disease. So, I’ve learned to 
be more open with him and talking about you know you’ve got Lewy body and that this is happening or that’s happening. I 
don’t know if he understands it all the time, but at least more openly talking about you have something that’s causing you to 
do that. I’m not just, you know, being mean. I’m doing this to try to help you. 
Learning from others I worked with a lot of families through my job who had somebody with dementia. I wish they were around now because they 
loved me and they thought I was so great and did all this stuff for them, but little do they know, I learned from them for what 
we are going through now. 




Learning to be flexible When I know that I’m rested and taken care of I can be very affirming and positive and know not to ask certain questions 
that can’t be answered because being able to keep on my toes and one step ahead is kind of the name of the game. 
Learning to be patient It’s a loved one and, unfortunately, she has no control. And you have to be understanding but you have to be beyond your 
wildest imagination patient. 
Major Theme: Rewarding 
Minor Themes*                                                                                       Example Quotations 
Increased togetherness due to 
dementia diagnosis 
He’s probably heading towards the end of his life so the up side is we’re getting to spend some quality time with him that 
you wouldn’t normally get. 
New opportunities It did great things for him, and um, then it also opened up this social opportunity because we had never been to a dog show 
and we put her in dog obedience and, you know, won of course. So, our dog trainer, she loves it because now she does our 
dementia stuff. Whenever we do a dementia training, she does our dementia stuff. And she’s like “I opened the dog world 
up to you and you opened up the dementia world to me. 
 
I keep thinking of taking a picture of him and sending it to the fellow that heads up the brain bank and telling him he’s 
keeping it warm now because you’re going to keep it on ice for a very long time (laughing). We try to have a little humor 
about all of this, but uh, he feels… He’s going to be able to literally keep doing something after he dies. How many people 
can say that? That he may literally do the most important thing he’s done in his entire life after he dies, you know, I mean 
it’s a pretty amazing things. 
Greater appreciation for the little 
things 
The other day we were out on the patio and she was just spontaneously starts dancing. We were playing the 60s and 
Motown music and it was cute. I took a couple of videos and sent it to people. She did it for 20 to 30 minutes and so that 
was nice. 
Opportunity to care for loved one Just being there for him. I think in some ways just helping him, um, helping him with things and making him feel good about 
himself, you know, especially when he’s kind of down or something to just be there for him. 
 
I guess rewarding or fulfilling for me is that when I am able to help him and he recognizes that that help is valuable and 
really appreciates it. He’s becoming as I see it more dependent on me and, um, he knows it. Again, he knows it and 
appreciates it, so 
 
The best is that I’m still able to take care of him at home, uh, you know, other than the five hours that I’m really doing some 
very direct caregiving, uh, we’re living in the same house that we’ve lived in for over 20 years and it’s familiar and there’s 
still a lot about him that’s familiar from time to time less, but generally more. Uh, and we’ve had a really nice life together. 
Increased togetherness due to 
pandemic 
The pandemic has given us an opportunity to be really close with one another and have more conversations. 
Simplification of caregiving process 
due to pandemic 
Of course, doctors’ appointments are great now that everybody is doing teledoc appointments. It’s almost easier for him 
because he would get very nervous because it’s something new. He would get very agitated when we’re going out or doing 
something that he’s not sure of what we’re doing. So, it makes it easy now. We’re sitting on the couch. The doctor chats 
with (stated first name) for a minute or two and then we can talk away so that’s been really helpful. 
 
Ironically, in some ways it makes it easier because before the quarantine went into place, he would want to go to the 
bookstore or the grocery store or the mall to do stuff and, frankly, his executive ability was so impaired that it was a matter 
of, um, just being indecisive. He’d get to the bookstore and he’d look at books for two or three hours until I would finally say 
“We need to go home and make dinner.” Um, and now, I can say “Barnes and Nobles is closed. Sorry.” 
Major Theme: Caregiver Perspectives 
Minor Themes*                                                                                       Example Quotations 




Views on caregiving Being a nurse helps. Over the years, I saw people who were navigating changes in their life and I think in my 20s as a 
nurse with spinal cord injuries, burns, multiple trauma, I learned that, hey, life is fragile and we don’t get to pick what gets 
thrown our way, and so um, I think that has helped me because even being a psych nurse helped me realize that navigating 
change is critical. Um, I used to love the saying normal is just a setting on your dryer. 
Views on long term care I started thinking I am never going to put him in a memory care facility, ever, which is why I bought this small condo retro 
kind of fitted for a wheelchair person that was there before because I was going to go home and have my family members 
help me because I decided that I was never putting him in memory care. 
Views on person with ADRD’s pre-
dementia characteristics  
Uh, in his own personality he is a person that within our marriage faces outward instead of inward, and he’s been that way 
with the family and, you know, so that has really exacerbated with the disease because it’s my understanding that they turn 
in on themselves even more. 
 
Now, that may seem weird but he has core goodness about him. And, for example, he won’t have a penny on him. Before 
COVID, we would be out. His wallet just had his ID and his emergency card for EMS people, and he would see a homeless 
person and he would like immediately grab for his wallet. 
Views on virtual resources during 
pandemic 
It strips away everything from you but just trying to do Zoom, and I don’t think he comprehends Zoom and who’s on the 
other end. I just don’t think it’s an interface he really connects to, the computer anymore. 
Views on social distancing during 
pandemic 
Well, being in the quarantine for 90 days was difficult but, in all honesty, I’ve lightened things up a little bit. Have I become 
foolish? Am I going to large gatherings?” No, but we walk on Wednesdays with a small group of people.  
Views on pre-pandemic degree of 
socialization 
A lot of people have found this profound change in their lives because of COVID, but we have been living that life for the 
last almost three or four years. In the initial three years of her disease, you know, we were able to travel and visit friends, 
family and everything but since 2015 we are mostly homebound. 
Major Theme: Care Strategies 
General Management Strategies 
Minor Themes*                                                                                       Example Quotations 
Self-care for caregiver I tell myself every day this; I just need to unplug and I do that. He goes to bed every night at nine faithfully, and I just stop 
everything and I sit down and I read a novel. 
Self-care for person with ADRD My husband has taken it upon himself to write a blog, and um, it’s based, um… It’s loosely based on his faith, Christian 
faith, and it’s interesting. It’s his thoughts with dementia and in one of his blogs I have an expiration date or I know my 
expiration date which is interesting. So, he at least has somewhat of a healthy attitude. 
Um, he has told me he’s reading up a lot lately on caregiving and how hard caregiving is and maybe that’s helped him too. 
 
Reorient person with ADRD The other thing that I started months ago that is clearly useful is, uh, we have a big whiteboard in the library and every 
evening I go in and write down what tomorrow’s activities will be including what’s for breakfast and what’s for dinner. Those 
are the things he can respond to and appreciate 
Incontinence care There were two different kinds of Depends. Some that are better for the short term and some that are called Nighttime 
Depends. And I just stopped ordering the daytime ones so he just wears the nighttime ones and changes them whenever 
he needs to, wants to, thinks it’s a good idea, and again, we have the financial resources that, you know, I can do that. 
Maintain routine I’m kind of a schedule oriented person and a routine oriented person so coming up with one that fit us both was something I 
did from the very beginning and I think it’s very helpful. 
Humor So, um, he sometimes sees two of me and I tell him that’s my evil twin. We kid about my evil twin. Sometimes he says “You 
know, your evil twin is kind of cute.” I said, “Well, she’s my twin, you know.” So, we kind of kid about it. It helps, you know, it 
puts it into perspective. 





I use a lot of humor repetitively as a measuring tool to see where he is, and um, that’s just like an example of the humor I 
use. I use a lot, a whole lot of sexual humor because, uh, I think men respond to sexual stimuli even an Alzheimer man. 
Support from healthcare providers I would advocate for training in medical schools for doctors because I have not had positive experiences with the doctors, 
um, and they don’t seem to know how to handle a person with dementia, or how to care for them.  
Respite care I tried taking him to an adult daycare, and I could see he was quickly spinning out of control. I didn’t realize how he just 
hated that place so anytime we go anywhere near that place, he starts getting so agitated now. He remembers that 
experience and he doesn’t like it. 
Virtual activities and social support 
programs  
We watched a concert. We have a band we like called the We Banjo 3, and they had a virtual concert last week or was it 
the week before? So, we watched that from here. So, that’s something that she can enjoy. It doesn’t require a lot of deep 
mental comprehension. 
Influence of pandemic on care 
strategies 
It made it all harder probably because he can’t go do the things he enjoyed doing, and I feel like that helped his OCD 
(obsessive compulsive disorder). You know, it made him more tired so he slept better at night. It just brought him joy. 
Care Strategies Related to the Emotional and Psychological Experiences of the Person with ADRD 
Minor Themes*                                                                                       Example Quotations 
Change caregiving perspective I talk in terms of Lewy being this third character that lives in our house. In fact, I actually use the words “There are three of 
us that live in this house now. You, me and Lewy, and the two of us have to work together to deal with Lewy.  
 
As opposed to saying to him “You’re not doing this. You can’t do this.” It’s like “Lewy is getting in the way of you doing this.” 
It puts a totally different spin on it from saying you can’t do it. 
Change caregiving behavior So managing it means managing me and managing sort of the environment or whatever it is that led up to it. 
 
When I talk to you about behavioral symptoms and signs of dementia, I see that fog and I can adjust myself accordingly so 
that he doesn’t have what people would say “those behavioral signs and symptoms” of dementia because I can adjust my 
approach to him. Now, if I’m not in tuned to it, we both pay the price, you know. 
Withdrawing from challenging 
situations 
I have little things… when I get sad or upset I, you know, I stay away from him for a few minutes and then I calm myself 
down and then I go back because he picks up my mood. 
 
I have to walk off. I have to because if I think continuing on with it is the answer to the problem, it is not. I say rule number 
one is give him space and walk off. 
Care strategies for anger/agitation Before COVID we started CBD (cannabidiol oil) and we had a night and day difference. I mean he has the frustration… but 
he doesn’t have the fearful, I’m so afraid of him anger. 
 
I think the most helpful thing is just waiting until he’s calm to go back and try to talk and, fortunately, he’s still okay enough 
to say “I didn’t realize I did that” or “I didn’t know I did it.” And “Is that really what happened?” And he trusts us. 
Care strategies for anxiety Our service dog Sophie is a huge… just the purpose of getting up, letting her go potty, training her. Yeah, and the sense of 
having her there he says it’s huge with his anxiety. He does not feel like he’s alone… 
 
He loves music. That’s been a really great thing. If I’m in my office doing work and he’s really restless, he’ll walk in my office 
to try to sort of see what I’m doing and, um, my son gave me some cordless… a cordless headset for my birthday and I love 
it because I can block him out. But he really likes wearing them so I find his favorite 80s music which brings back memories 
from college and he’ll sit down and he’ll listen to music. 
 




Yeah, one thing when she is really upset or something, we keep grapes handy, you know, and put grapes in her mouth or 
something. And what happens is that I think just the chewing, you know, the process takes her mind off whatever she may 
be, you know, so that helps. 
 
My wife loves to sit in the van. We have a Chrysler Pacifica. We always had minivan and somehow she loves to, you know, 
sit in the car so in a 24 hour day maybe she would sit in the car for one or two hours and that’s her time. She has her own 
time. 
Care strategies for paranoia “I’ve tried to be truthful. I’ll say, “I love you. I’m here for the journey.” “I’m not going anywhere.” “You leaving?” “No, I’m not 
leaving.” She’ll cry “They said you’re going.” “No.” And then if that doesn’t work being truthful, I’ll just go to the change the 
subject. You can’t explain and rationalize with them, correct? So, you just try to change the subject. 
Care strategies for sleep He takes a nap early, he’s often strikingly better for most of the afternoon and evening. 
Medications When he went on Seroquel, his hallucinations and his wanderings both subsided. 
 
I’m not going to drug her like...she’s her on Lexapro for anti-anxiety. And does it work? Who in the hell knows. Personally, I 
don’t. 
Note. ADRD Alzheimer’s disease or related dementias  
*Minor themes related to the COVID-19 pandemic specifically are highlighted in dark gray with white text. 
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Emotional and Psychological Experiences of Caregiver  
Caregivers described their own emotional and psychological experiences through 
stories and detailed narratives. This major theme is comprised of 8 minor themes 
experienced pre-pandemic: feelings of loneliness, frustration, stress, fatigue, feelings of 
being judged by others, and reflections on early stages of their relative’s ADRD (Table 
3.1). 
Caregivers described feelings of loneliness related to their relative’s ADRD 
diagnosis (Table 3.1). 
 
“I feel loneliness because of the dementia. I mean it changes everything. You 
know, it just changes everything and we’re really not equals in our marriage 
anymore.” 
 
Caregivers also provided examples of their feelings of frustration which linked to 
feelings of loneliness (Table 3.1). 
 
“The hardest part is probably my own impatience and my need to remind myself 
that this is the disease talking and not him talking. Sometimes he even reminds 
me of that when he’s got some insight, but otherwise I just get so frustrated that 
he’s not able to do the things he used to be able to do. Um, and at those points I 
feel somewhat alone.” 
 
They described how changes in their relative’s abilities often led to new 
responsibilities, which increased their feelings of stress and fatigue (Table 3.1). 
 
“I’m also more willing to order food in than I ever used to. I just have so much 
more on my plate and I just get exhausted. I’ll say “Let’s go get some food from 
somewhere and bring it home.” 
 
Some participants described situations where they felt judged by others (Table 3.1), 
which prompted efforts to protect themselves and their relatives from embarrassment 
when in public 
 
“I try to protect him a lot. I try to protect him from embarrassment and of being 







Caregivers reflected on how they responded emotionally to the early stages of their 
relative’s dementia (Table 3.1). 
 
“So, all those emotions happen, you know, some before… before, early on in the 
process is denial. Some people are in denial throughout the journey even after 
the person is no longer there.” 
 
They described many ways in which their experiences as caregivers were influenced 
by the COVID-19 pandemic. One caregiver said: 
 
“The COVID, um, concerns or the condition of having COVID in our lives is 
another layer of, um, things to cope with or manage or see your way through. 
Kind of every decision has a COVID overlay…” 
 
Most caregivers experienced feelings of isolation during the pandemic (Table 3.1).  
 
“Then with the COVID thing, it just kind of compounds it, compounds the isolation 
even more because we’ve been self-isolated for over three months.”  
 
Other caregivers described more neutral feelings towards they pandemic as the 
isolation they felt during the pandemic was less severe because they were already 
experiencing similar isolation due to the ADRD diagnosis. 
 
“I would wholeheartedly agree with that maybe because I’ve been prepped for it 
as this began and, therefore, the lifestyle had changed already when his 
dementia began. You know, my lifestyle changed back then already so it… the 
pandemic just didn’t do that much to change my life that drastically to be quite 
honest with you.” 
 
Emotional and Psychological Experiences and Responses of the Person with 
ADRD  
Caregivers described the experiences and responses of the person with ADRD 
without using the words symptoms or behaviors. Instead, caregivers described 
emotional and psychological experiences of their relatives, which in some cases were 
linked to certain responses that clinicians and investigators would consider BPSD. The 
stories and examples told by caregivers were often dynamic and reflected their 
relative’s thoughts, feelings, responses, and reactions to the disease, as well as to other 





analysis and the following narrative uses the terms “experiences” and “responses” 
instead of the clinical terms of “symptoms” and “behaviors”. This major theme is 
comprised of 14 minor themes: feelings of loneliness related to the ADRD, frustration, 
anger/agitation, anxiety, delusions, hallucinations, paranoia, depression, a lack of 
interest, a lack of filter (or acting in a way that is socially inappropriate), repetitive 
behaviors, hiding things, and sleep disturbances (Table 3.1). Caregivers also described 
their relative’s feelings of isolation related to the pandemic (Table 3.1). 
In addition to their own feelings, caregivers also described loneliness and frustration 
felt by their relatives with ADRD (Table 3.1). 
 
“I’m reading this diagnostic information and he and I are sitting together, not side 
by side, but where our knees were touching, and um, I read it and it was vascular 
dementia and a couple other things there. I was thinking we are physically 
touching but that we must be probably as far apart as any two people could be 




“I say he’s more frequently frustrated because he is now in a way, he has a level 
of awareness about the changes that are happening to him and not liking them.” 
 
Caregivers gave many examples of anxiety experienced by their relatives, such as 
separation anxiety, restlessness, pacing, panic attacks, loss of emotional control, worry, 
and physical complaints (Table 3.1). One caregiver described the following: 
 
“He gets anxious and panicky. He paces. He has a couple phrases he always 
says that don’t make any sense. He repeats them over and over and over, and 
he walks around the house. He goes outside. He’s just beside himself, um, and it 
is hard to deal with.” 
 
One caregiver described a distinction between a caregiver’s interpretation of anger 
in their relative, versus what the relative described as anxiety. 
 
“When I talked with the wives’ of these people living with dementia, and um, 
husbands or significant others, that’s when I discovered that the person living 
with dementia described it as anxiety. The care partner described it as anger. So, 






Anger and agitation were described as the most challenging responses for 
caregivers (Table 3.1), which often began with anxiety or frustration.  
 
“With his anger, there’s low level, there’s bubbling and then there’s overflow. We 




“I can help somebody eat. I can wipe a butt. I can do all that, but the anger and 
the insult is the hardest thing.” 
 
Caregivers described psychologic manifestations experienced by their relatives such 
as hallucinations, delusions, and paranoia (Table 3.1). Some caregivers described a 
disconnect with their relative that they felt due to paranoid delusions. 
 
“Back in November was the first time I was aware of how paranoid he was and 
how he was able to recreate a reality that had nothing to do with my reality” 
 
Many caregivers described how their relatives experienced depression and a lack of 
interest since the ADRD diagnosis (Table 3.1). Some caregivers attributed these 
feelings directly to the ADRD diagnosis. 
 
“The depression and the sadness, it came from the Alzheimer’s, being told he 
had Alzheimer’s. He was quite depressed about that and was worried.” 
 
“There’s a number of things we used to do that we don’t do anymore because 
she just doesn’t seem to have an interest in them.” 
 
Caregivers provided examples of when their relatives had a lack of filter or acted in a 
way that was socially inappropriate for the situation (Table 3.1). Some of these 
moments led to caregivers having feelings of embarrassment, or feelings of being 
judged by others. 
 
“Sometimes when we go out though she says things that are just really 
inappropriate in kind of a loud voice like if someone’s really tall or if someone’s 
kind of heavy or if someone has a lot of tattoos, you know, she’ll just make a 
comment and it’s not quiet and it’s really embarrassing. And I don’t know if 
people hear it or if they just ignore it or what, and I’m never sure what to do, um, 







Caregivers described specific habits that their relatives had that were once 
challenging for them (e.g., hiding things, repetitive actions) (Table 3.1), of which they 
learned to tolerate as they continued in their caregiving journey. 
 
“So, he had another habit of hiding… taking my things and hide them all around 
the house. Um, and it would just drive me crazy. And then, I just said, well, what 
the heck. He’s going to do it anyway.”  
 
Sleep disturbances experienced by relatives were described by most caregivers and 
included examples such as difficulty falling asleep, difficulty staying asleep, daytime 
sleepiness and fatigue, and restless sleep (Table 3.1). Some caregivers described how 
these sleep disturbances affected their own ability to sleep as they felt obligated to 
monitor their relative overnight to maintain safety. 
 
“He would wake up every two hours like clockwork and wake me up and want to 
get up and do something or just be angry for no reason or what was no apparent 
reason, so I wasn’t getting any sleep.” 
 
Related to the pandemic, caregivers that described their relative as someone who 
experienced challenging symptoms pre-pandemic often described how their symptoms 
had progressed more quickly during the pandemic:  
 
“It’s accelerated them you know, from COVID, that otherwise I don’t think he 
would have been experiencing them so quickly.” 
 
Meanwhile, caregivers that described their relative as someone who did not 
experience many symptoms before the pandemic described that the pandemic had not 
significantly affected their relative’s experiences during the pandemic:  
 
“I don’t think it’s affected him so much because, we just didn’t have any really 
challenging symptoms before.” 
 
Caregivers often attributed more pronounced symptoms and behaviors, as well as 
accelerated disease progression during the pandemic to the loss of socialization and 
activity for their relative due to pandemic related public health responses. One caregiver 






“I think if we were able to get out more, I think that he wouldn’t… it wouldn’t 
weigh so heavy on his mind.  He’d have other things to think about besides 
worrying about his ailments.” 
 
Cognition of Person with ADRD  
In addition to emotional and psychological experiences and responses, caregivers 
also described their relative’s cognition through descriptions of their decreased 
awareness, impaired decision making, and impaired comprehension (Table 3.1). One 
caregiver described:  
 
“The Alzheimer’s affected her ability to not be able to remember things but also 
not to comprehend what’s going on in her life and other people’s life.” 
 
The decrease in awareness sometimes influenced their relative’s emotional 
experience. 
 
“A lot of the times she’ll just sit on the couch and watch TV and kind of not be 
mindful of what else is going on and then it’s like she’ll have a little awakening 
and realize that she’s got a memory issue or an awareness issue and kind of talk 
about being frustrated by it and kind of get irritated by that fact.” 
 
Caregivers also described their relative’s lack of awareness of the pandemic 
specifically (Table 3.1), which impacted their ability to adhere to public health 
guidelines:  
 
“He doesn’t comprehend washing his hands, wiping his hands. He doesn’t 
comprehend the safety, the staying six feet from people.” 
 
They also noted the impact the pandemic had on their relative’s disease progression 
more generally (Table 3.1):  
 
“His cognitive decline was he was hanging in there and since we started 
quarantining, he has just plummeted in many ways, physically and cognitively.” 
 
Loss  
Descriptions of loss relating to the ADRD were very prevalent. Minor themes 





socialization (for caregiver and for the relative with ADRD), loss of sense of self in the 
relative with ADRD, and loss of pre-dementia relationship dynamics and roles (Table 
3.11). 
Caregivers described loss of their own independence, as well as the loss of their 
relative’s independence since diagnosis:  
 
“It’s pretty profound because not only does she lose her independence, you lose 
your independence because she needs 24/7 care.” 
 
Another caregiver said: 
 
“It limits my ability to do things for myself and that, you know, I just can’t run up to 
the store and leave him home. I can’t. I’m afraid he’ll wander if I do that. So, it 
just really limits your personal freedom to care for an Alzheimer patient.” 
 
The also described a loss of socialization, for both themselves and for their relatives 
(Table 3.1).  
 
“This is a very strange thing, you know, the people you know, the people you 
thought who very close. Somehow they’re not in your life anymore...” 
 
Caregivers gave examples of how their relatives experienced a loss of their sense of 
self since diagnosis (Table 3.1). 
 
“So, it’s unfortunate because she’s always considered her mind to be her 
greatest asset and that’s gone.” 
 
As reported by another caregiver: 
 
“He’s just pulling inward more which is… he’s not that kind of person. He’s more 
out… he’s an outgoing person.” 
 
Others described a loss of a previously known relationship roles and relationship 
dynamics since their relative’s diagnosis, which posed many challenges as caregivers 
often had to take on new responsibilities (e.g., paying bills, managing all the household 
chores, home repairs) (Table 3.1). 
 
“Um, well, I mean it’s not easy, it’s making that shift of me as a partner, a 






Another (adult child of the person with dementia) said: 
 
“As the child, it’s not always easy to say, you know, “You shouldn’t be buying 
that” or “You shouldn’t be acting like that” or “You shouldn’t”… so taking more of 
like a parent/guardian role and speaking up is hard.” 
 
Caregivers described a loss of socialization related to the pandemic (Table 3.1). 
Many said that the pandemic related restrictions exacerbated the loss of socialization 
that they already felt due to their relative’s ADRD. Descriptions of loss of activities and 
outings were common, such as loss of social activities, travel, religious services, and 
family gatherings (Table 3.1). Caregivers described loss of physical activities and 
exercise, which impacted their own and their relative’s overall health and well-being 
(Table 3.1). 
 
“He can’t go do the things he enjoyed doing like walking and going to the gym, 
and I feel like that helped his OCD. You know, it made him more tired so he slept 
better at night. It just brought him joy.” 
 
The most often mentioned lost outing was the opportunity to go out to eat at 
restaurants, which was a significant social activity for many caregivers and their 
relatives with ADRD. 
 
“One thing we used to go out to eat a lot and that was socialization for me, you 
know, just talking to the wait person a little bit or being just out. And he enjoyed it. 
It was an outing, you know, and we can’t do that anymore.” 
 
 Many described loss of access to dementia related support programs, such as adult 
day programs, support groups, and caregiver wellness programs, in addition to a 
general loss of access to resources (Table 3.1). These losses compounded challenges 
dyads were experiencing prior to the pandemic and presented new challenges to in-
home care during the pandemic. 
Anticipation  
Caregivers gave many examples of anticipation of their relative’s disease 





end-of-life planning (Table 3.1). Anticipation of disease progression and of unexpected 
changes was a concern for many caregivers:  
 
“Uncertainty as to how this disease will progress over time is a great source of 




“It has slowly but surely taken over our lives. We were at a point where we were 
really starting to talk about, you know, what life would be like when we retire and 
we have grown children so we’re super proud of them and visit them whenever 
we can and they come home whenever they can. It really stopped that 
momentum kind of forever, um, because we don’t really know what the future 
holds. I mean I can sort of predict and it’s not pretty so it stopped… it really 
stopped our lives in a slow progression.” 
 
These concerns about the future prompted the need for long-term-care and end-of-
life planning (Table 3.1). 
 
“In preparation, we did visit some senior communities. So, we did that together 
because I said I could be the one that has the stroke and you could need 
someone to cook for you, you know, because I take on most of the cooking. So, 
we had done some planning and we both decided that as long as we’re 
physically able we love staying in this house.” 
 
Caregivers anticipated the pandemic’s effects on their relative’s disease 
progression, as well as what would happen if they or their relative contracted the 
coronavirus (Table 3.1).  
 
“I think, that it’s going to shorten my husband’s life significantly. I don’t think that 
the world, or political powers are looking at the half-life of this stuff and the fallout 
and how long it’s going to last.” 
 
In general, caregivers described that the pandemic greatly inhibited their ability to 
plan for future care of their relative:  
 
“First of all, you can’t plan anything. There’s nothing you can plan under COVID. 








Caregivers described many ways in which their relatives with ADRD were reliant on 
them as caregivers. Their relatives were reliant on them to address their physical needs, 
to manage new responsibilities, and to maintain safety before and during the COVID-19 
pandemic (Table 3.1). This reliance often inhibited caregivers’ degree of independence.  
 
“You know, I have to get dressed. She has to get dressed. I have to wash. I have 
to wash her. I have to feed her. She can’t be a participant in a collaborative 
effort.”. 
 
“From time to time, I just have to quit work during the day and do something 
because he needs something or wants something or he just needs some 
attention.” 
 
Reliance on the caregiver to maintain safety was prevalent across interviews, which 
increased the caregiver’s level of responsibility. 
 
“I can leave him alone yet for periods of time, but I certainly wouldn’t go away for 
the whole day. If I were gone away most of the day, he might venture into trying 
things or doing things that aren’t the best choices for him and there would be 
more of a chance he’d get hurt.” 
 
Caregivers also described the challenges of having multiple caregiving demands:  
“I also watch my two grandkids all summer a couple days a week so it was 
bringing them up here and having the kids here and my dad here and trying to 
have all that activity and stuff. The kids would go one way. He would go another 
way. That was challenging.” 
 
The pandemic posed new challenges to care outside the home, as relatives with 
ADRD were often reliant on their caregivers to maintain COVID-19 specific safety 
precautions (Table 3.1). 
 
“Making sure the mask was with us when we went places; making sure we don’t 
separate from each other just because social distancing isn’t comprehended very 
well and to go places I have to be a supervisor of that.” 
 
Learning to Caregive  
Many caregivers described the process of learning to caregive as an experiential 






“It’s like having a kid. It’s like having… even though I don’t have children, you 
know, no one ever gives you the manual of how to do all these things, and you 
just kind of learn on the fly.” 
 
“I’ve learned the most is by talking with our group of eight people who have 
dementia and hear from them specifically what it’s like to have dementia.” 
 
Flexibility and patience were identified as important aspects to learn to be a 
caregiver for a relative with ADRD (Table 3.1). 
 
“You know, the hardest part is, uh, you know, as she’s changing, you know, I 
have to keep changing myself. So, I can’t be fixed in my thoughts, my strategy or 
anything so every strategy has to evolve.” 
 
Rewarding  
All caregivers identified rewarding aspects of caregiving including increased 
togetherness due to the relative’s ADRD, new opportunities, and a greater appreciation 
for the little things in life (Table 3.1). Feelings of love and increased togetherness as a 
couple were prevalent. 
 
“I love our life and we have a great life. I’m happy. I think my husband’s happy 
most of the time too.” 
 
Examples of rewarding new opportunities since the relative’s diagnosis, such as 
personal growth, and opportunities to contribute to society were also described.  
 
“So, the disease has taught me that, you know, to come to some level of 
emotional acceptance and another thing I would say; just taking care of her it 
requires a lot of love and care and compassion so I believe I have become a little 




“But our mission really is to do as much education as we can, be as transparent 
as we can. You know, I don’t want people to have to go to the point that we did 
before you get a diagnosis. I don’t want people to think that life can’t be good 
after a diagnosis. And so, we’re just very much just seeking opportunities so I 






Caregivers described a deeper appreciation for the little things since the relative’s 
diagnosis. 
 
“The other day we were out on the patio and she was just spontaneously starts 
dancing. We were playing the 60s and Motown music and it was cute. I took a 
couple of videos and sent it to people. She did it for 20 to 30 minutes and that 
was so nice.” 
 
Many caregivers described the opportunity to care for a loved one as the most 
rewarding aspect of the caregiving experience. 
 
“Just being there for him. I think in some ways just helping him, um, helping him 
with things and making him feel good about himself, you know, especially when 
he’s kind of down or something to just be there for him.” 
 
Some caregivers also identified rewarding aspects of the pandemic, such as 
increased togetherness and simplification of the caring process (Table 3.1). One 
caregiver said: 
 
“I would say the pandemic made it easier because we don’t have other 
challenges to our simple routine.” 
 
Meanwhile others maintained that the pandemic was not rewarding to them, but it 
represented a major threat to the health of their relative with ADRD. 
 
“I think he’s declined, but I totally think it’s the lack of socialization and engaging 
in life that has exponentially caused his decline. It’s COVID in my opinion, totally 
COVID.” 
 
Caregiver Perspectives  
Caregivers held many views and perspectives that shaped their experiences and 
their caring process. They described views on caregiving in general, on long-term-care, 
and on their relative’s pre-dementia characteristics (Table 3.1). In terms of views on 
caregiving, one participant said: 
 
“Words mean different things to different people. So, my very first time that 
somebody called me a caregiver I felt like they called me a babysitter. I’m like 





about each other. We’ve been partners for a lifetime. We are partners. It’s not a 
one way giver.”  
 
This view was prevalent in many caregivers as they described the caring process as 
a partnership experience.  
Caregivers described their perspectives regarding long-term care (Table 3.1). 
 
“I am enabling her life to be better as compared to let’s say she was in an 
assisted living space. I think I can provide her a better level of care and love that 
she wouldn’t get there. Um, you know, and we’ve been married 49 years so, you 
know, after all that time you develop, obviously a closeness for the person you’re 
caring for as opposed to being somebody that you’re not related to.” 
 
They also gave many examples of their perspectives on how characteristics that 
their relatives had before the dementia diagnosis influenced their experiences with the 
disease (Table 3.1). 
 
“He’s a little farm boy from way back and so he never spent much time in the 
house in his younger years. He would be out in the woods on his ten acres 
picking up branches, building a fire to burn the branches, trimming things that 
don’t need trimming, you know, so it’s very difficult for him to just sit. He doesn’t 
want to watch TV. He doesn’t want to play cards. He doesn’t want to read a 
book. Today he said, “Well, if we could just get an old tractor, we could go out 
and rebuild it out in the garage.” You know, so that’s the kind of activity he wants 
to do. It can’t be done now, I guess.” 
 
Caregivers also held views related to the pandemic, including views on virtual 
resources, social distancing, and how their pre-pandemic degree of socialization 
influenced their experiences during the pandemic (Table 3.1).  
Views on virtual resources during the pandemic were mixed (Table 3.1). Some 
caregivers held negative views and described how they were not useful to their relatives 
or their caregiving experience. 
 
“What minimal support we had, you know, we can’t go to Alzheimer’s meetings, 
right. We can Zoom but she can’t Zoom because why? Because she can’t see, 
she can’t hear. It leads to frustration for her so I don’t participate in that. So, 
there’s whatever little support is nil.” 
 
Others said that virtual approach was not preferred, but they appreciated having the 






“My husband belongs to a discussion group that he used to go to every 
Thursday. Well, that’s still going but on Zoom now, you know. So, he still does 
that. Our synagogue has a lot of stuff on Zoom, so um. Yeah, we listened to a 
speaker last night on Zoom. Uh, so it’s really helped. It helps. Is it ideal? No, it’s 
not.” 
 
Caregivers held views on social distancing during the pandemic (Table 3.1), most 
described relatively strict adherence to social distancing guidelines.  
 
“So, with COVID in our house, um, we are almost like when we were in total 
shutdown like when you were supposed to stay home. We’re almost like that but, 
like I said, we don’t have our housekeepers come in anymore. Um, we don’t go 
anywhere. I’ve gone to the grocery store a couple of times but mostly I do the… 
order my food and they put it in my trunk kind of thing.” 
 
Many caregivers also described how their pre-pandemic degree of socialization 
influenced the impact that the loss of socialization had on them during the pandemic 
(Table 3.1). 
 
“Yeah, so COVID-19… a lot of people have found this profound change in their 
lives because of COVID, but we have been living that life for the last almost three 
or four years. In the initial three years of her disease, you know, we were able to 
travel and visit friends, family and everything but since 2015 we are mostly 
homebound.” 
 
“We were already isolating because of the dementia, then with the COVID thing, 
it just kind of compounds it or, yeah, compounds it even more because we’ve 
been self-isolated for over what over three months.” 
 
Others described how they were very social before the pandemic, which came at a 
significant loss to them during the pandemic. 
 
“We used to be very social. We had friends. We went out. We went to events. 
We’re very political. We went to a political event. Um, and uh, that has basically 
not totally but basically stopped which has been one of the really hard things for 
him because he’s a very social person and he wants to be around a crowd.” 
 
Care Strategies  
Caregivers gave many examples of care strategies they used in the home to 





including general management strategies and care strategies related to the emotional 
and psychological experiences of the person with ADRD. 
General Management Strategies. Caregivers described general management 
strategies, such as self-care strategies (for themselves and for their relatives with 
ADRD), strategies to reorient their relatives, and for incontinence care (Table 1). They 
detailed the importance of using humor and maintaining a daily routine when caring for 
their relatives with ADRD. Some described their experiences in using respite care and 
support from healthcare providers (Table 3.1) 
Self-care strategies used by caregivers (e.g., yoga, tai chi, support groups, diaries), 
as well as those used by relatives with ADRD (e.g., blogging, “alone time”, music) were 
described as important to both caregivers and their relatives 
 
“For me, one of the things I find helpful is just to walk out of the room, leave him 
to his own devices for a little while, um. I used to go for a short walk. I’m a little 
less eager to do that now so I do go outside. We have a tree swing that I sit down 
on and swing for 10 or 15 minutes. Uh, I take a couple of Zoom yoga classes 
during the week and I’m able to say “Okay, this is my time. I’m going off to the 
family room to do some yoga”.” 
 
“So, he’s writing a book. He’s going to put it together and give it to the 
grandchildren but it’s very cute. It’s from the dog’s perspective about dementia. It 
is good for him to get out how he feels you know, even if doesn’t really finish it.” 
 
Other important general management strategies included maintenance of a daily 
routine and the use of humor (Table 3.1). Humor specifically was described as a 
strategy that was beneficial for the person with ADRD and the caregiver. 
 
“We have a lot of humor and like even when I’m cutting his hair… I do his 
haircuts and we just make events out of simple everyday things. Like we may 
have a beer and a wine while we’re doing a haircut. We have happy hour every 
day and happy hour is kind of for me because he might want to keep working into 
the evening if it was daylight and I’ll say “No, we’re quitting. We’re having music. 
We’re having happy hour. 
 
Many strategies designed to reorient the person with ADRD to place, time, and 
situation (e.g., the use of white boards with the date and reminders of the daily 






“He can still read. And so, we put as much things in writing as we can. We have 
big posters on the wall with people’s pictures and their relationship. So, we’re 
using that tool to kind of keep him informed of things.” 
 
Incontinence was a challenging aspect of ADRD for many caregivers. They had 
identified very few effective management options for incontinence. 
 
“I’ve tried a gazillion ways to try to figure out how to keep him from wetting all 
over himself. I can’t seem to figure out how to keep him dry at night. I bought 
these rubber pants from the internet that said they’re guaranteed, well not 
guaranteed but, you know, every review said that it stopped that. I bought those, 
$25 for one pair of rubber pants, right? Did nothing.” 
 
Some caregivers described their experiences with trying to receive support from 
healthcare providers, the majority of whom described that these supports were less 
helpful than they had expected them to be. 
 
“And the regular doctors, the primary care, or at least the ones I’ve seen didn’t 
really know how to handle the situation. They just shooed me off into that 
department to deal with it.” 
 
Another caregiver suggested the following: 
 
“I think all the doctors… they have a lot of elderly patients. They must have a lot 
of people with dementia so they need better training in my opinion. So, I think it 
would be great if someone with some knowledge on the topic did some training in 
medical schools. I don’t know if they do.” 
 
Respite care was described as a strategy employed by a few caregivers, but their 
relative’s emotional response to respite care environments limited the helpfulness of this 
resource. 
 
“I tried taking him to an adult daycare, and I could see he was quickly spinning 
out of control. I didn’t realize how he just hated that place so anytime we go 
anywhere near that place, he starts getting so agitated now. He remembers that 
experience and he doesn’t like it.” 
 
Relating to the pandemic, caregivers described their use of virtual activities and 





care strategies (Table 3.1). Most caregivers described that the specific in-home care 
strategies they used to help their loved one manage the disease remained unchanged 
during the pandemic, but that caring for their relative in general became more difficult. 
 
“It’s definitely more challenging. More challenging just to manage wellbeing and 
happiness, let alone address any behavioral manifestations or communications.” 
 
Caregivers described how specific in-home care strategies that were effective pre-
pandemic became increasingly important during the pandemic. 
 
“Okay, so he started the CBD before the pandemic.  If he wasn’t on the CBD and 
all these restrictions and having to stay home, I can almost predict what it would 
be like for him.  Um, because he really misses… I suspect without the CBD I 
think we would have had a stronger impact to the relationship too, um, behaviors 
that were manifested because of his lack of social interaction and just frustration 
level.” 
 
The loss of dementia related support programs because of the pandemic played a 
significant role in the impact the pandemic had on the caregiving process and disease 
management more generally. Caregivers described how some programs were 
cancelled, while others were modified in some way in response to the pandemic. These 
modifications were typically transferring of educational programs, support groups, group 
activities, and day programs to a virtual platform. 
 
“I am so grateful Zoom and all the other technologies. Had it been ten years ago, 
I don’t know that it would have been… I think I’d be pulling my hair out by now, 
but we’re involved in a lot.” 
 
Care Strategies Related to the Emotional and Psychological Experiences of 
the Person with ADRD. Participants described care strategies they used to support 
their relative’s emotional and psychological experiences. They identified the importance 
of changing their own caregiving perspective and behaviors, as well as withdrawing 
from challenging situations (Table 3.1). One caregiver said,  
 
“Really it’s like a two-way management; managing my own emotions as a 
response to it and then helping manage, you know, look at what set that off, you 







Another caregiver described: 
 
“If my wife is doing something, you know, it’s not her but it is her disease, you  
know. So, I am able to separate when she’s angry, you know, I know it’s her 
disease. It’s not her.” 
 
One caregiver described an innovative approach for helping both the person with 
ADRD and the caregiver to cope by essentially “naming” the disease and attributing the 
changes in thoughts and behaviors to the personified disease, and not the person 
specifically. 
 
“I talk in terms of Lewy being this third character that lives in our house (giggle). 
In fact, I actually use the words “There are three of us that live in this house now. 
You, me and Lewy, and the two of us have to work together to deal with Lewy”.” 
 
Withdrawing from particularly challenging situations was described as a short-term 
approach to help the caregiver and the person with ADRD to manage at home.  
 
“You know, there’s some reason for it, and um, if I feel like things are getting out 
of control, I back off and I might go to the bedroom and lock the door. And by 
next morning things are in much better shape but I know that it’s not a good idea 
to keep arguing at night.” 
 
Changing caregiving behavior, perspective, and withdrawing all involved caregivers 
taking the burden of symptom management on themselves, which was described as an 
experiential learning process. 
 
“Don’t be reactionary. That don’t work. So, again, it’s just not her fault and you 
have to learn that, and that’s tough…” 
 
Anger was described as the most difficult emotion to manage by all caregivers that 
reported that their relative experienced anger or displayed agitation. A few helpful anger 
management strategies were described, many of which were reliant on the caregiver 
changing their own behavior (e.g., not raising their voice, avoiding ultimatums) and 






Caregivers described that once agitation was present, there was not much to be 
done that helped reduce it. One caregiver detailed the importance of waiting for their 
relative to calm down then later approaching them to discuss the outburst and ways to 
prevent them in the future. 
 
“I think the most helpful thing is just waiting until he’s calm to go back and try to 
talk and, fortunately, he’s still okay enough to say “I didn’t realize I did that” or “I 
didn’t know I did it.” And “Is that really what happened?” And he trust us.” 
 
Helpful strategies for anxiety included the use of music, audio books, car rides, 
words of affirmation, and snacks as a form of distraction (Table 3.1). Pet dogs generally 
and dementia service dogs more specifically, were commonly described as anxiety 
reducing and provided the person with dementia with a renewed sense of purpose. 
 
“Our service dog Sophie is a huge… just the purpose of getting up, letting her go 
potty, training her. Yeah, and the sense of having her there he says it’s huge with 
his anxiety. He does not feel like he’s alone…” 
 
One caregiver described the use of cannabidiol oil (CBD) for anxiety and anger 
management as an important approach for their relative. CBD is an active ingredient in 
cannabis, which is derived from hemp.  
 
“Before COVID we started CBD and, um, we had a night and day difference. I 
mean does he have the frustration… but he doesn’t have the fearful, I’m so afraid 
of him anger.” 
 
Despite the many strategies described, most caregivers still highlighted anxiety, 
anger, and agitation as being difficult to manage at home. 
Helpful strategies for paranoia included words of affirmation and reassurance, while 
rationalization and reorientation were described as less helpful (Table 3.1). Most sleep 
specific strategies were described as less helpful (e.g., medications, blue light glasses), 
but one strategy that was helpful for many caregivers were planned daily naps for their 
relatives (Table 3.1).   
Caregivers described the use of medications by their relatives, including 
antidepressants, anti-anxiety medications, and anti-psychotics (Table 3.1). Comments 





symptoms, while others described medications as not at all helpful to their relative with 
ADRD. 
 
“He’s on two medications, He’s on rivastigmine and on Lexapro. The Lexapro 
has really made a huge difference in his anxiety. Um, it’s almost a wonder drug” 
 
Another caregiver said: 
 
“I’m not going to drug her...she’s on Lexapro for anti-anxiety. And does it work? 
Who in the hell knows. Personally, I don’t.” 
 
Discussion 
This study described multiple life changes and challenges to caregiving in the home 
for a loved one with ADRD, many of which were exacerbated by the pandemic. 
Caregivers’ experiences were dynamically related to those of their relatives with ADRD 
and the caring process was described as a partnership. Caregivers identified a need for 
in-home care strategies to promote their own and their relative’s well-being even before 
the pandemic began. The pandemic compounded many of those needs due to the loss 
of activities, access to resources, and ADRD related support services. 
Similar to previous studies focused on ADRD caregivers (Wang et al., 2019), 
findings demonstrated varying experiences across participants, as well as within 
participants over time. Experiences differed in terms of how changes in the relative with 
ADRD impacted the caregiver, how caregivers responded, and how they perceived their 
caregiving experience. Reflections on earlier stages of the relative’s disease 
demonstrate that the caregiving experience changed over time. Given that ADRD are 
known to have variable effects on those diagnosed with dynamic changes occurring 
throughout the disease process (Wu et al., 2018), it is reasonable to find variation within 
and across caregiver experiences. 
Caregivers and their relatives with ADRD experienced substantial changes in their 
lives because of the ADRD diagnosis. Changes described by caregivers spanned 
across many aspects of life, including social function, physical ability, cognitive ability, 
and emotional and psychological experiences. Descriptions of decline in the health of 





had on their caregivers. Although caregivers gave examples specific to their own 
experiences and their relative’s experiences, most of their narratives intertwined both 
perspectives together in a manner that were dynamically related. These findings are 
consistent with theories of interdependence which posit that the health, wellness, and 
behaviors of one member in a close partnership is dependent and interactive with the 
other member (Kershaw et al., 2015; Streck et al., 2020).  
The caring partnership described by participants is evident in research and practice 
as caregiving is now recognized as a primary component of the ADRD experience 
(National Academies of Sciences & Medicine, 2021). Some participants asked to be 
referred to as care partners to accurately reflect how they viewed themselves, and the 
caring partnership they had with their relative living with ADRD. Care partners often 
described caring as a process of co-managing their own emotions, responses, and 
reactions and those of their relative with ADRD. Care partnering was described as 
distinct from caregiving as it is not a one way, give-take relationship, but instead was 
described as a joint ongoing interaction with the relative with ADRD acting as an active 
participant in the caring process. The significance of the care partner further expounds 
upon the need for healthcare providers to address the multidimensional needs of the 
dyad (Miller et al., 2019). Dyadic care planning programs that connect people with early 
stage ADRD, their care partners, other relatives/friends, and service providers show 
promise for initiating early care discussions and promoting family-centered care 
planning (Orsulic-Jeras et al., 2019). Additional research is needed to examine 
effectiveness of these interventions to promote broader implementation and support for 
a wider range of families (Orsulic-Jeras et al., 2019, 2020). 
Findings showed that participants did not use the terms “behaviors” or “symptoms” 
for many of the examples that would be described as BPSD by clinicians and 
researchers. Instead, caregivers connected their relative’s experiences with the disease 
and their responses to different situations and circumstances, many of which related to 
their own experiences as caregivers. In some instances, these experiences and 
responses were directly related to the ADRD, while others were not related to the 
disease specifically. These findings suggest a need for clinicians and researchers to 





concept traditionally termed BPSD. Clinicians and researchers often focus on treating 
challenging symptoms of ADRD, as opposed to understanding the lived experience of 
those with ADRD and their families. By asking patients and families about broader 
factors related to BPSD (e.g., unmet needs, personality traits, communication, home 
environment, daily routines) clinicians may be able to assess for BPSD more 
comprehensively, as opposed to asking about symptoms and behaviors specifically 
(Kales, Gitlin, & Lyketsos, 2015). 
Findings from this study and prior research demonstrate substantial losses in terms 
of social support among families affected by ADRD, many of which were prevalent prior 
to the pandemic and were intensified by it (Gielbel et al., 2020). Cumulatively these 
findings support that in addition to modified social support programs, care strategies 
that can be used in the home without reliance on in-person interaction are needed. As 
nearly 1/3 of Medicare beneficiaries reported a lack of digital access at home (Reyes et 
al., 2020), support strategies that do not rely on internet access must also be prioritized. 
Caregivers described many home-based strategies to support their relatives that did 
not require internet or in-person access. Examples included pets and dementia support 
dogs, CBD oil for anxiety and agitation, mindfulness activities and meditation, 
reorientation tools (e.g., white boards, visual reminders), exercise (e.g., tai chi, yoga, 
walking), and journaling. Research is needed to explore how acceptable these 
interventions are to individuals and families affected by ADRD and to determine their 
efficacy for improving important outcomes such as BPSD, well-being, and quality of life.  
Dementia service dogs were described by many participants and represent an 
innovative in-home care strategy for families affected by ADRD. Dementia service dogs 
are specially trained to address needs unique to individuals with ADRD. They can be 
trained in tracking to locate and redirect people home or closer to their caregiver, to 
distract and engage potentially anxious or agitated people, and can provide physical 
support with activities of daily living (e.g., fetching medication and clothing items) 
(Markss & McVilly, 2020). As many participants in this study described, they can also 
provide companionship, emotional support, and a sense of purpose for people with 
ADRD. Despite the potential value of dementia service dogs, there has been limited use 





dementia service dog can cost anywhere between $15,000-$50,000 (“4 Paws for 
Ability”, n.d.). Insurance companies do not cover any costs related to service animals 
and much of the cost burden is placed on families. Additional research is needed to 
examine the effects of dementia service dogs on a variety of outcomes of interest to 
individuals and families affected by ADRD, as well as the cost benefit of ADRD service 
dogs (Markss & McVilly, 2020). Furthermore, efforts are needed to educate ADRD 
community support organizations and providers on their availability, but more 
importantly policy updates are needed to provide coverage for families interested in 
having dementia service dogs. 
Limitations 
Limitations of this study relate to the lack of variability of the sample. Participants 
were recruited through ADRD organizations that serve regions of a state comprised 
primarily of non-Hispanic White families, limiting diversity of the sample in terms of race 
and ethnicity. Additionally, most caring dyads were related by marriage, which is not 
congruent with the broader population, as most primary caregivers of people with ADRD 
are children caring for parents (Alzheimer’s Association, 2021). As the perceived value 
of different care strategies varies based on individual circumstances, situations, and 
contexts (National Academies of Sciences & Medicine, 2021), the lack of diversity of 
this study sample limits the understanding of the in-home care needs of families 
affected by ADRD from diverse sociodemographic backgrounds. The pandemic related 
experiences of caregivers may also vary substantially across groups given variations in 
virtual resource accessibility specifically and healthcare access more generally. 
Alternative recruitment strategies (e.g., through providers and programs that support 
families in disadvantaged communities, spiritual communities that offer services to older 
adults, rural outreach programs) will need to be used in future research to engage 
caregivers from a broader range of backgrounds and to enhance generalizability of the 
findings. 
Conclusion 
Findings from this exploratory study show that family caregivers and their relatives 
living with ADRD experienced challenges to in-home care prior to the COVID-19 





promise for future research to better understand the experiences of a broader range of 
caregivers and to bridge gaps between researchers, clinicians, community support 
providers, people living with ADRD, and their families. As community dwelling dyads 
living with ADRD continue to experience challenges to care, there is a critical need to 
examine strategies that can feasibly be delivered in the home to promote the well-being 




















   
CHAPTER IV 
 
Examining the Feasibility and Acceptability of a Virtually Delivered In-Home 
Weighted Blanket Intervention for Older Adults Living with Dementia and their 
Family Caregivers 
 
Background and Significance 
Up to 98% of individuals with Alzheimer’s disease and related dementias (ADRD) 
living in the community experience behavioral and psychological symptoms of dementia 
(BPSD) (Banerjee et al., 2006; Cerejeira et al., 2012). These behaviors and symptoms 
can have detrimental effects on the health and quality of life of not only those 
diagnosed, but also on family caregivers (Fonareva & Oken, 2014; Majer et al., 2019). 
Although psychotropic medications are commonly prescribed to treat BPSD, they have 
minimal effectiveness and are associated with several life-threatening risks including, 
falls, fractures, injuries and in worst cases, death in older adults with ADRD 
(Defrancesco et al., 2015; Jeste et al., 2008; Seyfried et al., 2011; Van Strien et al., 
2013). 
Due to these dangers, practice guidelines emphasize non-pharmacologic 
interventions as the primary treatment of BPSD among people living with dementia 
(PLWD) (Austrom et al., 2018; Reus et al., 2016). Non-pharmacologic interventions are 
those that do not rely solely on medication to treat or mitigate a specific disease, 
condition, or symptom. Findings from caregiver interviews revealed several non-
pharmacologic care strategies used by family caregivers (See Chapter 3). Most 
caregivers, however, noted that the availability and effectiveness of such interventions 
were limited before, as well as throughout the COVID-19 pandemic.  
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Many non-pharmacologic interventions have demonstrated improvements in BPSD 
outcomes in community dwelling PLWD (Trivedi et al., 2018). These interventions, 
however, have had limited uptake in real world community settings (Gitlin et al., 2015). 
To be implemented and sustained in practice, interventions must be accepted by those 
who use them (Carter & Wheeler, 2019).  
Previously investigated non-pharmacologic interventions may have limited use in the 
community setting due to the complexity of the interventions (e.g., multiple components 
and steps of the intervention, need for frequent interactions with trained or licensed 
professionals, costly resources not covered by current insurance structures), which can 
inhibit their acceptability and applicability. Crucial steps in developing acceptable and 
applicable interventions are to first explore the feasibility of delivering the intervention in 
a real world setting and second, to evaluate the acceptability of the intervention by the 
population of interest during the early stages of development (Baier et al., 2019). 
Evaluating acceptability before (prospectively) and after (retrospectively) delivery of an 
intervention provides insight into the opinions and needs of the target population 
throughout the intervention development and delivery process (Sekhon et al., 2017). 
Prospective evaluations of intervention acceptability provide valuable information 
regarding the preconceived notions of the target population towards the intervention, 
level of burden required for participation, the ethicality of the intervention, and/or the 
extent to which potential subjects understand the intervention. Retrospective 
evaluations examine the benefit of the intervention and satisfaction with the intervention 
by those who received it, barriers of the intervention, confidence in being able to 
participate in the intervention, and costs vs. benefit of participating in the intervention 
(Sekhon et al., 2017).  
Interventions that are likely to be successful are those that are feasible for the 
setting of interest and are acceptable to multiple stakeholders including those who 
deliver and receive them (Gadke et al., 2021). Thus, evaluating intervention feasibility 
and acceptability early in the intervention development process is paramount to future 
intervention testing and implementation. 





Sensory stimulation is one category of non-pharmacological interventions that has 
been tested among community dwelling PLWD (Trivedi et al., 2018). Sensory 
stimulation therapies are those that use everyday objects and tools to arouse at least 
one of the five senses (i.e., hearing, sight, smell, taste, touch) with the intent of 
promoting positive feelings and increased well-being (Strøm et al., 2016). Examples of 
sensory stimulation therapies include art therapy, music therapy and multi-sensory 
stimulation involving two or more stimulation therapies in a single program, such as 
combined auditory and tactile stimulation (also referred to as Snoezelen therapy) 
(Trivedi et al., 2018; Ueda et al., 2013). 
There has been limited research conducted on sensory stimulation for treating 
BPSD in community dwelling people with dementia (Trivedi et al., 2018). However, 
research supports that sensory stimulation therapies can reduce challenging behaviors 
and improve emotional well-being, as well as other important outcomes such as quality 
of life and functional ability in PLWD residing in long term care settings (Haigh & Mytton, 
2015; Strøm et al., 2016). Systematic reviews have recommended additional research 
focused on sensory stimulation therapies in PLWD residing in the community with 
broader outcomes examined, such as BPSD and quality of life (Haigh & Mytton, 2015; 
Strøm et al., 2016; Trivedi et al., 2018). 
Weighted Blankets as a Deep Pressure Tactile Stimulation Therapy 
Weighted blankets are a form of deep pressure tactile or touch stimulation that have 
shown to be safe for older adults (Parker, 2016). Research demonstrates that deep 
pressure tactile stimulation may increase the arousal of the parasympathetic nervous 
system, while also reducing sympathetic arousal (Chen et al., 2016; Reynolds, Lane, & 
Mullen, 2015). The increase in parasympathetic arousal is hypothesized to have a 
calming effect, while the decrease in sympathetic arousal is associated with changes in 
emotional and cognitive processes (Chen et al., 2016; Mullen et al., 2008; Reynolds et 
al., 2015). 
Regular nightly use of weighted blankets has demonstrated improvements in overall 
sleep maintenance, daytime fatigue, depression, and anxiety in non-cognitively impaired 
adults with a variety of psychiatric conditions (e.g., insomnia, major depressive, 





2020). Research on daily use of weighted blankets has also shown reductions in anxiety 
and stress related physiologic factors among non-cognitively impaired older adults with 
mental health conditions (Champagne et al., 2015; Mullen et al., 2008). Despite 
research in support of weighted blankets to improve stress and psychologic outcomes in 
other populations, no studies have tested the effects of weighted blankets on BPSD 
experienced by PLWD, including those living in the community (Eron et al., 2020). In 
fact, most studies testing weighted blankets exclude people with cognitive impairment 
without justification (Becklund et al., 2021; Ekholm et al., 2020). Furthermore, the 
acceptability of weighted blankets as perceived by older adults with ADRD and their 
family caregivers has not been explored. 
COVID-19 Pandemic and the Impact on Community Dwelling Dyads Affected by 
ADRD 
Findings presented in Chapter 3 demonstrated that the COVID-19 pandemic posed 
unique challenges that impacted the lives of PLWD and their family caregivers. 
Mandated stay-at-home orders and social distancing recommendations across the 
nation affected the day-to-day function of programs, businesses, primary care practices 
and healthcare systems that typically provide face-to-face support to dyads affected by 
ADRD (Brown et al., 2020). Restrictions in access to standard care and support 
programs impacted family caregivers’ ability to effectively manage challenging 
situations, experiences, responses, and reactions in relatives with ADRD in the home 
setting.  
Given the limited availability and effectiveness of non-pharmacologic interventions 
for PLWD in the community, in addition to the COVID-19 related restrictions, older 
adults with ADRD and their family caregivers have experienced an increased need for 
care strategies that can be easily implemented in the home setting (Alves et al., 2020). 
Weighted blankets are a potential non-pharmacologic care strategy that may feasibly be 
delivered by family caregivers in the home, even during this time of social distancing 
and limited access to typical ADRD related care programs and resources.  
Since no research has examined the use of weighted blanket by PLWD, this study 
will provide novel information regarding the feasibility and acceptability of weighted 





pandemic. Findings will inform future research focused on weighted blankets for 
reducing BPSD among community dwelling older adults living with ADRD. 
Specific Aims 
The aims of this feasibility and acceptability study were to: 
Specific Aim 1 
Explore the initial perceptions of family caregivers regarding weighted blankets as an 
in-home care strategy for community dwelling older adults with ADRD following a brief 
description and visual presentation of weighted blankets.  
Specific Aim 2 
Examine the feasibility and acceptability of a virtually delivered, in-home weighted 
blanket intervention for older adults with ADRD living in the community as perceived by 
the family caregiver and the person with ADRD.  
Specific Aim 3 
Examine the feasibility of collecting outcome measures of BPSD, cognitive function, 
and quality of life of care recipients with ADRD, and well-being and self-reported health 
status of family caregivers.  
Methods 
Study Design 
Two study designs were used to address these aims which are described below.  
Aim 1 
An exploratory qualitative design was used for Aim 1. Participants were those 
enrolled in the Perceptions of Family Caregivers of Older Adults Living with Dementia 
Regarding Behavioral and Psychological Symptoms of Dementia and the Impact of the 
COVID-19 Pandemic study (See Chapter 3, Methods-Study design, p. 52). Participants 
were provided with a brief description and virtual demonstration of the weighted blanket 
followed by semi-structured interviews using the following questions:  
1. What do you think about use of the weighted blanket for your loved one? 
2. Can you give any examples as to why the weighted blanket might work or not 
work for them? 
3. Do you have any questions, worries, or concerns about using a weighted blanket? 





A feasibility and acceptability study using a prospective, within subjects, pre-post 
design was used for Aims 2 and 3 (See Figure 4.1). The weighted blanket intervention 
period was 4 weeks. Measures were collected at baseline (within 1 week prior to the 
start of the intervention period) and at post-intervention (within 1 week of completing the 
intervention period). The consenting process, data collection sessions, and the 
intervention introduction session were all conducted over Zoom virtual conferencing 
system, or by telephone. Weekly intervention check-in sessions were conducted by 
telephone. 
Study Sample 
The sample was 21 community-dwelling older adults with ADRD and their family 
caregivers (21 dyads). The projected sample size was 20, which was selected based on 
prior dyadic, non-pharmacologic intervention community-based feasibility studies, which 
have ranged from 5-22 dyads (Hamel et al., 2016; Moyle et al., 2014; Sprange et al., 
2015).  
A wide range of definitions are used to define family caregivers for eligibility to 
participate in ADRD research (Novelli et al., 2018; Robinson et al., 2018). Family 
caregivers were defined for this study as any relative, partner or other family member 
who provides a broad range of assistance for an older adult with dementia and lives in 
the same household (Family Caregiver Alliance, 2014). The following criteria were used 




   
Figure 4.1  







Inclusion criteria for participants with ADRD (Aim 2 and 3): 
1) Aged 60 and over with a diagnosis of ADRD as reported by the family caregiver  
2) Lived in the home with a family caregiver 
3) Demonstrated at least 2 behavioral or psychological symptoms listed on the 
Neuropsychiatric Inventory (NPI) within the most recent 4 weeks as reported by the 
family caregiver (Novelli et al., 2018), with symptoms or behaviors occurring at least 
once a week. The NPI is described in the Data Collection section. 
4) Weight of 100 pounds or more, as reported by the family caregiver 
5) Was able to lift at least 10 pounds, as reported by the family caregiver 
 
Exclusion criteria for participants with ADRD:  
1) Lived in assisted living or long-term care setting 
2) Had a diagnosis of asthma, sleep apnea, or other respiratory disorder that inhibits 
respiratory function 
3) Had paralysis or limited mobility of the upper or lower limb(s)  
4) Had a history of claustrophobia, or fear of confined and/or enclosed spaces 
5) Had open wounds or rashes on the skin 
6) Had diabetes 
7) Had used a weighted blanket within the most recent month 
8) Had a current diagnosis of an acute or chronic unstable medical condition 
anticipated to limit the individual’s ability to participate in the study as reported by the 
family caregiver 
 
Inclusion criteria for family caregivers (Aims 2 and 3): 
1) 21 years of age or older  
2) Identified as a primary caregiver of an older adult (60 years of age or older) with 
ADRD 
3) Lived in the same household as the family member with ADRD who met the 
above inclusion criteria 
4) Had lived with the care recipient for at least one month 
5) Had access and ability to use a telephone, smart phone (with internet access), 
tablet (with internet access), or computer (with internet access) to access the virtual 
Zoom sessions 
 
Exclusion criteria for family caregivers:  
1) Less than 21 years of age 
2) Was unable to read or speak English 
3) Had a hearing or visual impairment that limits the ability to complete the screening 
or consenting process  
Although Alzheimer’s disease and vascular dementia were anticipated to be the 





of ADRD (e.g., Alzheimer’s disease, vascular dementia) was not a criterion for inclusion 
for several reasons, 1) distinguishing between types of dementia can be difficult and 
requires advanced testing (e.g., PET imaging, CSF biomarker analysis) that individuals 
in earlier stages of disease living in the community may not have received; 2) diagnoses 
made without advanced testing may not always be accurate; and 3) people with ADRD 
do not always receive a specific type of diagnosis from physicians (Alzheimer’s 
Association, 2021).  
Recruitment 
Dyads were recruited through the Alzheimer’s Association of Greater Michigan 
Chapter, the Michigan Alzheimer’s Disease Research Center, and the Family Caregiver 
Alliance National Center on Caregiving. 
Alzheimer’s Association of Greater Michigan Chapter. The Alzheimer’s 
Association Greater Michigan Chapter serves over 60 counties in Michigan and 
provides support to individuals and families affected by ADRD through a variety of 
services. This study was promoted by word of mouth and electronic flyers displayed at 
support groups, care consultations, helpline packets, education programs, conferences, 
and other virtual events. Interested caregivers contacted the PI (Ms. Harris) directly 
using the contact information provided on the study flyer (Appendix B-1). Six dyads 
were recruited through the Alzheimer’s Association. 
Michigan Alzheimer’s Disease Research Center. The Michigan Alzheimer’s 
Disease Research Center (MADRC) is based in the Department of Neurology in 
Michigan Medicine and is directed by Henry Paulson, MD, PhD; Associate Director is 
Bruno Giordani, PhD (dissertation committee member). This was an MADRC supported 
study which permitted sharing of study information with MADRC clients (including 
diagnosed individuals and their care partners) interested in research opportunities. 
Study information was shared on the MADRC’s Currently Enrolling Studies webpage, 
through e-newsletters, online support groups and outreach programs. The MADRC also 
provided contact information (names, addresses, telephone numbers) of potential 
research participants from the MADRC MiNDSet Research Registry, which lists 
individuals with ADRD and their caregivers who are interested in participating in 





participants along with the study flyer. Interested individuals contacted the PI directly 
using the provided contact information. Ten dyads were recruited through the MADRC. 
Family Caregiver Alliance National Center on Caregiving. The Family Caregiver 
Alliance (FCA) is a national organization that offers services, education programs, and 
resources designed for caregivers. They provide support, tailored information, and tools 
to manage the complex demands of caregiving. This study was listed on the graduate 
student research registry via the FCA website, as well as through monthly FCA e-
newsletters distributed to caregivers nationwide. Postings included Ms. Harris’ contact 
information. Interested individuals contacted her directly by phone or email. Five dyads 
were recruited through the FCA. 
Eligibility Screening 
When potential participants expressed interest in the study, they received a study 
overview booklet either by e-mail, or by U.S. mail (Appendix B-2). The PI further 
described the purpose of the study, the eligibility criteria, and the web-based format 
through a telephone conversation. The PI completed an eligibility determination form 
(Appendix B-3) directly in REDCap (See Data Security and Management section below 
of more information) for each dyad. Family caregivers provided responses relating to 
their own eligibility, as well as the eligibility of their relative with ADRD.  
Setting 
The consenting process, all data collection sessions and the intervention 
introduction session were conducted through Zoom conferencing system, which was 
accessed virtually, or by telephone. The weekly intervention check-in sessions were 
conducted by telephone.  
The use of the weighted blankets occurred in the homes of participant dyads. Dyads 
received education about use of the weighted blanket during the Weighted Blanket 
Introduction Session (See Weighted Blanket Intervention section below).  
Consent 
Interested and eligible dyads received a study consent form, which was delivered 
electronically by e-mail, or through U.S. Mail based on participant preference. Dyads 
reviewed the form with the PI by telephone, or by Zoom. Both care recipients and 





were unable to sign for themselves, their caregiver signed on their behalf as a proxy. 
Participants signed consent forms via SignNow software, which is a secure, HIPAA 
compliant electronic signature service (SignNow, 2021). Three dyads did not have 
reliable internet access and instead received a consent form via U.S. Mail, they signed 
the hardcopy consent form and returned it using a stamped, preaddressed envelope.  
Weighted Blanket Intervention 
Participant dyads received a weighted blanket and a Weighted Blanket Use Guide 
along with other intervention materials after completion of the virtual baseline data 
collection session (See Data Collection Procedures section below). After receipt of the 
intervention materials, each dyad participated in an introduction session with the PI via 
Zoom. The use of the weighted blanket by the care recipient with ADRD was 
individualized based on the needs and preferences of the dyad. All dyads were 
encouraged to have the care recipient use the blanket daily for at least 5 minutes at a 
time for a total of at least 20 minutes throughout each day (day referring to each 24-
hour period, meaning the blanket could be used during the daytime or overnight). They 
could use the blanket for a total of 20 minutes at one time, or they could use the blanket 
multiple times for shorter periods throughout the day. Although this was the minimum 
recommended time, dyads were encouraged to have the participant with ADRD use the 
blanket as often as they liked. Caregivers played a significant role in initiating and 
encouraging daily use of the blanket. The intervention is described in the following 
sections and includes a description of the weighted blankets, safety information, the 
Weighted Blanket Use Guide, the delivery of the intervention materials, the weighted 
blanket introduction session, and the weekly intervention check-in sessions. 
Weighted Blankets 
A weighted blanket is similar to a traditional comforter, except it is filled with non-
toxic, hypoallergenic plastic pellets to add weight to the blanket. Blankets in this study 
were supplied by Magic Weighted Blanket ©. (https://magicweightedblanket.com/), 
which is a family created business that invented the first weighted blanket in 1997. 
Participants were provided a blanket by the study.  As compensation for participation, 





No definitive weight recommendations have been established across studies for 
weighted blanket use by older adults (Eron et al. 2020); however, the suggested weight 
across practical reports and by weighted blanket manufacturers is 10% of the 
individual’s body weight (Parker, 2016). In consideration of this recommendation, two 
different blanket weights were used. Dyads received a 10-pound blanket if the care 
recipient with ADRD weighed under 120 pounds, or a 12-pound blanket if they weighed 
120 pounds or more. All blankets were navy blue or gray and made of cotton material. 
They were 42 inches wide by 72 inches long.  
Safety Considerations. There are no adverse effects associated with weighted 
blanket use across prior research (Champagne et al., 2015; Eron et al., 2020; Mullen et 
al., 2008). There are two anecdotal reports that misuse of weighted blankets resulted in 
the death of a 9-year-old child, and a 7-month-old baby. In these cases, the blankets 
used were well over the 10% body weight recommendation (e.g., a 39-pound blanket 
was used for the 9-year-old child) and the blankets were applied over the children’s 
faces (Parker, 2016). There are no reports of adverse effects regarding the use of 
weighted blankets by adults. 
There are no standardized safety guidelines for the use of weighted blankets by 
older adults. The guidelines below were developed for this study based on prior 
research (Champagne et al., 2015; Eron et al., 2020; Mullen et al., 2008), and 
experiences in use of weighted blankets among individuals across age groups (Parker, 
2016).  
▪ Weighted blankets should never be used as a restraint.  
▪ The individual using the weighted blanket should be able to remove the 
blanket on his/her own.  
▪ A person should not be rolled up in the blanket. 
▪ The blanket should not be used when the person is standing or walking. 
▪ The blanket should not cover a person’s face or head. 
▪ There is a minor risk for infection if the blanket is used by multiple people 
and not washed between uses. 
▪ Weighted blankets should be used with caution by people with 
claustrophobia, or fear of confined and/or enclosed spaces. 
▪ Weighted blankets should be used with caution in people with asthma, 
sleep apnea, or other disorders that inhibit respiratory function. 
▪ Providers should consider the mobility of individuals interested in using a 





▪ Weighted blankets should be used with caution in people with open 
wounds, fragile skin, rashes, or those with diabetes who may be prone to 
diabetic ulcers. 
▪ Although unanticipated, if plastic pellets come out of the blanket, the 
blanket should not be used.  
▪ Plastic pellets should not be ingested or swallowed. If swallowed, the 
individual should seek medical attention. 
▪ The blanket should not be put in the microwave, as this can melt the 
plastic pellets.  
These safety guidelines were addressed in this study in the eligibility criteria for 
study inclusion and in the Weighted Blanket Use Guide, which was provided and 
reviewed with all participant dyads (described below). 
Weighted Blanket Use Guide 
A Weighted Blanket Use Guide was developed for this study based on prior 
research and experiential reports (See Appendix C-1). The guide was reviewed by 3 
older adults who identified as family caregivers of people with ADRD. These individuals 
assessed the guide for readability, clarity, and cohesion. Based on their feedback, edits 
were made, and the guide was finalized.  
The PI reviewed the guide with each dyad during the Weighted Blanket Introduction 
Session (See Weighted Blanket Introduction Session section below). Dyads were 
encouraged to refer to the guide together throughout the study period. After completion 
of the baseline data collection session, one guide was provided for both the caregiver 
and the care recipient to use, which included the following: 
▪ Description and purpose of the weighted blanket 
▪ Suggestions of when to use the weighted blanket 
▪ Directions for applying the blanket 
▪ Recommended duration of use 
▪ Safety recommendations 
▪ Blanket cleaning recommendations 
 
Delivery of Weighted Blanket and Weighted Blanket Use Guide to Dyads 
Study materials were delivered to participants using UPS shipping services. 
Packages included the weighted blanket (either 10, or 12 pounds depending on the 
participant with ADRD’s body weight), the Weighted Blanket Use Guide, and the 
Weighted Blanket Daily Use Diary (See Data Collection Procedures for more 





using the blanket, or open the Weighted Blanket Use Guide, or Daily Diary until after the 
Weighted Blanket Introduction Session (described below). On average, shipping of 
study materials took 3 days to reach participants.  
Weighted Blanket Introduction Session 
Upon delivery of the study materials, participant dyads participated in an introduction 
session with the PI using Zoom, which was accessed by participants virtually or by 
telephone. During this session, the PI reviewed with both the caregiver and the care 
recipient the Weighted Blanket Use Guide and provided directions on how to complete 
the Weighted Blanket Daily Use Diary (See Data Collection Procedures for more 
information). For introduction sessions over Zoom, the PI demonstrated how to apply 
the weighted blanket. If participants were using the video function, the PI then asked 
them to return demonstrate use of the blanket. Both members of the dyad were 
encouraged to participate in this session, but if the participant with ADRD was unable to 
participate in the full session, the family caregiver participated independently. These 
sessions lasted 20-30 minutes on average. 
Completion of the Weighted Blanket Introduction Session marked the beginning of 
the 4-week intervention period. Each week, family caregivers and care recipients 
participated in a telephone check-in conversation with the PI. If care recipients were 
unable to fully participate, caregivers participated in the calls independently. The 
purpose of these check-in calls was to 1) answer questions or address concerns of the 
participants throughout the intervention period, 2) explore the recommended duration 
and frequency of use of the weighted blankets by participants with ADRD, and 3) help 
participants identify strategies to improve the use of the blanket if applicable. A Weekly 
Intervention Telephone Check-In Form (Appendix C-2) was used by the PI to guide the 
phone conversations and to document participant responses. These calls lasted 
approximately 10 minutes. 
Outcome Measures and Instruments 
The following sections describe the outcomes and corresponding instruments for 
Aims 2 and 3. 





Outcomes for Aim 2 were measures of feasibility and acceptability of a virtually 
delivered, in-home weighted blanket intervention for older adults with ADRD living in the 
home with family caregivers, as perceived by the family caregiver and the person with 
ADRD. 
Feasibility of Intervention. Feasibility was conceptually defined as the extent to 
which the intervention was appropriate for further testing with emphasis on whether the 
intervention was carried out as intended in the setting and with the population of interest 
(i.e., community setting, older adults with ADRD living with family caregivers) (Bowen et 
al., 2009).  
Feasibility was operationalized as the:  
▪ Enrollment rate (calculated by the number of people who were enrolled 
divided by the number of people who were screened) 
▪ Length of time (in days) to recruit the desired number of participants  
▪ Average number of days the weighted blanket was used for the 
recommended duration (at least 20 minutes) across participants (Items 1-3 of 
the Weighted Blanket Daily Use Diary, described below, was used to capture 
the number of days care recipients used the blanket for at least 20 minutes 
each day over the 4-week intervention period) 
▪ Withdrawal rate and reasons for withdrawal (participants were asked, but not 
required to report their reasons for withdrawal, which were tracked using the 
Study Completion Form (Appendix D-1) 
▪ Injuries and adverse events (any adverse events, or injuries were to be 
tracked using an Adverse Event Form (Appendix D-2) and then reported to 
the IRB) 
There are no established criteria to determine non-pharmacologic intervention 
feasibility in research focused on this population. Benchmarks set a priori for this study 
were selected based on findings from prior non-pharmacological intervention studies 
that were considered feasible. Benchmarks were modified from studies that were similar 
in terms of population, projected sample sizes, and study durations (Farina et al., 2019; 
Tamplin et al., 2018). This intervention would be considered feasible if the following 
were achieved: 1) no adverse events or injuries, 2) recruitment of the target sample size 
within five months, 3) use of the blanket for the recommended duration, on average, at 
least 21 of the 28 intervention days across participants who completed the intervention 
period, and 4) withdrawal of less than 25% of the participant dyads that were enrolled in 
the study. Most non-pharmacologic intervention ADRD studies have not reported 





based research is highly variable and can range between 1%-80%, with no standard 
across studies (Bartlett et al., 2018; Cooper et al., 2014). The enrollment rate for this 
study was predetermined to be feasible if at least 50% of individuals screened were 
enrolled.  
Measure of Use of the Weighted Blanket. A Weighted Blanket Daily Use Diary 
completed by family caregivers captured the number of days that the weighted blanket 
was used for the recommended duration by the care recipient (See Appendix D-3). 
Semi-structured daily diaries have been used as a tool to collect both qualitative and 
quantitative data relating to individualized use of non-pharmacologic interventions 
(Logsdon et al., 2005; Lowery et al., 2014; Mausbach et al., 2011; McCurry et al., 1998). 
The daily diary was developed by using items generated based on prior research 
focused on weighted blankets and prior studies testing other interventions that have 
used a daily diary tool (Champagne et al., 2007; Logsdon et al., 2005; Lowery et al., 
2014; Mausbach et al., 2011; McCurry et al., 1998). The family caregiver completed one 
diary entry at the end of each day to document the use of the weighted blanket by the 
person with ADRD. As no prior studies have used daily diaries to explore the use of 
weighted blankets by research participants, the percentage of completion of daily 
diaries was used to ascertain the feasibility of using this tool as a measure of daily use 
of the weighted blanket.  
Acceptability of the Weighted Blanket Intervention. Intervention acceptability 
was conceptually defined as a multi-faceted concept that reflects the extent to which the 
people receiving the intervention tolerate it, consider it to be beneficial, and their 
satisfaction with the intervention (Sekhon et al., 2017). Intervention acceptability in this 
study was operationally defined as 1) the extent to which the weighted blanket 
intervention was tolerated by care recipients with ADRD, 2) the degree of satisfaction 
with the intervention, and 3) benefit as reported by the care recipient with ADRD and the 
family caregiver.  
Tolerability. Tolerability was quantitatively measured using a single item on the 
Weekly Intervention Telephone Check-In Form that was assessed during each of the 
four phone sessions (Appendix C-2). Family caregivers were asked to rate on a scale 





care recipients’ degree of tolerability of the weighted blanket over the past week. 
Information regarding barriers to use of the weighted blanket that may have reduced a 
person’s tolerability was captured through item 6 of the Weighted Blanket Daily Use 
Diary, which provides qualitative data pertaining to what made the use of the weighted 
blanket a challenge on days where caregivers indicated the blanket was not used at all 
by the care recipient. 
Satisfaction. Satisfaction with the weighted blanket as perceived by caregivers and 
care recipients with ADRD was measured using the Weighted Blanket Satisfaction 
Scale - Caregiver and Care recipient versions. There are no prior tools used to measure 
satisfaction with weighted blankets, so items were generated from a review of research 
on intervention acceptability of non-pharmacologic, community-based intervention 
studies focused on individuals with ADRD (Harris & Titler, 2020; Qiu et al., 2019; 
Robinson et al., 2007).  
The caregiver and care recipient versions of the Weighted Blanket Satisfaction 
Scales were constructed for this study using items and response scales modified from a 
tool used to measure satisfaction of a psychoeducational intervention called FOCUS 
delivered to dyads affected by cancer, of which content validity and reliability 
(Cronbach’s 𝝰=0.89 for care recipients with cancer, Cronbach’s 𝝰 =0.93 for family 
caregivers) have been established (Northouse et al., 2002; Titler et al., 2020). 
Items and response scales were also modified from tools used in the 
multicomponent non-pharmacologic intervention studies focused on community dwelling 
PLWD and their caregivers by Gitlin et al. (2010a, 2010b) (Table 4.1). Psychometric 
properties were not reported for the tools used in these studies; however, both studies 
demonstrated statistically significant differences in satisfaction scores among caregivers 
who received the non-pharmacologic intervention, compared to those in the active 
control groups. These between-group differences provide some evidence regarding 
content validity of the satisfaction tool by their ability to demonstrate differences 
between those who received the intervention and those who did not.  
Table 4.1  
Items of Satisfaction with Weighted Blanket Intervention - Caregiver and Care Recipients Versions 
Concept Items Response Scale 
Satisfaction – 
Caregiver version  
How satisfied were you with having the weighted 
blanket to be used by your relative in the home?  






 How satisfied were you with having the intervention 
materials delivered to your home?  
1 = not satisfied to 5 = very 
satisfied 
How satisfied were you with how the weighted blanket 
was explained to you during the Weighted Blanket 
Introduction session? 
1 = not satisfied to 5 = very 
satisfied 
How satisfied were you with using a web-based 
platform to learn how to use the weighted blanket? 
1 = not satisfied to 5 = very 
satisfied 
How satisfied were you with participating in weekly 
check-in telephone call with the research team? 
1 = not satisfied to 5 = very 
satisfied 
How satisfied were you with the Weighted Blanket Use 
Guide that came with the blanket? 
1 = not satisfied to 5 = very 
satisfied 
How satisfied were you with the way your questions 
were answered throughout the study period? 
1 = not satisfied to 5 = very 
satisfied 
How satisfied were you with how you were involved in 
the process of encouraging your relative to use the 
weighted blanket? 
1 = not satisfied to 5 = very 
satisfied 
How heavy was the blanket that your relative used? 10 pounds 
12 pounds 
I don’t know 
What did you think about the weight of the blanket for 
your relative? 
1 = The weight was about right for 
my relative.  
2 = I would have liked it to be 
heavier. 
3 = I would have liked it to be 
lighter. 
What is your opinion about the recommendation that 
the weighted blanket be used daily by your relative? 
1 = The recommended every day 
use of the weighted blanket was 
about right for us. 
2 = I would have liked less 
recommended blanket use time. 
3 = I would have liked more 
recommended blanket use time. 
What is your opinion about the recommended amount 
of time the weighted blanket was to be used by your 
relative each day? (Reminder: the weighted blanket 
was recommended to be used for at least 5 minutes at 
a time for a total of at least 20 minutes throughout 
each day) 
1 = The recommended amount of 
time was about right for us. 
2 = I would have liked less time 
recommended. 
3 = I would have liked more time 
recommended. 
What did you think about completing a Weighted 
Blanket Daily Use Diary? 
1 = Completing a diary entry every 
day was about right for me. 
2 = I would have liked to complete 
fewer diary entries. 
3 = I would have liked to complete 
more diary entries. 
Overall, would you recommend the use of a weighted 
blanket to other individuals caring for someone with 
dementia? 
Yes, No 
Will you continue to encourage your relative to use the 
weighted blanket? 
Yes, No 
Satisfaction -   
Care recipient 
version 
How did you like using the weighted blanket? 1 = Not at all  
2 = Some 
3 = A great deal 
How did you like being able to choose when you used 
the weighted blanket? 
1 = Not at all  
2 = Some 
3 = A great deal 
How did you like being able to choose how often you 
used the weighted blanket? 
1 = Not at all  
2 = Some 





How comfortable did you feel when using the weighted 
blanket? 
1 = Not at all  
2 = Somewhat comfortable 
3 = Very comfortable 
How did you like the feeling of the fabric of the blanket 
that you used? 
1 = Not at all  
2 = Some 
3 = A great deal 
How did you like the warmth of the blanket that you 
used? 
1 = Not at all  
2 = Some 
3 = A great deal 
How did the weight of the blanket feel to you? 1 = The weight was about right for 
me.  
2 = I would have liked it to be 
heavier. 
3 = I would have liked it to be 
lighter. 
Will you continue to use the weighted blanket? Yes, No 
Overall, would you recommend using a weighted 
blanket to other individuals with dementia? 
Yes, No 
What did you like most about using the weighted 
blanket? 
Free-text response 




Benefit. Table 4.2 outlines items of the Weighted Blanket Benefit Scale - Caregivers 
and Care recipient versions. Items and response scales were modified from the studies 
by Titler et al. (2020), Gitlin et al. (2010a, 2010b), and from the program evaluation tool 
used in the dyadic skills training intervention by Judge et al. (2010). No psychometric 
properties were reported for the intervention evaluation tool used by Judge et al. (2010), 
but approximately 81% of the care recipients that received the intervention completed 
the program evaluation tool, which supports that they were able to answer the items 
with the provided responses, despite having cognitive impairment.  
Table 4.2  
Items of Benefit of the Weighted Blanket Intervention - Caregiver and Care Recipients Versions 
Concept Items Response Scale 
Benefit - 
Caregiver version 
How much did the use of the weighted blanket help in 
decreasing challenging symptoms displayed by your 
family member with dementia? (such as anxiety, 
agitation, restlessness, difficulty sleeping) 
1 = Not at all  
2 = Some 
3 = A great deal  
 
How beneficial was the study information booklet in 
explaining the study process? 
1 = Not at all  
2 = Some 
3 = A great deal  
How beneficial was the Weighted Blanket Use Guide 
in explaining the use of the weighted blanket? 
1 = Not at all  
2 = Some 
3 = A great deal 
How beneficial were the four weekly telephone calls? 1 = Not at all  
2 = Some 
3 = A great deal 
When was using the weighted blanket most helpful for 
your relative? 
Free-text response 
When was using the weighted blanket the least helpful 






Overall, how much did the use of the weighted blanket 
by your relative benefit you as the caregiver of 
someone with dementia? 
1 = Not at all  
2 = Some 
3 = A great deal 
Overall, how much did the use of the weighted blanket 
benefit your family member with dementia 
1 = Not at all  
2 = Some 
3 = A great deal 
Do you have any comments or suggestions about the 
study materials (such as the study booklet, the 
Weighted Blanket Use Guide, or the Weighted Blanket 
Daily Use Diary)? 
Yes, No 
If yes, please described: (Free-text 
response) 
Do you have any comments or suggestions about the 
weighted blankets specifically? 
Yes, No 
If yes, please described: (Free-text 
response) 
Would you recommend or suggest any changes for 
using the weighted blanket? 
Yes, No 
If yes, please described: (Free-text 
response) 
Benefit - Care 
recipient version 
How relaxed did you feel when using the weighted 
blanket? 
1 = Not at all  
2 = Some 
3 = A great deal 
How else did you feel when using the weighted 
blanket? 
Free-text response 
Would you recommend or suggest any changes for 
using the weighted blanket? 
Yes, No 
If yes, please described: (Free-text 
response) 
 
Weighted Blanket Intervention Acceptability Tools. The satisfaction scales and 
benefit scales formulated the Weighted Blanket Intervention Acceptability Tools 
(WBIAT) – Caregiver version (Appendix D-4) and Care recipient version (Appendix D-
5). The caregiver version evaluated acceptability from the perspective of the family 
caregiver at the post-intervention data collection period. The WBIAT – Caregiver version 
included items scored on 1 to 5 rating scales, 3 choice option items, and open-ended 
questions. The care recipient version evaluated acceptability from the perspective of the 
care recipients with 1 to 3-point Likert scaled items and simpler (yes-no) responses and 
open-ended questions (See Tables 4.1 & 4.2). Care recipients could receive some 
assistance from caregivers in completing the WBIAT – Care recipient version if needed, 
but caregivers were instructed not to complete it by proxy without input from the care 
recipient.  
Outcomes Aim 3 
Aim 3 examined the feasibility of collecting outcome measures for care recipients 
and family caregivers before and after receipt of the weighted blanket intervention.  The 
following concepts derived from the conceptual framework (See Figure 1.1, Chapter 1, 
p. 6) were examined: cognitive function, behavioral and psychological symptoms of 





specific outcomes collected relevant to the care recipient were cognitive function, 
BPSD, and quality of life. Caregiver specific outcomes were caregiver well-being and 
self-reported health status. Table 4.3 outlines the concepts, conceptual definitions, 
operationalized definitions, measures, and psychometric properties of the instruments. 
Instruments are included in Appendix E, along with information on completing and 
scoring each instrument. 
Care Recipient Cognitive Function. Cognitive function refers to multiple mental 
abilities, including attention, memory, language, perception, decision making and 
problem solving. In this study cognitive function was specified as the severity of 
cognitive function impairment, or premature decline in cognitive function that is 
attributed to the limitations caused by neuropathological changes in the brain caused by 
ADRD (Cheung et al., 2011; Rabinovich et al., 2008).  
The Montreal Cognitive Assessment Test (MoCA) was used to measure cognitive 
function (Appendix E-1) (Nasreddine et al., 2005). The MoCA assesses short-term 
memory; visuospatial abilities; executive functions; attention, concentration and working 
memory; language; and orientation to time and place. The maximum number of possible 
points on the MoCA is 30, with a score higher than 26 considered normal cognitive 
function. Scores less than 26 are indicative of some form of cognitive impairment. It 
takes approximately 10 minutes to complete and is completed by interview. 
The MoCA has demonstrated high internal consistency (Cronbach’s 𝝰- 0.83), and 
test-retest reliability (r=0.92). The MoCA has demonstrated a 100% sensitivity to 
detecting Alzheimer’s disease, and 90% for detecting mild cognitive impairment 
(Nasreddine et al., 2005). Construct validity of this instrument has been established 
through confirmatory factor analysis (Freitas et al., 2012). The full MoCA can be 
delivered remotely using audio-visual conference (Lindauer et al., 2017). The MoCA-
Telephone format is identical to the full MoCA, except it does not include the trail 
making, cube, or clock drawing items. The MoCA-Telephone is scored the same but 
has a possible 22 points instead of 30. The MoCA-Telephone score is converted back 
to 30. Example: a participant score of 19/22 converts back to 30 by performing the 
following equation: ((19/30) ÷  22) (Chapman et al., 2019; DeYoung & Shenal, 2018; 
Wittich et al., 2010).  
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Table 4.3  
Concepts, Conceptual Definitions, Operationalized Definitions, Measures and Psychometric Properties of Selected Instruments  




A mental action or 









decision making and 
problem solving 
(Glisky, 2007).  
Severity of cognitive 
function impairment, which 
in dementia is defined as a 
premature decline in 
cognitive function that is 
attributed to the limitations 
caused by 
neuropathological changes 
in the brain caused by 
ADRD (Cheung, Chien, & 
Lai, 2011; Rabinovich, 
Huerta, Varona, & 




Cronbach's α range: 0.83 
Test-retest reliability: r = 0.92 




Construct validity of this instrument has been established 
through confirmatory factor analysis 
 








behavior resulting from 
the decreased ability to 
manage and respond 
to stress (Cerejeira, 
Lagarto, & Mukaetova-
Ladinska, 2012; 
Steinberg et al., 2008) 
Individual and collective 
disturbance or change 




and aggression, depression 
and dysphoria, anxiety, 
euphoria, apathy, 
disinhibition, irritability and 
lability, aberrant motor 
behaviors, sleep 
disturbance and nighttime 
behavior, and eating and 
appetite behavior 
(Cummings et al., 1994).  
Global BPSD  
Neuropsychiatric 
Inventory-12 item 
(Cummings et al., 
1994) 
Cronbach's α range: 0.71-0.88 
Percentage agreement between raters: 93.6%-100% 
Test-retest reliability range (r): 0.79-0.86 
 
(Jackson et al., 2014; Lai, 2014) 




Cronbach's α range: 0.86-0.91 
Inter-rater reliability: 0.41 
 
(Cohen-Mansfield et al., 1989; Finkel et al., 1992) 
 
Construct validity has been established through 
confirmatory factor analysis (Rabinowitz et al., 2005) 
Anxiety Specific 
Rating Anxiety in 
Dementia Scale 
(RAID) 
Cronbach's α: 0.83 
Inter-rater reliability k range: 0.51-1 
Test-retest reliability k range: 0.53-1 
 
Content validity established through expert consultation, 
concurrent validity established with other anxiety scales 
including the Clinical Anxiety Scale and the Anxiety 
Sensitivity Index, construct validity established through 
factor analysis 
 









Cronbach's α range: 0.71-0.88 


















Test-retest reliability range (r): 0.79-0.86 
 
(Jackson et al., 2014; Lai, 2014) 
 
PSQI 
Cronbach's α: 0.85 




(Backhaus et al., 2002) 
 
ESS 
Cronbach's α: 0.73-0.86 
Convergent validity established by comparing ESS with 
PSQI scores 
 




reflective of the quality 
of life of the care 




function, physical and 
psychological domains 
(Lawton, 1997). 
Care recipient and 
caregiver appraisal of the 
care recipient’s physical 
condition, mood, 
interpersonal relationships, 
ability to participate in 
meaningful activities, 
financial situation and 
overall assessment of self 
as a whole, and life quality 
as a whole (Logsdon, 
Gibbons, McCurry, & Teri, 
1999).    
Quality of Life in 
Alzheimer’s Disease 
Scale (QOL-AD) 
(Logsdon et al., 1999) 
CR Report 
Cronbach's α: 0.83 
 
CG Proxy Report 
Cronbach's α: 0.90 
 
ICC between CR and proxy CG proxy report:  
r = 0.14-0.39 
Inter-rater reliability: ICC ≥0.75 (p<0.001) 
(Logsdon et al., 2002)  
 
Criterion concurrent validity established with four other 
quality of life indices in dementia. Construct validity 





concept comprised of 
caregiver health 
status, assets and 




physical and mental 
well-being, while 
assets and resources 
include a basic needs 
Caregiver perception of 
their overall health status 
(physical and mental well-
being) and the extent to 
which their basic human 
needs (emotional needs, 
physical needs, self-
security) are met and 
degree to which they are 
able to attend to their 
activities of daily living (i.e. 
self-care, connectedness, 
Caregiver Well-Being 
Scale (CWBS) (short 
form, 16 items about 
basic needs and 
activities of daily living)  
(Tebb et al., 2013) 
 
Content validity established using experts and use of items 
from the long form (Tebb et al., 2013) 
 
Construct validity through confirmatory factor analysis 
(Tebb et al., 2013) 
 
Overall 
Cronbach's α: 0.83 
 
Basic Needs Subscale 






dimension and an 
activities of daily living 
dimension.  (George & 
Gwyther, 1986; Tebb 
et al., 1995).  
time for self) (Rubio et al., 
1999; Tebb et al., 2013) 
Activities of Daily Living Subscale 
Cronbach's α: 0.74 
(Rubio et al., 1999; Tebb et al., 2013) 
Optum SF-12v.2 
Health Survey 
(Ware et al., 1996) 
 
Physical Composite Scale 
Cronbach's α: 0.85 
Test-retest reliability: 0.89  
 
Mental Composite Scale 
Cronbach's α: 0.76 
Test-retest reliability: 0.76 
(Jakobsson, 2007; Jenkinson et al., 1997) 
 
Construct validity established through confirmatory factor 
analysis (Okonkwo et al., 2010)  
Note. ADRD Alzheimer’s disease and related dementias 
 
99 
   
Care Recipient BPSD. BPSD was defined for this study as individual and collective 
disturbance or change across behavioral and psychiatric domains including delusions, 
hallucinations, agitation and aggression, depression and dysphoria, anxiety, euphoria, 
apathy, disinhibition, irritability and lability, aberrant motor behaviors, sleep disturbance 
and nighttime behavior, and eating and appetite behavior (Cummings et al., 1994). To 
inform measurement selection for a future pilot study, this study explored the feasibility 
of collecting multiple measures of BPSD which are described below.  
Global BPSD. The Neuropsychiatric Inventory (NPI) was used to measure the 
global cluster of BPSD (Appendix E-2) (Cummings et al., 1994). The NPI assesses 12 
symptoms and behavioral domains commonly manifested by individuals with ADRD: 
hallucinations, delusions, agitation and aggression, dysphoria and depression, anxiety, 
irritability, disinhibition, euphoria, apathy, aberrant motor behavior, appetite and eating 
disorders, and sleep and nighttime behavior disorders. Each behavioral domain is rated 
based on frequency (1=rarely, 2=sometimes, 3=often, 4=very often), severity (1=mild, 
2=moderate, 3=severe) and level of caregiver distress (0=not at all, 1=minimal, 2=mild, 
3=moderate, 4=severe, 5=very severe). Ratings are reported by caregivers based on 
behaviors and symptoms experienced by care recipients within the most recent 4 
weeks. Frequency and severity scales for each domain are multiplied together to yield 
domain scores, domain scores are then summed to yield a total NPI score (Cummings 
et al., 1994). Total NPI scores range from 0-144 with higher scores indicative of greater 
frequency and severity of neuropsychiatric symptoms. Caregiver distress scores for 
each domain are added together to yield a caregiver distress subscale total score 
(range 0-60) with higher scores indicative of greater caregiver distress. 
The NPI does not have any cut points indicative of “abnormal” results, as some 
symptoms are always considered abnormal (e.g., hallucinations and delusions), while 
others may be expected in dementia, as well as other psychiatric conditions (e.g., 
depression and anxiety). Typically, a decrease in 4 points, or a 30% reduction in 
baseline score is regarded as a clinically meaningful change in symptoms and 
behaviors, but a smaller change in certain symptoms and behaviors may be meaningful 
to caregivers, thus changes should be interpreted on an individual study basis 





persons with ADRD. Internal consistency reliability has ranged from 0.71-0.88, the 
interrater reliability ranged from 0.936-1.0 (Jackson et al., 2014; Lai, 2014). Test-retest 
reliability was 0.79 for frequency scores and 0.86 for severity scores (Cummings et al., 
1994; Jackson et al., 2014; Lai, 2014).  
Agitation was measured using the Cohen-Mansfield Agitation Inventory (CMAI) – 
Relatives Version (Appendix E-3) (Cohen-Mansfield, Marx, & Rosenthal, 1989). This 
inventory is completed by relatives of community-dwelling older adults. The CMAI 
assesses the frequency with which subjects demonstrate up to 34 agitated behaviors 
from four different domains: verbal aggressive behaviors, verbal non-aggressive 
behaviors, physical aggressive behaviors, and physical non-aggressive behaviors. Each 
behavior is rated on a 7-point scale (1=never, 7=several times an hour) to indicate the 
frequency that a behavior is demonstrated in the most recent 2 weeks. Total scores 
range from 34-238, with higher scores indicative of greater agitation severity.  
Internal consistency (Cronbach's α range: 0.86-0.91) and interrater reliability 
(k=0.41) of the CMAI have been demonstrated in older adults with ADRD (Cohen-
Mansfield, Marx, & Rosenthal, 1989; Finkel, Lyons, & Anderson, 1992).  Construct 
validity has been established by confirmatory factor analysis (Rabinowitz et al., 2005). 
Specific BPSD of Anxiety. Anxiety was measured using the Rating Anxiety in 
Dementia (RAID) scale (Appendix E-4) (Shankar et al., 1999), which measures five 
anxiety-related domains: worry, apprehension, vigilance, motor tension, autonomic 
hyperactivity. It includes 18 items, that are scored from 0 to 3 (0=symptom is absent; 1= 
symptom is mild or intermittent; 2=symptom is moderate; 3=symptom is severe). This 
measure takes about 15 minutes to complete and requires interviewing both members 
of the dyad separately (the caregiver first, then the care recipient). The same items and 
response options are used for the care recipient self-report and the caregiver proxy 
report. Scores for each of the 18 items are summed for the caregiver to yield a 
caregiver score, then the care recipient to yield a care recipient score, then averaged to 
yield a total RAID score. Scores ≥11 suggests significant clinical anxiety.  
Internal consistency (Cronbach's α: 0.83), interrater reliability (k range: 0.5-1.0) and 
test-retest reliability (k range: 0.5-1.0) of the RAID scale have been demonstrated 





scales including the Clinical Anxiety Scale and the Anxiety Sensitivity Index, while 
construct validity has been established through factor analysis (Shankar et al., 1999). 
Specific BPSD of Sleep Disturbances. Sleep disturbances were measured using 
three instruments: the Neuropsychiatric Inventory-Sleep item (NPI-Sleep) (Appendix E-
2, item 11) (Cummings et al. 1994), the Pittsburgh Sleep Quality Index (PSQI) 
(Appendix E-5) (Buysse et al., 1989), and the Epworth Sleepiness Scale (ESS) 
(Appendix E-6) (Johns, M., 1991).  
The NPI-Sleep item was used to assess sleep disordered behaviors, which was 
obtained through the NPI (See Global BPSD section above for more information). Sleep 
and nighttime behaviors of PLWD are rated based on frequency (1=rarely, 
2=sometimes, 3=often, 4=very often), severity (1=mild, 2=moderate, 3=severe) and 
level of caregiver distress (0=not at all, 1=minimal, 2=mild, 3=moderate, 4=severe, 
5=very severe). 
The PSQI evaluates overall sleep quality and includes 9 items pertaining to one of 7 
subcategories: subjective sleep quality, sleep latency, sleep duration, habitual sleep 
efficiency, sleep disturbances, use of sleeping medication and daytime dysfunction 
(Appendix E-5). In ADRD research, the PSQI is completed by caregivers to indicate 
care recipients’ sleep habits over the most recent month. Items are combined to yield 
subscale component scores. Each of the component scores range from 0-3 with higher 
scores indicative of worse sleep quality (Component 1), longer sleep latency 
(Component 2), shorter sleep duration (Component 3), lower sleep habitual sleep 
efficiency (Component 4), more severe sleep disturbances (Component 5), more sleep 
medication use (Component 6), and more severe daytime dysfunction due to sleep 
disturbances (Component 7). Subscale component scores are added together to yield a 
global score that ranges from 0-21, with higher scores indicative of overall worse sleep 
quality.  
The PSQI has been widely used among older adults. Internal consistency 
(Cronbach's α=0.85), and test-retest reliability (r=0.87) of the PSQI have been 
demonstrated (Backhaus et al., 2002). The PSQI has been used in many studies 





Kinnunen et al., 2017; Kwok et al., 2013; Simoncini et al., 2015), but has not been 
validated among older adults with cognitive impairment specifically.   
The ESS assesses daytime sleepiness through 8-items rated on a 4-point scale (0- 
would never doze, 3=high chance of dozing), to indicate an individual’s chances of 
dozing off or falling asleep while engaged in eight different activities. In ADRD research, 
the ESS is completed by caregivers based on care recipients’ recent daytime behaviors. 
Higher scores indicate more severe daytime sleepiness.  
Internal consistency (Cronbach's α: 0.73-0.86) of the ESS has been demonstrated 
and convergent validity established by comparing ESS with PSQI scores (Kendzerska 
et al., 2014; Spira et al., 2011). The ESS has been used in studies of older adults and 
completed by caregivers but has not been validated among older adults with cognitive 
impairment specifically.   
Care Recipient Well-Being. The concept of care recipient well-being was measured 
using the Quality of Life in Alzheimer’s Disease Scale (QOL-AD) (Appendix E-7) 
(Logsdon et al., 1999). The QOL-AD is a brief, 13-item measure designed to obtain a 
rating of the quality of life for a person with ADRD, from both the perspective of the care 
recipient and the caregiver as a proxy reporter. The measure uses simple and 
straightforward language to assess the care recipient’s relationships with friends and 
family, concerns about finances, physical condition, mood, and an overall assessment 
of life quality.  
Each of the13-items are rated on a 4-point Likert scales (1=poor to 4=excellent). 
Scoring of the scale is the sum of all items, with total scores ranging from 13-52. Higher 
scores are reflective of higher quality of life. The same items and response options are 
used for the care recipient self-report and for caregiver proxy. Caregiver and care 
recipient item scores are summed separately to yield a caregiver and a care recipient 
specific score. These scores are then averaged to yield a total QOL score. This tool has 
been psychometrically tested in samples of community-dwelling individuals with ADRD 
and their informal caregivers. Internal consistency (Cronbach’s α: 0.83 for care recipient 
report, and 0.90 for caregiver report) and inter-rater reliability (ICC ≥ 0.75, p<0.001) 





established with four other quality of life indices in dementia, while construct validity was 
established through factor analysis (Thorgrimsen et al., 2003). 
Caregiver Well-Being. Caregiver well-being was defined as caregivers’ perception 
of their overall health status (physical and mental well-being), the extent to which their 
basic human needs (emotional needs, physical needs, self-security) are met, and the 
degree to which they are able to attend to their activities of daily living (i.e., self-care, 
connectedness, time for self) (Rubio et al., 1995; Tebb et al., 2013). Caregiver well-
being was measured with the Caregiver Well-Being Scale-short form (CWBS) 
(Appendix E-8) (Rubio et al., 1995; Tebb et al., 2013), and the Optum SF-12v.2 Health 
Survey (Appendix E-9) (Ware et al., 1996). 
The CWBS includes 16-items composed of two subscales with a basic needs 
domain (factors associated with meeting the biopsychosocial needs to sustain life) and 
an activities of daily living domain (implementation of the biopsychosocial needs) (Rubio 
et al., 1995; Tebb et al., 2013). Eight items are asked in each domain. Respondents 
rate each item on a 5-point Likert scale (1=rarely, 2=occasionally, 3=sometimes, 
4=frequently, 5=usually). Scores are summed across items within each subscale then 
divided by 8 to yield a basic needs score and an activities of daily living (ADL) score. A 
combine scale total score is calculated by summing all items and dividing by 16. Higher 
needs and activities of daily living domain scores indicate that the needs and activities 
are being met.  
 Internal consistency reliability for the basic needs subscale (Cronbach’s α=0.73), 
the ADL subscale (Cronbach’s α=0.74), and overall total scale (Cronbach’s α=0.83) 
have been demonstrated (Rubio et al., 1995; Tebb et al., 2013). Construct validity was 
established through confirmatory factor analysis (Table 4.3) (Tebb et al., 2013).  
The Optum SF-12v.2 Health Survey is a commonly used 12-item self-report survey 
composed of a mental and physical health components, and 8 domains: physical 
functioning, role functioning physical, role functioning emotional, bodily pain, general 
health, vitality, social functioning, and mental health (Appendix E-9) (Ware et al., 1996). 
The physical health component and the mental health component subscales both have 
a range from 0-100, which are averaged to yield an overall SF-12 score. Higher scores 





functioning, while higher overall SF-12 scores are indicative of better overall self-
reported health (Ware et al., 1996).  
This measure has been psychometrically tested across many populations, but not 
specifically caregivers of individuals with ADRD. Among a sample of community 
dwelling older adults, internal consistency (Cronbach’s α: 0.85 for the physical 
composite scale and 0.76 for the mental composite scale) and test-retest reliability (0.89 
for the physical composite scale and 0.76 for the mental composite scale) have been 
demonstrated. Construct validity has been established through confirmatory factor 
analysis (Okonkwo et al., 2010). 
Demographic and Health History Data. A Demographics Form from Dr. Laura 
Struble’s (dissertation committee member) pilot study, Using Laser Acupuncture to 
Decrease Behavioral and Psychological Symptoms of Dementia in Assisted Living 
Facilities, was adapted to the community setting to collect demographic information 
relating to the caregivers and the care recipients. The form included items related to 
age, gender, race, education level and marital status of both members of the dyad 
(Appendix E-10). It also included caregiving specific related items, including the 
relationship of the caregiver to the participant with ADRD, when the family caregiver 
began acting as primary caregiver, how many hours of caregiving he/she provided on 
average per week, and when the dyad began living together. A Health History Form was 
used to collect information regarding the dementia type, date of dementia diagnosis, co-
morbidities, and medications of the person with ADRD (Appendix E-11). A Health Status 
Update Form completed at post-intervention collected information on changes in 
medications and health status of the care recipient with ADRD that occurred throughout 
the study period (Appendix E-12). 
Measures Completed by Interview at Baseline and at Post-Intervention 
Some instruments were completed by interviewing the caregiver (i.e., NPI, RAID – 
CG), others were completed by interviewing the care recipient (i.e., MoCA, RAID – CR, 
QOL-AD – CR). Interviews with the caregiver occurred first, followed by the interview 
with the care recipient. Table 4.4 outlines the average time taken to complete each of 
interview sessions, the data source (who completed the interview), the instruments that 





Table 4.4  
Instruments Completed by Interview at Baseline and at Post-Intervention 
Data Collection 
Timepoint 
Average Time to 
Complete 
Source of Completion Instruments and Order of 
Completion 
Baseline 22 minutes Caregiver NPI  
RAID – CG* 
28 minutes Care recipient MoCA 
RAID – CR* 
QOL-AD – CR* 
Post-intervention 22 minutes Caregiver NPI  
RAID-CG* 
28 minutes Care recipient MoCA 
RAID – CR* 
QOL-AD – CR* 
Note. CG caregiver, CR care recipient, MoCA Montreal Cognitive Assessment Test, NPI Neuropsychiatric Inventory, 
QOL-AD Quality of Life in Alzheimer’s Disease Scale, RAID Rating Anxiety in Dementia Scale 
*The RAID and QOL-AD were completed by self-report by the care recipient with ADRD and by proxy report by the 
caregiver  
 
Data Collected by Questionnaires at Baseline and at Post-Intervention 
The Baseline Caregiver Questionnaire (Appendix F-1) and the Follow-Up Caregiver 
Questionnaire (Appendix F-2) were developed incorporating each of the scales (Table 
4.5) with directions for each section. Table 4.5 summarizes the average time 
participants took to complete each questionnaire, the source of completion (who 
completed the questionnaire), the instruments included in each questionnaire, and the 
order in which they appeared in the questionnaire at each data collection timepoint. 
Table 4.5  
Instruments Completed by Questionnaire at Baseline and at Post-Intervention 
Data Collection 
Timepoint 
Average Time to 
Complete 
Questionnaire Source of 
Completion 
Instruments and Order 















QOL-AD – CG* 
CWBS 
SF-12 
WBIAT – CG version  
Health History Update 
10 minutes WBIAT – CR version  
 
Care recipient WBIAT – CR version  
 
Note. CG caregiver, CMAI Cohen-Mansfield Agitation Inventory, CR Care recipient, CWBS Caregiver Well-Being 
Scale Short Form, ESS Epworth Sleepiness Scale, PSQI Pittsburgh Sleep Quality Index, QOL-AD Quality of Life in 
Alzheimer’s Disease Scale, WBIAT Weighted Blanket Intervention Acceptability Tool 






Data Collection Procedures  
Aim 1 Data Collection 
The same data collection procedures used in the Perceptions of Family Caregivers 
of Older Adults Living with Dementia Regarding Behavioral and Psychological 
Symptoms of Dementia and the Impact of the COVID-19 Pandemic study were used in 
this study (See Chapter 3, Methods, p. 51). The PI provided a brief description of 
weighted blankets using the prompt below: 
“Weighted blankets feel like regular blankets or comforters; however, they are filled 
with materials to add weight to the blanket and can range from 10 to 12 pounds. The 
feeling of weighted blankets is said to have a grounding effect that increases a person’s 
level of relaxation. People have compared it to a feeling of being swaddled, while others 
describe it as a feeling like a long-term gentle hug. They are commonly used for people 
with ADRD in hospital settings and are typically used multiple times throughout the day 
for 15-25 minutes at a time when individuals are anxious, restless, or agitated. There is 
not enough research to say definitively that weighted blankets help with challenging 
dementia symptoms. The goal of the next stage of my dissertation work is to explore the 
potential use of weighted blankets as a treatment option for individuals with ADRD who 
live at home to help with symptoms such as anxiety, agitation and restlessness.” (If the 
participant was able to view the PI’s video, she shared her screen to show a picture of 
weighted blankets as an example). Following this description, participants responded to 
three questions (see page 97) included in the semi-structured interview guide (Appendix 
A) about weighted blankets over a Zoom interview that was recorded using the audio 
recording function.   
Aim 2 Data Collection 
Feasibility Data Collection. The PI tracked the number of individuals screened, 
enrolled and those that completed the study using a tracking sheet. This tracking sheet 
included the date participants began and ended the study, as well as reasons for ending 
the study. The PI completed a Study Completion Form (Appendix D-1) for every 
participant when they reached the end of the study. Participants that withdrew from the 
study were asked by phone but were not required to report their reason for withdrawal, 





Items 1-3 of the Weighted Blanket Daily Use Diary (Appendix D-3) were completed 
every day by caregiver participants. Responses were used to summarize the number of 
days care recipients used the blanket for the recommended duration over the 4-week 
intervention period. All caregiver participants were provided with a hardcopy Weighted 
Blanket Use Diary with the delivery of the weighted blanket and the Weighted Blanket 
Use Guide. At home, caregivers completed one entry at the end of each day throughout 
the 4-week intervention period. Directions for completing the diary entries were 
reviewed with the caregiver by the PI during the Weighted Blanket Introduction Session 
and reiterated throughout the weekly check-in telephone calls. Completed diaries were 
returned to the PI by U.S. Mail at the end of the 4-week intervention period using a 
stamped, pre-addressed envelope. 
Acceptability Data Collection. 
Tolerability Data. Tolerability data were collected during the Weekly Intervention 
Telephone Check-In sessions. Near the end of the calls, caregivers were asked to rate 
on a scale from 0-10, with 0 being the care recipient did not tolerate the blanket at all, 
10 being the care recipient tolerated the blanket all of the time, the number that best 
described the care recipient’s degree of tolerability of the weighted blanket over the past 
week. This was asked for each of the 4 weeks, yielding a total of 4 tolerability scores. 
Semi-structured Weighted Blanket Intervention Telephone Check-In Forms were 
completed by the PI electronically in REDCap during the calls (Appendix C-2).  Open 
ended responses pertaining to challenges to use were collected through item #6 of the 
Weighted Blanket Daily Use Diary on days caregivers reported the care recipient did not 
use the blanket at all. 
Weighted Blanket Intervention Acceptability Tool Satisfaction and Benefit 
Data. The Weighted Blanket Intervention Acceptability Tool (WBIAT) – Caregiver 
(Appendix D-4) and Care recipient versions (Appendix D-5) - was composed of the 
weighted blanket satisfaction scale and the weighted blanket benefit scale. The WBIAT 
– Caregiver version was completed by caregivers through the Follow-Up Caregiver 
Questionnaire at the end of the intervention period. Care recipients completed the 
WBIAT – Care recipient version by hardcopy questionnaires, which were mailed to 





prompted to complete the WBIAT independently but could receive assistance from their 
family caregivers if unable to do so. Completed WBIAT – Care recipient versions were 
returned by U.S. using preaddressed and stamped envelopes. 
Aim 3 Data Collection of Care Recipient and Caregiver Specific Measures 
Baseline data collection occurred within a week prior to the start of the 4-week 
weighted blanket intervention period and consisted of interviews (See Table 4.4) and 
questionnaires (See Table 4.5). Post-intervention data collection occurred within 1 week 
after completion of the weighted blanket intervention period and also consisted of 
questionnaires and interviews (See Tables 4.4 and 4.5). 
Collection of Measures by Interview. Measures completed by interview (See 
Table 4.4) were conducted over Zoom virtual conferencing system accessible by 
internet or by telephone. Data were entered directly by the PI in REDCap secure data 
management system (See Data Security and Management section for more information 
about REDCap) as the interview was being conducted. The PI checked all data entry 
after completion of each interview to ensure data entry was accurate and complete.   
Collection of Baseline and Follow-up Questionnaires. Caregivers were 
encouraged to complete the Baseline (Appendix F-1) and the Follow-Up Caregiver 
Questionnaires (Appendix F-2) electronically by completing REDCap surveys e-mailed 
to them by the PI. Four caregivers chose to complete hardcopy versions, which they 
received through U.S. Mail. Instructions for completing the questionnaires were 
embedded in the hardcopy forms, and the REDCap electronic surveys.  
Electronic Baseline Caregiver Questionnaires were sent to participants after 
completion of the Baseline Interview Data Collection Zoom sessions. The electronic 
Follow-Up Caregiver Questionnaires were sent after completion of the Post-Intervention 
Interview Data Collection Zoom session. For participants that preferred to complete 
questionnaires electronically through the REDCap’s survey function, an email was 
generated by the PI through the REDCap system with a secure link to complete the 
questionnaires at the designated time (at baseline, or post-intervention). Once surveys 
were completed, the results were auto populated into the REDcap secure data 






For the four caregivers that preferred hardcopy versions of questionnaires, the 
Baseline Caregiver Questionnaires were mailed to caregivers after informed consent 
was obtained. Follow-Up Caregiver Questionnaires were mailed during the third week of 
the intervention period. Dyads were provided with pre-addressed stamped envelopes to 
return the completed questionnaires to the PI. 
Data Security and Management  
All electronically signed consent forms were stored directly in the PI’s SignNow 
account, accessible only to her. SignNow is a HIPAA compliant E-Signature service 
(SignNow, 2021). Hardcopy forms were scanned upon receipt and saved into SignNow, 
then immediately shredded. All outcome measures, demographics, and health history 
data collected electronically was stored in REDCap, which is a secure, HIPAA 
compliant, web-based application designed to support electronic data capture for 
research projects (Harris et al., 2009). All hardcopy completed questionnaires were 
entered into REDCap upon receipt then shredded. All hardcopy diary entries were 
immediately scanned and saved to a Shared Account folder within Box.com, U-M ‘s 
secure cloud storage and collaboration service. The PI was the only one with access to 
these secure records in SignNow, REDCap, and the Shared Account folder. 
All data collection forms were coded using unique ID numbers for each participant 
individually (caregivers and care recipients), and for the dyad. An electronic list of the 
IDs and participant names was kept in a separate Shared Account folder in Box.com, 
accessible only to the PI to protect the participants’ confidentiality.  
Data Analysis  
Qualitative Data Analysis (Aim 1) 
The same analysis outlined in Chapter 3 was carried out to address Specific Aim 1 
of this study (See Chapter 3, Data Analysis, p. 55). In brief, descriptive statistics 
[frequencies, percentiles, means, standard deviations (SDs)] were used to describe the 
demographics of the 21 family caregivers. Audio recordings were transcribed.  
Transcripts were analyzed inductively and iteratively using content analysis and 
constant comparative methods (Glaser & Strauss, 1967). Three analysts independently 
coded and identified minor themes that emerged from the data. Minor themes were 





reach consensus regarding minor theme clusters and names of major themes. 
Discrepancies were resolved through consensus. 
Demographic, Caregiving and Health History Data Analysis (Aims 2 and 3) 
To describe the characteristics of the dyads, descriptive statistics [frequencies, 
percentiles, means, standard deviations (SDs)] were performed to analyze demographic 
data of both care recipients and caregivers, the caregiving information data, and the 
health history data specific to the care recipients. 
Feasibility Data Analysis (Aim 2) 
Enrollment rate was calculated by the number of people enrolled divided by the 
number of people screened, which was reported as a percentage by multiplying by 100. 
The length of time to recruit the desired number of participants (20 dyads) was reported 
in days and the timeline began the day the IRB application was approved (October 26, 
2020). Withdrawal rate was calculated by the number of people that withdrew from the 
study, divided by the total number of people that enrolled, which was multiplied by 100 
to report as a percentage. 
Items 1-3 of the Weighted Blanket Daily Use Diary captured the number of days care 
recipients used the blanket for the recommended duration over the 4-week intervention 
period. The number of days the weighted blanket was used for the recommended 
duration was calculated for each care recipient participant by adding the number of days 
that the 20 minutes was completed across the 4-week intervention period. A group 
mean (SD) of days that the weighted blanket was used for the recommended duration 
was calculated for the sample by adding the total number of days for each participant 
and dividing by the total number of participants. 
The analysis plan for adverse event or injuries was to group events into similar 
clusters and reporting them as frequencies reported by the number of individuals that 
experienced a similar adverse event or injury.  
Acceptability Data Analysis (Aim 2) 
Findings related to acceptability of the weighted blanket intervention are presented 
below and includes findings related to tolerability, satisfaction, and benefit. 
Tolerability. To analyze the measure of tolerability of the weighted blanket, 





tolerability scores (ranged 0 to 10) on the single item from the semi-structured Weekly 
Intervention Telephone Check-In forms (See Appendix C-2). At the subject level, each 
participant received 4 tolerability scores, which were added and divided by 4 to 
determine an overall individual tolerability score for each participant. The mean (SD) 
was then calculated for the group by adding all participants individual tolerability scores 
and dividing by the total number of participants with data collected during the 
intervention period.  
Qualitative data relating to tolerability of the weighted blanket from item #6 of the 
Weighted Blanket Daily Use Diary (See Appendix D-3) were analyzed using content 
analysis and grouping responses that clustered together into categories. Frequencies 
were calculated for each of the categories.  
Weighted Blanket Intervention Acceptability. Descriptive statistics were used to 
analyze satisfaction and benefit of the weighted blanket. An overall caregiver 
satisfaction score was calculated for each participant by adding the responses (1=not 
satisfied to 5=very satisfied) for items #1-8 of the Weighted Blanket Satisfaction Scale 
included in the Weighted Blanket Intervention Acceptability Tool (WBIAT) - Caregiver 
version (See Appendix D-4) and dividing by 8. A group mean (SD) of caregiver 
satisfaction was then calculated by adding the individual caregiver satisfaction scores 
and dividing by the total number of caregivers that completed the WBIAT - Caregiver 
version (See Appendix D-4). Satisfaction items with categorical responses (#9 through 
#13) and dichotomous yes-no responses (#20 and #21) (See Appendix D-4) were 
analyzed using frequencies and percentages. 
An overall care recipient satisfaction score was calculated for each participant by 
adding the responses (1, 2, 3) for items #1-6 (See Appendix D-5) and dividing by 6. A 
group mean (SD) for care recipient satisfaction was calculated by adding the individual 
care recipient satisfaction scores and dividing by the total number of care recipients that 
completed the Weighted Blanket Intervention Acceptability Tool (WBIAT) - Care 
recipient version. Satisfaction items with categorical responses (#7) and dichotomous 
yes-no responses (#10 and 11) (See Appendix D-5) were analyzed using frequencies 





by grouping responses that clustered together into categories. Frequencies were 
calculated for each category.  
An overall caregiver benefit score was calculated for each participant by adding the 
responses (1=not at all, 2=some, 3=a great deal) of items #14-19 (See Appendix D-4) 
and dividing by 6.  A group mean (SD) was calculated by adding the individual caregiver 
benefit scores and dividing by the total number of caregivers that completed the 
Weighted Blanket Intervention Acceptability Tool-Caregiver version. Open ended items 
(#22-26) relating to caregiver benefit (See Appendix D-4) were analyzed using content 
analysis, grouping responses that clustered together into categories, and calculating 
frequencies for each category.  
The care recipient benefit item was scored for each participant (1 = Not at all, 2 = 
Some, 3 = A great deal) (See Appendix D-5). A group mean (SD) for this item was 
calculated by adding each individual care recipient’s score and dividing by the total 
number of care recipients that completed the Weighted Blanket Intervention 
Acceptability Tool (WBIAT)-Care recipient version. The open-ended items (#9, #14) on 
the care recipient WBIAT related to benefit (See Appendix D-5) were analyzed using 
content analysis by grouping responses that clustered together into categories, which 
are reported as frequencies.  
Feasibility of Collecting Outcomes Measures Data Analysis (Aim 3) 
Participant and overall sample level analysis for Aim 3 are summarized in Table 4.6. 
Each measure completed at each data collection timepoint for each participant was 
scored as “Complete” or “Not Complete”. A measure was considered complete if there 
were no missing item responses. A group percentage of participant completion for each 
measure was calculated by summing the number of participants that fully completed the 
specific measure at the specific time point divided by the total number of participants 
with data collected at the specific data collection timepoint then multiplying by 100 to 
arrive at a percentage. 
Table 4.6 
Aim 3 Instrument Completion Outcomes, Measures, Individual Calculations and Group Analysis Plans 





Participant completion of 
measures (analyzed at 
baseline and at post-
intervention) 
Percentage of completion 
by participants of each 
individual measure at each 
timepoint 
Each measure at each 
timepoint was scored 
using a dichotomous 
response of “Complete” or 
“Not Complete”. A 
measure was considered 
complete if there were no 
missing item responses 
Group percentage of 
participant completion = 
total # of subjects that fully 
complete the specific 
measure at the specific 
timepoint / total # of 
subjects  
Missing data (analyzed at 
baseline and at post-
intervention) 
Percentage of missing 
data of each individual 
measure at each timepoint 
N/A Percentage of missing 
data = (total # of missing 
items across subjects for 
each measure at each 
timepoint / (total # of items 
in the measure x total # of 
subjects)) multiplied by 
100 
Note. CG Caregiver, CR Care recipient with ADRD 
 
The percentage of missing data for each measure at each timepoint was calculated 
by adding the number of items missed across participants for each measure at each 
timepoint, divided by the number of items in the specific scale multiplied by the total 
number of participants who completed the scale, then multiplying by 100. For example, 
there are 34 items in the Cohen-Mansfield Agitation Inventory (CMAI). If three 
caregivers had data collected using the CMAI at baseline and one caregiver missed 2 
items, the second caregiver missed 5, and the third caregiver missed 0, the percentage 
of missing data for the group would be calculated as ((2+5+0)/(34x3)) x 100 = 6.9% 
Each of the outcome measurement tools were scored for each subject at baseline 
and at post-intervention. A mean (SD) for all scales and subscales were calculated 
across participants at baseline and at post-intervention by adding individual subject 
scores and dividing by the total number of subjects (See Table 4.7).   
The QOL-AD and RAID scales were completed by proxy report by caregivers and by 
self-report by care recipients which were scored separately to yield caregiver and care 
recipient overall scores. According to the scoring guidelines and recommendations of 
the instrument developers, individual caregiver and care recipient scores are averaged 
to yield a total score for each instrument for each participant dyad (Logsdon et al., 1999; 
Shankar et al., 1999). The group mean (SD) of caregiver scores, care recipient scores, 






Scoring and Analysis of Instrument Scores at Baseline and at Post-intervention 




Analysis Across Subjects 
CMAI 
 
34-238 N/A Mean (SD) for baseline and post-intervention overall 
scale scores  
PSQI 
 
0-21 Component 1: 0-3 
Component 2: 0-3 
Component 3: 0-3 
Component 4: 0-3 
Component 5: 0-3 
Component 6: 0-3 
Component 7: 0-3 
Mean (SD) for baseline and post-intervention overall 
scale and subscale scores  
ESS 
 
0-24 N/A Mean (SD) for baseline and post-intervention overall 
scale scores  
NPI-Sleep 
Item 
0-12 Frequency: 1-4 
Severity: 1-3 
CG distress 0-5 
Mean (SD) for baseline and post-intervention overall 
scale and subscale scores 
QOL-AD – CG  
 
13-52 N/A Mean (SD) for baseline and post-intervention CG scale 
scores  





  Caregiver and care recipient scores were averaged for 
each participant to yield an overall QOL-AD score. 
Group mean (SD) of overall scores were calculated at 
baseline and post-intervention 
CWBS 
 
1-5 Basic Needs 
Subscale: 1-5 
ADL subscale: 1-5 
Mean (SD) for baseline and post-intervention overall and 
subscale scores  
SF-12 
 




Mean (SD) for baseline and post-intervention overall and 
subscale scores  
MoCA 0-30 N/A Mean (SD) for baseline and post-intervention overall 
scale scores  
NPI 
 
0-144 CG distress 
subscale: 0-60 
 
Mean (SD) for baseline and post-intervention overall and 
CG distress subscale scores 
RAID – CG 0-54 N/A Mean (SD) for baseline and post-intervention CG scale 
scores 




0-54 N/A Caregiver and care recipient RAID scores were 
averaged for each participant to yield an overall RAID 
score. Group mean (SD) of overall RAID scores were 
calculated at baseline and post-intervention 
Note. ADL Activities of daily living, CG caregiver, CMAI Cohen-Mansfield Agitation Inventory, CR care recipient, 
CWBS Caregiver Well-Being Scale Short Form, ESS Epworth Sleepiness Scale, MoCA Montreal Cognitive 
Assessment Test, NPI Neuropsychiatric Inventory, PSQI Pittsburgh Sleep Quality Index, QOL-AD Quality of Life in 
Alzheimer’s Disease Scale, RAID Rating Anxiety in Dementia Scale 




Aim 1 Participant Characteristics  
Of the 21 caregivers, the majority were female (n=17; 81%) and non-Hispanic white 





education levels of some college or above. Most of the participants were caring for a 
spouse (n=17), while 4 were caring for a parent with ADRD. 
Participants reported having acted as the primary caregiver for an average of 40.0 
months (SD=36.0), or approximately 3.33 years. The mean number of hours of 
caregiving per week was 84 (SD=55.9). Based on participants’ self-report, nine cared 
for a relative with Alzheimer’s disease, 1 with vascular dementia, 1 with a mixed 
dementia diagnosis, 1 with frontotemporal dementia, 7 with Lewy Body dementia, 1 with 
posterior cortical atrophy, and 1 with an unspecified dementia diagnosis. 
Family Caregivers’ Initial Perceptions of Weighted Blankets (Aim 1) 
Caregiver perceptions’ about the use of weighted blankets consisted of three minor 
themes (underlined below) that clustered into one major theme, “Caregiver perspectives 
on weighted blankets” (See Table 4.8). 
Caregivers made suggestions relating to weighted blankets after hearing the brief 
description and seeing a visual presentation of the blankets (See Table 4.8).  
 “I would definitely need to be able to wash it. My husband is incontinent, I wash 
 his bedding every day. If it isn’t washable, I can’t use it.” 
Some caregivers mentioned potential concerns.  One caregiver mentioned cost 
being a concern. 
 “I don’t know if I’d want to spend that kind of money on something without having 
 tried it out first to see if it would be of benefit.” 
One caregiver described how her loved one had tried a weighted blanket before, but 
his experience was a concern for her. 
 “He was using a really heavy blanket. He was saying he couldn’t stand it 
 because he couldn’t move. And so, it wasn’t, you know, normally that weight is 
 supposed to feel good even with your autism. He doesn’t like that. It’s almost like 
 it’s the opposite effect for  him. 
Others expressed positive initial perceptions towards the weighted blanket.  
 “She got a blanket for her birthday from (stated name), and we have some 
 blankets here and a couple from Costco that we’ve had a long time. They are all 
 on the heavier side. I think it’s secondary to the warmth but who wouldn’t like it? 








Major and Minor Themes Relating to Family Caregivers’ Initial Perceptions of Weighted Blankets 
Major Theme Minor Theme Examples 
Caregiver perspectives on weighted 
blankets 
Suggestions I know for him, he would want something bright. He 
loves bright colors, blues, yellows, reds. The primary 
colors. If it was bright yellow, oh he would be surely be 
more likely to use it.  
 
How soft is it? You have two different kinds in that 
picture, a softer looking one and one that looks like 
cotton. I think my husband would like the softer one, but 
wouldn’t have much interest in the cotton one. Would 
he have a choice in the type of fabric? 
Concerns I’m looking at the pictures of blankets. The other thing 
is, um, especially since I bought such a heavy one is 
could a weighted blanket ever turn into a form of 
restraint? 
 
I don’t know if I’d want to spend that kind of money on 
something without having tried it out first to see if it 
would be of benefit. 
Positive 
perceptions 
I had heard of the heavy blanket but when I heard of it 
in terms of Alzheimer’s patients, I thought boy that’s 
interesting if that blanket on him, the weight of it would 
bring comfort somehow and maybe settle him down 
more. 
 
When I take her into the bedroom I put this weighted 
blanket, I mean she has a sigh of relief that, okay, it’s 
something I know and within three, four, five minutes 
she’s sleeping. 
 
Participant Characteristics of Study Sample for Aims 2 and 3 
Of the 21 participant dyads that were enrolled, 20 completed the study. The 
sociodemographic characteristics, along with characteristics relating to the dementia 
diagnoses and caregiving patterns of the 20 dyads that completed the weighted blanket 
intervention period are in Table 4.9. Overall, the sample was mostly non-Hispanic White 
and well-educated. Most dyads were married or partnered. Most care recipients had 
Alzheimer’s disease and on average caregivers reported providing 19 hours of care a 
day to their relatives with ADRD (Table 4.9). Characteristics of the dyad that withdrew 
were similar to the sample that was retained (e.g., female caregiver, caregiver and care 
recipient were both 82 years old, both were non-Hispanic white, and both had at least 
some college education). 
Table 4.9 
Sociodemographic, Dementia Diagnosis, and Caregiving Characteristics of Study Sample  
 Care Recipients (n=20) Caregivers (n=20) 
Female (%) 35 80 
Mean age (SD) 77.7 (10.2) 66.4 (11.2) 
Race/ethnicity (%)   





Non-Hispanic Black  5 5 
Education (%)   
< High school  10 0 
High school  15 20 
Some college  20 10 
College and above  55 70 
Relationship between members of 
dyad % (n) 
  
Married or partnered 80 (16) 
Child caring for parent 20 (4) 
Mean duration of ADRD diagnosis in 
months (SD) 
45.7 (28.1) 
Number of care recipients with type of 
ADRD 
 
Alzheimer’s dementia 13 
Vascular dementia 1 
Mixed type dementia 1 
Lewy Body dementia 1 
Posterior cortical atrophy 1 
Not specified or unknown 3 
Mean number of years having lived 
together (SD) 
35.6 (19.7) 
Mean number of hours of care 
provided by caregiver each day (SD) 
19.0 (32.3) 
 
Table 4.10 outlines health conditions of care recipients and describes the 
psychotropic, sleep, and memory related medications care recipients were taking at 
baseline. No new conditions were reported at follow up. One care recipient had started 
taking Rivastigmine and one had stopped taking Ativan during the 4-week study period.  
Table 4.10 
Health Conditions and Select Medications of Care Recipient Participants as Reported by Caregivers at Baseline  
Conditions n   Medication Indication n 
Hypertension 3   Donepezil Enhance cognition 11  
Other heart conditions 4  Namenda Enhance cognition 7  




Cancer  2  Lexapro Treat depression and/or 
anxiety 
4  
Congestive heart failure 2 Celexa Treat depression 3  
Anxiety  2 Trazodone Promote sleep 2 
Hearing impairment 2 Bupropion Treat depression 1 
Urological conditions 2 Rivastigmine Enhance cognition 1 
Arthritis  1 Xanax Treat anxiety 1 
Chronic traumatic encephalopathy 1 Ativan Treat anxiety 1 
Cerebrovascular accident 1 Clonazepam Treat anxiety 1 
Depression 1 Melatonin Promote sleep 1 
Enlarged prostate 1 Seroquel Treat psychosis 1 









Macular degeneration 1 
Obsessive compulsive disorder 1 
 
Feasibility Results (Aim 2) 
Feasibility results and the a priori feasibility benchmarks are in Table 4.11. The 
enrollment rate was higher than anticipated and the withdrawal rate was low. Eleven 
dyads did not enroll which was due to: care recipients with ADRD had sleep apnea 
(n=6), care recipients had COPD (n=2), the perceived time commitment to participate 
was too much (n=2), and the care recipient had a shoulder injury (n=1). One dyad 
withdrew due to caregiver sickness before the intervention period began.  
Table 4.11 
Results of Feasibility Measures Compared to Predefined Benchmarks of Feasibility 
Measures of Feasibility Predefined Benchmarks of Feasibility Results of This Study 
Enrollment percentage ≥ 50% 64% 
Length of time to recruit desired 
sample 
≤ 5 months 3.9 months 
Average number of days 
weighted blanket was used for 
the recommended duration (SD) 
≥ 21 23.8 days (SD=6.4) 
Withdrawal percentage < 25% 5% 
Injuries and adverse events None None 
 
On average, participants used the weighted blanket for 3.7 (SD=3.9) hours a day, 
which was more than the minimum recommended 20 minutes a day. Information about 
the use of weighted blankets by care recipients throughout the 28-day intervention 
period is in Table 4.12. Over half of the participants did not use the blanket at all at least 
one of the days throughout the intervention period, and three did not use it for the 
recommended 20 minutes for 10 or more days (Table 4.12). 
Table 4.12 
Patterns of Use of Weighted Blankets by Participants with Dementia Throughout the 28-Day Intervention Period 
Use of the Weighted Blanket  Care Recipients (n=20) 
Mean number of hours of WB use per day (SD) 3.7 (3.9) 
Number (%) of CRs that did not use the WB at all at least 1 
day* 
12 (60) 
Number (%) of CRs that did not use the WB for the 
recommended 20 minutes or more for: 
 
1 day* 3 (15) 
2 to 3 days* 3 (15) 
4 to 5 days* 3 (15)  
10 or more days* 3 (15) 
Note. CR care recipient, WB Weighted blanket 






Acceptability Results: Tolerability, Satisfaction and Benefit (Aim 2)  
Results pertaining to acceptability of the intervention consists of measures of 
tolerability, satisfaction, and benefit. The descriptive statistics for each of the 
quantitative measures are in Table 4.13.  
Table 4.13 
Results of Measures of Acceptability: Tolerability, Satisfaction and Benefit  




Tolerability*   20 CRs 8.9 (2.1) 10 1-10 0 did not tolerate the blanket 
at all to  




20 CGs 4.7 (0.4)  4.9 3.6 to 5 1 = Not satisfied to  
5 = Very satisfied 
Care Recipient 
Satisfaction 
13 CRs 2.8 (0.2) 2.8 2.5-3.0  1 = Not satisfied to  
5 = Very satisfied 
Caregiver Benefit  20 CGs 2.5 (0.4) 2.7 1.7 – 3.0  1 = Not at all to  
3 = A great deal 
Care Recipient 
Benefit  
13 CRs 2.8 (0.4) 3 2-3 1 = Not at all to  
3 = A great deal 
Note. CG caregivers, CR care recipients, SD standard deviation 
*Care recipient tolerability of the weighted blanket as reported by caregivers 
 
The results of other informational items in the satisfaction scales from the caregivers 
and care recipients are in tables 4.14 and 4.15 respectively. 
Table 4.14 
Information about the Weighted Blanket in the Caregiver Satisfaction Scale (N=20)  
Item Response Options Frequency (%) 
How heavy was the blanket that 
your relative used 
 
10 pounds 1 (5) 
12 pounds 15 (75) 
I don’t know 4 (20) 
What did you think about the weight 
of the blanket for your relative 
The weight was about right for my relative 16 (80) 
I would have liked it to be lighter 4 (20) 
I would have liked it to be heavier 0 (0) 
What is your opinion about the 
recommendation that the weighted 
blanket be used daily by your 
relative? 
The recommended everyday use of the weighted 
blanket was about right for us. 
17 (85) 
I would have liked the recommended use of the 
weighted blanket be less than every day. 
2 (10) 
I would have liked the recommended use of the 
weighted blanket be multiple times a day. 
1 (5) 
What is your opinion about the 
recommended amount of time the 
weighted blanket was to be used by 
your relative each day? 
The recommended amount of time was about right 
for us. 
11 (57.9) 
I would have liked less recommended blanket use 
time. 
1 (5.3) 
I would have liked more recommended blanket use 
time. 
7 (36.8) 
What did you think about completing 
a Weighted Blanket Daily Use 
Diary? 
Completing a diary entry every day was about right 
for me. 
16 (80) 
I would have liked to complete fewer diary entries. 4 (20) 
I would have liked to complete more diary entries. 0 (0) 
Overall, would you recommend the 
use of a weighted blanket to other 
Yes 19 (95) 





individuals caring for someone with 
dementia? 
Will you continue to encourage your 
relative to use the weighted blanket? 
Yes 19 (95) 
No 1 (5) 
 
Table 4.15 
Information about the Weighted Blanket in the Care Recipient Satisfaction Scale (N=13) 
Item Response Options Frequency (%) 
How did the weight of the blanket 
feel to you? 
The weight was about right for me. 12 (92.3) 
I would have liked it to be heavier. 0 (0) 
I would have liked it to be lighter. 1 (7.7) 
Will you continue to use the 
weighted blanket?  
Yes 12 (92.3) 
No 1 (7.7) 
Overall, would you recommend 
using a weighted blanket to other 
individuals with dementia? 
Yes 13 (100) 
No 0 (0) 
 
Qualitative Findings Related to Tolerability 
Twelve caregivers recorded days that the blanket was not used at all by their 
relatives with ADRD and described situations or circumstances that made using blanket 
a challenge which clustered into 4 categories: dyads were too busy, care recipients did 
not want to use the blanket (reason not specified), contextual circumstances (e.g., 
holiday celebrations, warm climates), the blanket was too heavy (Table 4.16). 
As these data were collected using the Weighted Blanket Daily Diary (See Appendix 
D-3), many provided more than one example for each category because the diary was 
completed daily. The number of instances for which an example was provided for the 
category and the total number of participants that gave examples is noted in Table 4.16. 
Table 4.16 
Reasons Using the Weighted Blanket was a Challenge as Reported by Caregivers (n=12) 
Category Examples Number of Instances per 
Category (Number of Participants 
that Gave Examples) 
Dyads were too busy We were busy and hardly sat down at all 
today, so she didn’t use the blanket. 
23 (6) 
Contextual circumstances We were busy with the holiday celebrations, 
we had family over today. With all the 
excitement, he just did not use the blanket.  
 
It was very warm out today, so he did not 
want to use the blanket. 
9 (4) 
Care recipients did not want 
to use the blanket (reason 
not specified) 
I tried to encourage him to use it multiple 
times, but he just didn’t want to. 
7 (4) 
Blanket was too heavy I asked her to use it, but she said, “too heavy, 







She asked to use her lighter, softer blanket 
today instead of the weighted blanket. 
 
Qualitative Findings Related to Satisfaction 
When care recipients were asked, using the Satisfaction Scale in the Weighted 
Blanket Intervention Acceptability Tool, what they liked most and least about using the 
weighted blanket, the responses clustered into three (See Table 4.17) and four 
categories (See Table 4.18), respectively.  
Table 4.17 
What Care Recipients Liked Most About Using the Weighted Blanket (n=12) 
Category Examples Number of Participants that 
Gave Examples 
It provided comfort It was cozy and comfy and blue is my favorite 
color      
 
It was very comfortable, relaxing, and made 
me feel safe.     
6 
It improved sleep I liked how much better I slept at night.          4 
It provided warmth It was so warm and cuddly. 2 
 
Table 4.18 
What Care Recipients Liked Least About Using the Weighted Blanket (n=9) 
Category Examples Number of Participants that 
Gave Examples 
It was too heavy (at times) It got heavy after a while and I needed to 
move my legs. 
3 
The weighted beads clumped 
together 
The small balls that cluster together. I have to 
break them apart with my hands or my feet.                                                                 
2 
It was too hot (at times) At times it was too hot in the Florida climate 2 
It could be softer I prefer a regular, softer blanket.                                                                                                                         2 
 
Qualitative Findings Related to Benefit 
When caregivers were asked about when the weighted blanket was most helpful and 
least helpful for their relatives using the weighted blanket benefit scale, responses 
clustered into 3 categories (See Table 4.19) and 2 categories respectively (See Table 
4.20). 
Table 4.19 
When Using the Weighted Blanket was Most Helpful as Reported by Caregivers (n=16) 
Category Examples Number of Participants that 
Gave Examples 
Overnight It was most helpful overnight, his sleep 
improved noticeably.  
6 
Afternoon naptime It helped her get into relax mode during her 
afternoon naps. 
6 
After dinner/evening time I noticed much less confusion at sundowning 









When Using the Weighted Blanket was Least Helpful to Care Recipients as Reported by Caregivers (n=7) 
Category Examples Number of Participants that 
Gave Examples 
Overnight From what I observed, at bedtime/overnight. I 
believe that the weight was too much to be 
comfortable and get a good night's rest for him. 
5 
When relative was restless 
or agitated 
When he was already agitated, he would pull it 
off.   
2 
 
Two caregivers provided suggestions regarding the weighted blankets.  
 “Not sure how the weight by body weight was determined but I wonder if my Dad 
 would  fare better with a lighter weight blanket especially come summer heat and 
 humidity. Because of our success with the weighted blanket through this study, it 
 is my intention to purchase a lighter weight version to use as our weather 
 changes.” 
 
 “Maybe a soft cover that's removable” 
 
Care recipients provided responses on the Benefit Scale regarding how they felt 
when using the weighted blanket, which clustered into 3 categories (See Table 4.21). 
Table 4.21 
How Care Recipients Felt While Using the Weighted Blanket (n=13) 
Category Examples Number of Participants that 
Gave Examples 
Comfortable It felt comfortable, great and warm. 8 
Warm It made me feel warm, safe and secure. 7 
Sleepy Made me fall right to sleep.  2 
 
Three care recipients provided recommendations and changes for the weighted 
blanket. One recommended that couples use the blanket together. The other 2 care 
recipients suggested the blanket be made of a softer material, such as fleece instead of 
cotton. One also suggested making a grid in the fabric, so the weighted beads stayed 
more evenly disbursed throughout the blanket. 
Feasibility of Collecting Outcomes Measures (Aim 3) 
The feasibility of collecting care recipient outcome measures (i.e., BPSD, cognitive 
function, quality of life) and caregiver measures (well-being, self-reported health) is 
reported here. Specifically, information on the completion of measures and missing data 





Participant Completion of Measures and Missing Data Results 
Overall participant completion percentages and percentages of missing data of all 
measures are in Table 4.22. Completion rates of caregiver measures (i.e., CMAI, PSQI, 
ESS, QOL-AD – CG, CWBS, SF-12, NPI, RAID – CG) ranged from 80-100% across 
timepoints. The completion rate for the MoCA for those with ADRD was 100%. The 
RAID – CR and the QOL – CR completed by interview of those with ADRD had over 
50% missing data and low completion rates. 
Table 4.22 
Participant Completion Rates and Missing Data for Each Outcome Measure 
Measure Source of Completion Baseline (n=21) Post-Intervention (n=20) 
% of Participant 
Completion A*  
% of Missing 
Data B* 
% of Participant 
Completion A* 
% of Missing 
Data B*   
CMAI CG questionnaire 100.0 0  90.0 0.3  
PSQI CG questionnaire 95.0 0.5 100.0 0  
ESS CG questionnaire 100.0 0  100.0 0  
QOL-AD – CG CG questionnaire 81.0 1.5 80.0 1.5  
CWBS CG questionnaire 100.0 0  100.0 0  
SF-12 CG questionnaire 100.0 0  100.0 0  
NPI CG interview 100.0 0 100.0 0  
RAID – CG CG interview 100.0 0  100.0 0  
RAID – CR CR interview 47.6 52.3 40.0 50.0 
QOL-AD – CR CR interview 38.1 61.1 35.0 50.8 
MoCA CR interview 100.0 0  100.0 0  
Note. CG caregiver, CR care recipient, CMAI Cohen-Mansfield Agitation Inventory, CWBS Caregiver Well-Being 
Scale Short Form, DC data collection, ESS Epworth Sleepiness Scale, MoCA Montreal Cognitive Assessment Test, 
NPI Neuropsychiatric inventory, PSQI Pittsburgh Sleep Quality Index, QOL-AD Quality of Life in Alzheimer’s Disease 
Scale, RAID Rating Anxiety in Dementia Scale 
A % of Participant Completion = total # of subjects that fully complete the specific measure at the specific timepoint / 
total number of participants (n=21 at baseline, n=20 at post-intervention). 
B % of missing data = total # of items missed across participants for each measure at each timepoint, divided by the 
number of items in the specific scale multiplied by the total number of participants, then multiplying by 100 
*Columns A and B will not necessarily add up to 100, as the unit of analysis for A was each measure as a whole, and 
for B was items within each measure.  
 
The only item that was missed more than once across participants was from the 
QOL-AD, item #7 which asked caregivers and care recipients to rate the care recipient’s 
quality of life in terms of their marriage. This item was missed by 4 caregiver and 2 care 
recipient participants at baseline and at post-intervention. For these participants, the 
care recipients were widowed, so this item was skipped, thus missing. Other items were 





Results of Outcome Measures  
The mean (SD) for overall scale and subscale scores for each instrument at each 
data collection time point for the 20 dyads that completed the intervention are in Table 
4.23. The cognitive impairment severity of the sample varied but was overall moderate 
with a mean MoCA of 9.2 (SD=8.0) at baseline (Saczynski et al., 2015). Given the large 
amount of missing data on the RAID and QOL-AD measures completed by care 
recipients, a RAID Total and QOL-AD Total score were not calculated, which are 
typically calculated by averaging care recipient and caregiver scores.  
Overall, 4 of 6 measures of BPSD showed improvements from baseline to post-
intervention (NPI-Total and caregiver distress scores, CMAI, RAID – CG, ESS; See 
Table 4.23), but efficacy testing was not performed, and these improvements are not 
indicative of clinical significance. Total NPI scores were similar to prior community-
based samples of PLWD (Charlesworth et al., 2016; Maidment et al., 2020), while the 
caregiver distress scores were higher (Huang et al., 2015). The CMAI scores were 
overall higher than other community-based samples of PLWD, while the RAID scores 
were lower (Figueiro et al., 2019; Livingston et al., 2017; Stanley et al., 2013). The RAID 
scores of the 10 care recipients able to complete this measure tended to be lower than 
those reported by their caregivers (Table 4.23). RAID scores suggest that overall, the 




   
Table 4.23 
Results of Scored Outcome Measures Collected at Baseline and at Post-Intervention 
Concept Measures and Subscales Scale Ranges A Baseline (n=20)* Post-Intervention (n=20)* 
Mean (SD) Mean (SD) 
CR Cognitive Function  MoCA  0-30 9.2 (8.0) 9.1 (8.2) 
CR BPSD (Global BPSD)  NPI Total  0-144 25.0 (16.0) 22.8 (20.1) 
CG Distress Subscale 0-60 13.2 (7.6) 11.3 (9.8) 
CR BPSD (Agitation Specific)  CMAI 34-238 59.1 (13.4) 55.8 (14.4) 
CR BPSD (Anxiety Specific)  RAID     
RAID – CG  0-54 9.7 (6.0) 7.7 (5.0) 
RAID – CR (n=10) 0-54 5.7 (5.8) 5.4 (4.8) 
CR BPSD  
(Sleep Disturbance Specific)  
NPI-Sleep Domain Total 0-12 3.9 (2.9) 4.3 (3.7) 
Frequency 0-4 1.9 (1.0) 2.0 (1.1) 
Severity 0-3 1.8 (0.7) 1.9 (0.8) 
CG Distress 0-5 2.8 (1.4) 2.8 (1.4) 
PSQI Total 0-21 6.3 (3.1) 6.3 (3.5) 
C1 Subscale 0-3 0.9 (0.7) 1.0 (0.8) 
C2 Subscale 0-3 0.8 (0.8) 1.0 (0.8) 
C3 Subscale 0-3 0.3 (0.6) 0.3 (0.6) 
C4 Subscale 0-3 0.7 (0.8) 0.7 (1.0) 
C5 Subscale 0-3 1.4 (0.5) 1.2 (0.5) 
C6 Subscale 0-3 1.0 (1.3) 0.9 (1.3) 
C7 Subscale 0-3 1.3 (0.9) 1.4 (1.0) 
ESS 0-24 9.9 (5.7) 9.3 (6.3) 
CR Well-Being  QOL-AD     
QOL-AD – CG  13-52 33.3 (5.7) 33.7 (5.3) 
QOL-AD – CR (n=10) 13-52 41.3 (5.1) 42.4 (3.0) 
CG Well-Being  CWBS Overall 1-5 3.9 (0.6) 4.0 (0.6) 
Basic Needs Subscale 1-5 4.2 (0.7) 4.2 (0.6) 
ADL Subscale 1-5 3.8 (0.7) 3.8 (0.7) 
SF-12 Total 0-100 50.2 (5.5) 48.3 (6.1) 
PCS 0-100 56.9 (6.7) 52.8 (9.2) 
MCS 0-100 43.1 (12.6) 43.9 (11.1) 
Note. ADL Activities of daily living, BPSD behavioral and psychological symptoms of dementia, C* Composite* (*=1,2,3,4,5,6, or 7) subscale, CG caregiver, CR 
care recipient, CMAI Cohen-Mansfield Agitation Inventory, CWBS Caregiver Well-Being Scale Short Form, DC data collection, ESS Epworth Sleepiness Scale, 
MCS Mental Composite Scale, MoCA Montreal Cognitive Assessment Test, NPI Neuropsychiatric inventory, PCS Physical Composite Scale, PSQI Pittsburgh 





*All measures scored using data from the 20 dyads that completed the intervention period. The QOL-AD and the RAID by care recipient report were only 
completed by 10 care recipients, thus the n for these scored measures is 10 instead of 20. 
A   Information on Scale and Subscale Ranges 
 -MoCA: Higher scores indicate better cognitive function. ≤9 indicative of moderate dementia, ≤17 indicative of mild dementia, ≤23 indicative of mild 
 cognitive impairment, ≤30 normal cognitive function 
 -NPI: Higher scores indicative of greater frequency and severity of neuropsychiatric symptoms. Higher caregiver distress scores indicate of greater 
 caregiver distress related to neuropsychiatric symptoms.  
 -CMAI: Higher scores indicative of greater agitation severity. 
 -RAID: Higher scores indicative of greater anxiety, a score of 11 or more suggests significant clinical anxiety. 
 -PSQI: Higher total scores indicative of overall worse sleep quality. Component 1: higher scores indicate worse sleep quality. Component 2: higher scores 
 indicate longer sleep latency. Component 3: higher scores indicate shorter sleep duration. Component 4: higher scores indicate lower sleep habitual 
 efficiency. Component 5: higher scores indicate more severe sleep disturbances. Component 6: higher scores indicate more sleep medication use. 
 Component 7: higher scores indicate more severe daytime dysfunction due to sleep disturbances. 
 -ESS: Higher scores indicate more severe daytime sleepiness. 
 -QOL-AD: Higher scores are reflective of higher reported quality of life. 
 -CWBS: Higher total scores indicate greater reported well-being. Higher needs and activities of daily living domain scores indicate that the needs and 
 activities are being met. 
 -SF-12: Higher scores on subscale scores are reflective of better physical and mental self-reported health functioning, while higher overall SF-12 





The Pittsburgh Sleep Quality Index and Epworth Sleepiness Scale scores were 
similar from baseline to post-intervention and were comparable to another sample of 
older adults with ADRD (Figueiro et al., 2019). PSQI scores of ≥ 5 are typically 
indicative of moderate or severe sleep difficulties (Buysse et al., 1989), which suggests 
that overall, participants did experience sleep difficulties. The highest component scores 
were component 5, which measures sleep disturbances and component 7, which 
measures daytime dysfunction. NPI-Sleep item scores increased from baseline to post-
intervention (See Table 4.23), but this increase was not clinically significant (Aarsland et 
al., 2007). 
Regarding measures of care recipient quality of life, the QOL-AD scores were similar 
from baseline to post-intervention (See Table 4.23). The scores of the 10 care recipients 
that reported on the QOL-AD tended to be higher than those reported by their 
caregivers (Table 4.23). Similar differences in self-reported quality of life by PLWD and 
their caregivers have been shown in prior research (Moyle et al., 2014). 
Measures of caregiver well-being demonstrated that CWBS scores remained the 
same from baseline to post-intervention, while scores on the total SF-12 Health Survey 
decreased reflecting a decrease in overall self-reported health (Table 4.23). The Mental 
Health Component scores (MCS) stayed relatively the same, while the Physical Health 
Component scores (PCS) decreased reflecting a decrease in self-reported physical 
health (Table 4.23). Compared to a similar community-based sample, the PCS scores 
were higher in this study and MCS scores were lower (Farina et al., 2017). 
Discussion 
Findings support that weighted blankets are a feasible and acceptable non-
pharmacologic in-home care strategy as perceived by older adults with ADRD and their 
family caregivers. Collecting outcomes of care recipient BPSD and quality of life, as well 
as caregiver well-being and self-reported health by caregiver completed measures was 
feasible. It was feasible to collect the outcome of cognitive function by interview of 
participants with ADRD but collecting measures of BPSD and quality of life by care 
recipient self-report was not. Findings provide information to further refine the 
development and testing of the virtually delivered weighted blanket intervention for 





Significance of Findings 
This study provides preliminary support for 4 key areas that are essential to the 
development of successful community-based interventions for families affected by 
ADRD including safety, acceptability, feasibility of the virtual delivery, and feasibility of 
collecting multiple types of caregiver and care recipient specific outcomes. 
Safety 
No side effects were reported with the use of the weighted blanket. This is the first 
study to indicate safety with use of weighted blankets by older adults with ADRD who 
have historically been excluded from weighted blanket intervention studies (Eron et al., 
2020). Safety is an essential component of successful, widely adopted community-
based interventions (Gadke et al., 2021), yet safety has proven to be difficult to maintain 
when managing BPSD, particularly with the use of pharmacologic approaches (Seitz et 
al., 2013). Alternatively, non-pharmacologic interventions have consistently 
demonstrated high degrees of safety (Trivedi et al., 2018), which is consistent with the 
findings of this study. Given the critical need for home-based non-pharmacologic 
interventions to treat BPSD and the essential role of safety in promoting broader use of 
these interventions in the community, findings of this study are a promising indication of 
the potential of weighted blankets for community dwelling PLWD. 
High Degree of Intervention Acceptability 
Overall high scores of tolerability, participant satisfaction, and benefit with the 
intervention in this study are meaningful indicators of intervention acceptability. As 
acceptability is often an underexamined, but key factor in promoting widespread, 
sustained use of interventions in the community (Gadke et al., 2021; Harris & Titler, 
2020), this study’s findings related to acceptability are significant. By involving 
participants with ADRD and their family caregivers as key stakeholders and by 
determining acceptability in the preliminary stages of development, this intervention has 
an increased likelihood of successful implementation and greater capacity to make a 
meaningful impact in the future in the lives of families affected by ADRD (Gitlin et al., 
2020; Qiu et al., 2019). These findings are a steppingstone in the development of an 
intervention that has the potential to be well tolerated, satisfying, and beneficial to 





Feasibility of Virtual Delivery of the Intervention 
Feasibility of the virtual delivery of the weighted blanket intervention was 
demonstrated by high degrees of satisfaction with the web-based delivery and the 
intervention overall. These findings are significant as there is a critical need for virtually 
delivered home-based interventions even before the COVID-19 pandemic began 
(Hopwood et al., 2018), but in many ways pandemic related public health restrictions 
heightened this need (Aledeh & Adam, 2020).  
Key barriers to use of virtual interventions by this population include increased 
complexity in accessing virtual study resources and lack of tailoring interventions to the 
unique needs of participants (Hopwood et al., 2018). This study addressed these 
barriers by using a widely adopted, user friendly virtual conferencing system (Zoom) to 
interact with study participants. For those that did not have reliable internet access, all 
virtual components (e.g., consent, data collection, review of study materials) could be 
completed by accessing Zoom by telephone. Having the option to participate using the 
internet or by telephone is significant when considering more widespread intervention 
adoption, as nearly 1/3 of Medicare beneficiaries report not having reliable digital 
access at home (Reyes et al., 2020). Tailoring the intervention to the needs of 
participants was prioritized in this study by offering multiple avenues to interact and 
participate in the study, by providing blankets of different weights based on participant 
body weight, and by encouraging personalized daily use of the blanket based on 
individual preferences and circumstances. The design of this intervention and study 
components addressed primary barriers to online-intervention success (Hopwood et al., 
2018), which likely bolstered the feasibility of the virtual delivery. 
Feasibility of Collecting Multiple Outcomes 
To promote broader use by individuals, families, and clinicians, it will be necessary 
to determine the effects of weighted blankets on outcomes of importance to families 
affected by ADRD, such as BPSD. Although this study did not examine efficacy, it does 
provide valuable information that can be used to inform measurement selection in future 
weighted blanket intervention randomized clinical trials. Despite limitations in collecting 
outcomes by care recipient self-report, findings of this study demonstrate that multiple 





and caregiver specific outcomes. These outcomes can be included in future community 
based, non-pharmacologic intervention ADRD research to measure key concepts of 
cognitive impairment, BPSD, and well-being of PLWD and their caregivers. 
Limitations 
There are 4 major limitations of this study. First, the sample lacked diversity in race 
and ethnicity, socioeconomic status, and educational level thereby limiting the 
generalizability regarding feasibility and acceptability of the weighted blanket in more 
diverse populations. Recruitment strategies relied on organizations that offer support to 
families affected by ADRD, which likely excluded those who have limited access, 
knowledge, or do not regularly use these services. People from disadvantaged 
socioeconomic backgrounds have historically had limited access to and knowledge of 
support services, which could have resulted in the lack of variation in sociodemographic 
characteristics of this study’s sample (Cooper et al., 2010). There is a need to examine 
the feasibility of use of weighted blankets in more diverse populations in terms of 
socioeconomic and demographic contexts. Alternative recruitment strategies to target 
those with limited access to support services will need to be prioritized, such as through 
programs offered in disadvantaged communities, spiritual communities that offer 
services for older adults, and rural outreach programs. 
Second, outcomes completed by self-report of the care recipient had significant 
amounts of incomplete data. Although the high degree of missing data limits the 
interpretation of the scored measures, this limitation does highlight an important area for 
future research in terms of developing and refining measurement tools that can be 
completed by people with varying degrees of cognitive impairment (further described 
below, see Implications for Future Research). 
Third, self-reported measures inherently have a risk of response bias and 
satisfaction surveys have demonstrated a risk of participants being more inclined to 
provide socially acceptability answers (Mazor et al., 2002). In attempt to mitigate this 
risk, clear directions were embedded in the Weighted Blanket Intervention Acceptability 
Tools advising participants to provide honest answers, but it is possible that participants 





Fourth, the Weighted Blanket Daily Use Diary was developed to collect information 
regarding daily use of the blankets by participants with ADRD based on caregivers’ 
observations. These diaries may not be an accurate indicator of actual blanket use, 
especially for dyads that were not bed partners, or for those that did not spend as much 
time in the same physical space throughout the day. In these cases, PLWD could have 
used the blanket more or less than their caregivers observed.  
Implications for Future Research 
Findings of this study carry implications for future research focused on weighted 
blankets for PLWD, as well as other populations. Areas that hold promise for future 
research include studies focused on: safety of use of weighted blankets by people with 
respiratory conditions and those living in warm climates; refining of measurement tools 
completed by self-report by PLWD; pilot testing this study’s intervention to inform a 
larger randomized controlled trial (RCT) to determine efficacy; cost benefit of weighted 
blankets; use of other types of deep pressure stimulation tools such as compression 
garments and deep pressure massage tools by PLWD; the use of weighted blankets by 
people with other stress related conditions. 
Safety Considerations for Future Research 
Although safety was demonstrated in this study, there are other important areas 
regarding safety to consider in future research focused on this population. These 
considerations include the use of weighted blankets by individuals with respiratory 
conditions and by those that live in warmer climates. As little is known about the safety 
of weighted blankets for people with respiratory conditions (Parker, 2016), the exclusion 
criteria for this study were comorbidities like sleep apnea, asthma, and COPD. Sleep 
apnea was the primary reason participants were excluded from participation. To 
promote broader use of weighted blankets by PLWD, additional research is needed to 
better understand the relationship between use of weighted blankets and respiratory 
function to determine if this exclusion criteria is necessary. This is critical, as PLWD with 
sleep apnea often experience more severe sleep disturbances and likely have an even 






In terms of climate, a few participants that lived in warmer climates expressed that 
excessive warmth was a barrier to use of the weighted blanket. Older adults with ADRD 
are typically less able to adapt to temperature changes and maintain body temperature, 
particularly when living in environments with high degrees of temperature variability 
(Wei et al., 2019). The weighted blanket may potentiate difficulties in maintaining body 
temperature for those living in warmer climates, which poses a potential safety concern. 
Additional research is needed to examine differences in feasibility and acceptability 
based on climate and to determine the safety of weighted blankets by PLWD in very 
warm climates  
Refining of Measurement Tools Completed by Self-Report by PLWD 
 Given the limited feasibility of collecting measures completed by self-report by 
PLWD, research is needed that addresses development of new and/or refining current 
measures. Modifications may include limiting the number of items, modifying response 
options to simpler dichotomous responses, and field testing to ensure items and 
responses are appropriate for a broad range of people with cognitive impairment 
(Clarke et al., 2020). Measures of “in the moment” feelings may be needed as PLWD 
are often less able to reflect on past experiences (Clarke et al., 2020). For this 
intervention specifically, the Weighted Blanket Daily Use Diary presents an option to 
capture “in the moment” experiences with the weighted blanket, as it is completed each 
day rather than at the end of the study period. As an example, an item could be added 
that asks caregivers to ask their relative with ADRD how they are feeling while they are 
using the blanket. Responses to this item would provide some indication of their 
relative’s feelings towards the blanket throughout the study period. Modifications are 
also needed for the care recipient version of the Weighted Blanket Intervention 
Acceptability Tool to improve completion rates, which may include limiting the number of 
items and modifying response items that have 3 response choices to simpler 
dichotomous responses. 
Pilot Study 
Study findings will be used to further refine the development of the virtually delivered 
weighted blanket intervention and to inform a future pilot study. A critical next step is to 





RCT to determine the efficacy of the weighted blanket intervention on BPSD outcomes. 
(Bothwell et al., 2018). The future pilot study will be designed to determine an effect size 
by having an intervention and a control group to compare the mean differences in BPSD 
from pre to post intervention. The effect size will then be used in a power analysis to 
determine the number of participants needed in the RCT. 
An important outcome that was not included in this study was stress. A future pilot 
study will need to include an outcome of stress to provide information to further inform 
measurement selection for the RCT. As collection of measures completed by self-report 
by PLWD is less feasible, a biomarker to measure stress is preferred. Collection of 
blood and salivary cortisol (a biomarker of stress) has demonstrated to be feasible in 
PLWD living in the community and present as potential measures of stress for the pilot 
study (Ng et al., 2020). By collecting a measure of stress, the pilot study and following 
RCT will be able to explore the relationships between weighted blankets, stress, and 
BPSD. 
As no prior research has examined the optimal amount of use of weighted blankets 
needed to yield therapeutic effects (Eron et al., 2020), another important next step for 
this research is to determine the optimal dose, or amount of weighted blanket use 
needed to demonstrate an effect on BPSD. An adaptive study design would be useful in 
determining optimal dose, which allows for the comparison of intervention components 
through adaptation of those components throughout the intervention period (Bothwell et 
al., 2018). In this case, the component being modified could be the dose. Another 
potentially modifiable component of the intervention could be daytime vs. nighttime use. 
By comparing intervention components, the dose finding study will be able to determine 
the minimum amount of use of the weighted blanket and optimal time of day to 
demonstrate meaningful effects on BPSD. 
Cost Benefit of Weighted Blankets 
Cost is another important area for future research, as weighted blankets range in 
price from $50-$150. This may be a barrier to use for some families, which caregivers 
identified as a potential concern in this study. Weighted blankets are covered as a 
medical device by some private insurance for some populations, but currently they are 





for PLWD in future research and efficacy will need to be determined to convince 
insurers that these are cost efficient tools that effectively improve health outcomes. 
Other Types of Deep Pressure Stimulation Tools  
Other types of deep pressure stimulation tools include weighted and compression 
garments, weighted lap pads, deep pressure massage tools, and therapy dogs trained 
to provide deep pressure stimulation (Davis et al., 2013; Duvall et al., 2016; Lloyd et al., 
2019). Very little is known about the use of these tools by older adults with ADRD. 
Although this study demonstrated the feasibility of daily use of weighted blankets, 
weighted and compression garments may be preferred as they can be worn throughout 
the day even during times of physical activity. While additional research is warranted 
that focuses on use of weighted blankets in this population, studies focused on other 
types of deep pressure stimulation are also promising areas to explore to identify the 
most feasible option for delivering deep pressure stimulation therapy in the home 
setting. 
Weighted Blanket Research Focused on Other Populations 
This study can inform weighted blanket research focused on other populations (Eron 
et al., 2020). Prior weighted blanket research has focused primarily on physiologic 
safety outcomes and therapeutic effects (Becklund et al., 2021; Ekholm et al., 2020). To 
increase the likelihood of implementing weighted blankets in other populations, it is 
critical to examine outcomes beyond effectiveness such as feasibility and acceptability. 
This study provides specific tools to examine acceptability of weighted blankets that can 
be modified and used to inform weighted blanket studies focused on other populations. 
Populations that may benefit most are those with other stress-related conditions, such 
as individuals with post-traumatic stress disorder, anxiety, and insomnia (Crowley & 
Kirschner, 2015). 
Implications for Practice 
Weighted blankets are a care strategy already being used in some clinical settings, 
yet there is limited research to support them. This has likely been a factor leading to the 
lack of standardization for use of weighted blankets in practice. Safety standards are 
important to clinical practice, yet no formal technical standards have been published 





this study are based on available research and experiential reports. They may be 
helpful in guiding policies focused on use of weighted blankets in settings that already 
use them; however, determinations of efficacy are needed prior to making 
recommendations for widespread use in practice for PLWD. 
Implications for Families Affected by ADRD  
For those living with ADRD and their caregivers, findings from this small study 
suggest that weighted blankets can be a satisfying and beneficial tool to use in the 
home. They are feasible, well tolerated, and they can be used daily even during times of 
disruption and challenging circumstances. Participants with ADRD described feelings of 
comfort and warmth, while caregivers described how it helped their relatives with 
relaxation and sleep. Although additional research is needed to determine the effects of 
weighted blankets on BPSD, this study supports that weighted blankets at the very least 
are a promising “tool for the toolkit” of comfort and relaxation promotion. During stress-
inducing times such as the pandemic, having in-home care strategies to promote 
comfort is necessary, especially for older adults with ADRD and their caregivers who 
needed such strategies even before the pandemic began.  
Conclusion 
This study found use of weighted blankets to be a feasible and acceptable in-home, 
non-pharmacologic care strategy for PLWD residing with their family caregivers. The 
virtual delivery of the intervention was feasible, as well as the collection of care recipient 
and caregiver specific outcome measures completed by caregivers; however, collection 
of measures completed by care recipient self-report was not. Key findings will inform 
future research focused on use of weighted blankets for managing BPSD experienced 
by PLWD living in the community with family caregivers. As PLWD and their families are 
in desperate need of simple, in-home care strategies, weighted blankets are a potential 







Synthesis and Conclusions 
 
The purpose of this three-paper dissertation was to explore the use of non-
pharmacologic care strategies, specifically acutherapy and use of weighted blankets as 
potential interventions for treating behavioral and psychological symptoms of dementia 
(BPSD) experienced by people living with dementia (PLWD). This research informs 
future research about non-pharmacological interventions to address BPSD for those 
with Alzheimer’s disease or related dementias (ADRD) and to improve care for those 
living with ADRD and their families residing in the community. 
This research was carried out in three phases. The first phase (Chapter 2) identified, 
examined, and synthesized the state of the science relating to acutherapy and its 
effects on BPSD using a scoping review methodology. 
The second phase (Chapter 3) explored the perspectives of family caregivers (n=21) 
living with older adults with ADRD regarding their experiences as caregivers, BPSD 
experienced by their relatives with ADRD, and their experiences with non-
pharmacologic interventions for BPSD management (Aim 2). Changes in family 
caregivers’ experiences, BPSD, and BPSD management during the COVID-19 
pandemic were also explored (Aim 3). 
The third phase comprised three components (Chapter 4). First, family caregivers’ 
initial perceptions regarding use of weighted blankets as an in-home care strategy for 





A prospective study was then conducted to examine the feasibility and acceptability 
of a virtually delivered in-home weighted blanket intervention for older adults with ADRD 
living in the community (n=20) (Aim 5). This study also examined the feasibility of 
collecting outcome measures of BPSD, cognitive function, and quality of life of care 
recipients with ADRD, and well-being and self-reported health of family caregivers (Aim 
6). 
The purpose of this chapter is to summarize and synthesize major findings across all 
3 papers of this dissertation. Findings across papers are synthesized and integrated 
with the Conceptual Framework of Sensory Stimulation Therapies for Reducing 
Behavioral and Psychological Symptoms of Dementia presented in Chapter 1 (See 
Figure 1.1, p. 6). Significance of the findings is described followed by the strengths and 
limitations of the dissertation studies. Directions for future research are then presented.  
Summary of Major Research Findings 
This dissertation research has six key findings: 1) Acutherapy is a safe non-
pharmacologic care strategy for PLWD and a potential treatment option for BPSD, but 
additional research is needed to determine efficacy; 2) The caregiving experience of 
family caregivers of community dwelling PLWD is perceived as an interdependent 
partnership between the caregiver and the relative with ADRD; 3) Family caregivers and 
PLWD experience challenges to in-home care prior to the COVID-19 pandemic, many 
of which were compounded by it; 4) The virtually delivered in-home weighted blanket 
intervention for community dwelling PLWD is feasible and acceptable to care recipients 
with ADRD and their family caregivers; 5) Collecting outcome measures of care 
recipient cognitive function, as well as caregiver well-being and self-reported health is 
feasible; 6) Collecting outcomes measures of care recipient BPSD and quality of life is 
feasible through measures completed by caregivers, but not by care recipient self-
report.  
In many ways these key findings are congruent with prior research, including 
findings relating to interdependence (Kershaw et al., 2015; Streck et al., 2020), the 
safety of non-pharmacologic interventions (Kales et al., 2015), the challenges to in-
home care for families affected by ADRD (Lee et al., 2019), the feasibility of collecting 





and the limitations of collecting measures by self-report by PLWD (Perfect et al., 2021). 
Findings expand the state of the science in this area by deepening the understanding of 
the experiences of family caregivers during the COVID-19 pandemic, by highlighting 2 
interventions that have been underexamined in past research focused on this 
population (acutherapy and weighted blankets), and by identifying multiple areas that 
show promise for future research on improving symptom management for families 
affected by ADRD living in the community. Overall, findings add considerably to the 
conceptual framework guiding this research by further substantiating some concepts 
and relationships in the model, while also indicating major gaps in this area of science. 
Integration of Findings Through Conceptual Framework 
Multiple concepts and relationships proposed in the conceptual framework were 
explored in this dissertation. Findings related to key concepts and relationships are 
integrated below followed by modifications made to the framework based on the 
findings. Modifications are illustrated in Figure 5.1 and described in Table 5.1 at the end 
of the narrative. 
Concept of Non-Pharmacologic Interventions 
Each phase of this dissertation research detailed non-pharmacologic care strategies 
that may benefit PLWD. Acupressure and acupuncture are feasible therapies for PLWD 
with varying degrees of cognitive impairment and have had positive effects on BPSD 
but their efficacy for reducing BPSD is not confirmed. Additionally, findings do not fully 
support the feasibility of acutherapy delivered in the community, or home delivered 
acutherapy.  
Caregivers of those with dementia identified a number of in-home care strategies 
beneficial for the dyad (e.g., the use of humor, caregivers managing the environment 
and their own behaviors and reactions, pets and dementia service dogs, maintaining a 
daily routine), the caregiver (e.g., meditation, tai chi, yoga, mindfulness, reading, 
journaling), and the PLWD (e.g., CBD oil, reading, blogging, music, designated alone 
times). Of these interventions, only 2 are substantiated by prior research to effectively 
reduce BPSD experienced by community dwelling PLWD. Music has demonstrated a 
moderate effect on BPSD of PLWD in the community (Ueda et al., 2013). Interventions 





behaviors and responses have demonstrated significant effects on BPSD and caregiver 
distress (Brodaty & Arasaratnam, 2012).  
Feasibility of some of the other care strategies described by caregivers (e.g., animal 
assisted therapies, CBD oil, tai chi, mindfulness, meditation) have been explored in prior 
research. Overall, the quality of the evidence is low and there are not enough high-
quality studies to determine efficacy of nonpharmacological interventions for reducing 
BPSD (Park et al., 2020; Tampi et al., 2018; Trivedi et al., 2018). 
The findings of the weighted blanket study support the potential of weighted blankets 
as an in-home care strategy for community dwelling PLWD by demonstrating feasibility 
and acceptability. This study did not examine efficacy for reducing BPSD or improving 
any other outcomes, but 4 of 6 measures of BPSD did show improvements from 
baseline to post-intervention which are promising results.  
Together, findings across this dissertation research demonstrate potential benefits 
that non-pharmacologic interventions can have for PLWD and their family caregivers, 
while some interventions have also shown promising effects on BPSD specifically. But 
overall, there is limited knowledge pertaining to their efficacy for reducing BPSD, as well 
as the feasibility of their use among PLWD in the community.  
Concept of BPSD 
This research has important findings relating to the concept of BPSD. Cumulatively 
the findings show that BPSD are highly prevalent, but severity varies among those with 
ADRD living in the community. Findings collectively demonstrate that although 
caregivers describe many of the same symptoms and behaviors that researchers and 
clinicians would term BPSD, they do not use the terms “behaviors” or “symptoms”. 
Instead, family caregivers described their relatives’ experiences in terms of their 
emotions, feelings, and psychological responses. They also described other prominent 
feelings their relatives experienced that are not included in the cluster of BPSD 
including feelings of isolation, loneliness, and a sense of purpose. Experiences and 
responses of PLWD were intertwined with the experiences of their caregivers, in this 
way their “symptom management” strategies were dependent on both members of the 
dyad, or the partnership. The findings support that many of the emotional and 





currently used in the home do not adequately address the needs of PLWD and their 
families. 
Relationships Between Sensory Stimulation Therapies, Stress, and BPSD 
Although stress reduction is a hypothesized mechanism of action for non-
pharmacologic interventions and sensory stimulation therapies more specifically for 
influencing BPSD (Chen et al., 2016; Mullen et al., 2008; Reynolds et al., 2015), there is 
limited exploration of the relationships between these interventions, stress, and BPSD. 
Although stress is an important concept in theoretical and conceptual frameworks 
relating to BPSD, it has been under examined as an outcome measure in community 
based ADRD intervention research. 
Concepts of Caregiver Well-Being, Care Recipient Well-Being, and the 
Relationship Between Them  
Findings support that family caregivers play a pivotal role in providing care for PLWD 
(Brodaty & Donkin, 2009; Huang et al., 2015). In this study, however, caregivers 
describe the caring process as a partnership involving interactions between the 
experiences and responses of both members of the dyad. Their experiences as 
caregivers were deeply rooted in those of their relatives with ADRD. These findings are 
congruent with theories of interdependence commonly used in caregiving research 
(Bom et al., 2018; Graham & Bassett, 2006; Kershaw et al., 2015; Norton et al., 2009). 
Interdependence supports that a dynamic, interactive relationship exists between 
caregivers and PLWD and that the health and well-being of one member of the dyad 
influences the other (Harris, Titler, & Hoffman, 2020; Stall et al., 2019).  
The dyadic, partnership experience was prevalent throughout caregivers’ stories in 
how they managed the disease at home. It was also evident in the weighted blanket 
study by collaborative efforts of caregivers with the care recipient throughout the 
intervention period to use the blanket and to engage in the study. Their engagement 
exemplified the dyadic process of caring that occurs between caregivers and PLWD.  
Concept of Internal Factors 
Given the lack of variation in sociodemographic characteristics of study samples, 
this dissertation does not provide insight into the experiences of the broader population 





internal factors such as demographic characteristics (e.g., race, ethnicity, marital status, 
education level) relate to other concepts in the framework. The lack of understanding of 
how these internal factors influence outcomes is congruent with prior community based 
ADRD research, which has historically underrepresented those from diverse racial and 
ethnic backgrounds and those who have been stigmatized due to disease (Babulal et 
al., 2019; Brewster et al., 2019). 
Concept of External Factors  
Similar to restrictions in findings related to internal factors, the lack of variation in the 
study samples limit the findings related to external factors. Specifically related to the 
scoping review of acutherapy, the homogeneity of the study characteristics (i.e., most 
studies were conducted in China and most in long-term care settings) limits the 
understanding of how contextual circumstances such as setting and location may 
influence the delivery of acutherapy to PLWD and their response to it. Most caregivers 
in the studies presented in paper 2 (Chapter 3) and paper 3 (Chapter 4) were related to 
their relatives with ADRD by marriage, which is not representative of the broader 
population of community dwelling PLWD and their family caregivers (Alzheimer’s 
Association, 2021). This limits the understanding of how the external factor of social 
relationships may differentially impact the experiences of PLWD and their family 
caregivers. Caregiver participants in these studies (papers 2 and 3) were also restricted 
to those that were family members living with their relatives with ADRD, which limits the 
understanding of how care provided by caregivers outside the home influences BPSD. 
Contextual Circumstance of the COVID-19 Pandemic as an External Factor 
The COVID-19 pandemic presents as a unique, historical global contextual 
circumstance that represents an external factor influencing multiple aspects of life of 
PLWD and their family caregivers. Findings of this dissertation show that the COVID-19 
pandemic that began in the Spring of 2020 has compounded feelings of loss and 
decreased socialization of family caregivers, which has intensified in-home care 
challenges for PLWD and their families. Cumulatively, findings suggest that PLWD and 
their family caregivers living in the community desperately needed in-home care 
strategies to manage BPSD and promote well-being prior to the pandemic, but the 





provide a preliminary understanding of the contextual circumstance of the COVID-19 
pandemic and its influence on the lives of PLWD and their families. 
Relationships Between Internal and External Factors and Other Concepts in the 
Framework 
Findings support that the internal and external factors of PLWD likely influence other 
concepts in the model besides just the stress process. Some examples identified 
through this research are listed below: 
▪ Caregivers described how their relatives’ cognition varied from day to day 
and was often dependent on their physical health (an external factor)  
▪ Caregivers identified contextual circumstances (external factors such as busy 
schedules, holiday celebrations, pandemic restrictions) that made using non-
pharmacologic care strategies challenging and sometimes inhibited their use. 
▪ Internal factors also influenced use of the weighted blanket specifically, such 
as temperature regulation and fabric preference 
▪ The COVID-19 pandemic (a contextual, external factor) influenced many 
aspects of life of PLWD and their families (e.g., physical health, social well-
being, functional abilities) 
These examples suggest that internal and external factors are not only related to the 
stress process of PLWD as depicted in the original framework in Chapter 1 (See Figure 
1.1, p. 6), but more broadly influence many if not all the concepts in the framework. The 
concepts of internal and external factors in the original framework were modified from 
the need-driven dementia-compromised behavior model, which is linear in nature 
(Algase et al., 1996). The stress process model by Judge, Menne, and Whitlatch (2009) 
relates internal and external factors to the stress process, as well as to other concepts 
including outcomes of well-being of PLWD, which is more aligned with findings of this 
research.  
Modifications Made to Framework Based on Findings 
Based on the findings, modifications and additions were made to the conceptual 
framework as illustrated in the updated framework in Figure 5.1. Relationships between 
concepts shown with dotted lines represent hypothesized relationships between 
concepts that may be areas to explicate through future research. Table 5.1 includes 
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Gaps Identified Through this Research 
Through the findings of this dissertation and integration with the conceptual 
framework, key gaps in research have been identified. These gaps are listed below: 
▪ There are discrepancies in how researchers, clinicians, PLWD and their 
families communicate about emotional and psychological experiences of 
PLWD and their responses. This gap in common terminology was also 
Table 5.1 
Modifications Made to Conceptual Framework Based on Dissertation Research Findings 
Addition or Modification Rationale 
Concept of BPSD changed to 
Emotional and Psychological 
Experiences and Responses 
of PLWD (EPER) 
To more accurately depict the broad experiences of PLWD described by 
family caregivers. BPSD is still encompassed in this concept, but EPER can 
also include other emotions felt by PLWD such as feelings of isolation, 
loneliness, and a sense of purpose, which were described by caregivers in this 
research and prior research (Balouch et al., 2019).  
Concept of Caregiver well-
being changed to Well-being of 
care partner 
For multiple caregivers, the term “caregiver” did not reflect their experience in 
caring, as it did not capture the significance of the partnership. The term “care 
partner” is being increasingly used in research and practice to more accurately 
depict the partnership experience described by those caring for people with 
ADRD (Zhou et al., 2020). 
Concept of Care recipient well-
being changed to Well-being of 
PLWD 
To capture the significance of the partnership and depict the active role PLWD 
play in the caring process, as described by their care partners in this research. 
This terminology also takes a strengths-based approach by recognizing the 
abilities of PLWD, not just their disabilities or impairments and highlights the 
importance of living well even with ADRD (McGovern, 2015). 
Added concept of Well-being of 
partnership 
The prior model did include a bidirectional arrow between care recipient well-
being and caregiver well-being with a note regarding the interactive, dynamic 
relationship between them. But care partners in this research highlighted the 
importance of the partnership and the well-being of the dyad as a whole and 
brought the well-being of the partnership to the forefront. For this reason, the 
bidirectional arrows are still in the framework to connect well-being of PLWD 
and care partners, but the well-being of the partnership is emphasized as a 
unique concept.  
Internal and External factors 
moved, and arrows added to 
hypothesize relationships to 
other concepts in the framework 
These modifications were made based on the stress model by Judge et al. 
(2009), and the many examples described by care partners in this research 
relating to how internal and external factors influenced other concepts in the 
model including cognitive function, non-pharmacologic intervention use, 
EPER, and well-being. Internal and external factors were moved to the top 
and a bidirectional arrow was added to represent that it is hypothesized that 
these factors interact with one another, while the bold black arrows represent 
that these factors are hypothesized to influence other concepts in the 
framework. Examples of potentially relevant factors are included in the 
framework. 
Concept of Decreased ability to 
cope with stress removed 
This concept is redundant to the concept before that includes the decreased 
stress threshold, heightened perception of stress, and the dashed line. The 
dashed line, as indicated in the model key, illustrates the dynamic, progressive 
interaction between the decreased stress threshold and heightened perception 
of stress in PLWD that decreases the person’s overall ability to cope with 
stress. For the sake of parsimony, this concept was removed.  
Title changed to Conceptual 
Framework of Sensory 
Stimulation Therapies for 
Improving Emotional and 
Psychological Experiences and 
Responses of People Living with 
Dementia 
As BPSD was changed to EPER the title was changed to include the broader 
concept. Using terms “improving” instead of “reducing” takes a strengths-






identified as a major gap in community based ADRD research through a 
systematic review by Trivedi et al, (2018). 
▪ Few high-quality studies have examined efficacy of non-pharmacologic 
interventions for improving emotional and psychological experiences and 
responses (EPER) of PLWD residing in the community, including limited 
studies focused on sensory stimulation therapies and care strategies that 
families report already using in the home (e.g., service dogs and animal 
assisted therapies, CBD oil, tai chi, mindfulness, meditation). 
▪ Very few studies have examined stress related outcomes in sensory 
stimulation intervention studies focused on PLWD, thus limiting support for 
the hypothesized relationships between these interventions, stress, and 
EPER in the conceptual framework.  
▪ There are limitations in measurement of BPSD and well-being by care 
recipient self-report that decreases the feasibility of available measures. 
▪ How varying internal (e.g., sociodemographic characteristics, pre-ADRD 
personality traits, personal care preferences) and external factors (e.g., the 
pandemic restrictions, access to services, social network, relationship to 
caregivers) influence concepts such as EPER and non-pharmacologic 
intervention use among PLWD residing in the home is not fully understood. 
▪ There is limited understanding of the pandemic’s effects on PLWD and their 
families from diverse sociodemographic backgrounds.  
 
In addition to gaps in this area of research, a couple of key gaps in care for 
community dwelling PLWD and their families were also identified. First, care partners 
described challenges to in-home care prior to the pandemic, many of which were 
compounded by it due to the limited availability of helpful in-home care strategies during 
the pandemic. Their experiences with and feelings towards virtual resources during the 
pandemic were mixed. Not all families transitioned well to virtual support groups, 
educational programs, and activities. Second, many care partners described challenges 
they and their relatives with ADRD faced in obtaining ADRD diagnoses from providers, 
as well as accessing support services after diagnosis. These findings further 
substantiate significant gaps in coordination of care for older adults with cognitive 
decline and their families, which have been identified as critical areas that need to be 
addressed to tackle the challenges of caring for PLWD (National Academies of 
Sciences, Engineering and Medicine, 2021). 
Significance 
The findings of this dissertation add to the knowledge base pertaining to non-





several ways. This research was among the first to explore family caregivers’ 
experiences with symptom management for PLWD and in-home care strategies used 
during the COVID-19 pandemic. Findings relating to their in-home care needs are highly 
relevant as the pandemic is likely to remain a contextual factor influencing the lives of 
PLWD and their families for the foreseeable future. In addition, the pandemic is 
anticipated to have long-term effects on those with neurological conditions (Aggarwal et 
al., 2020). 
There has historically been limited use of conceptual and theoretical frameworks to 
guide the development of non-pharmacologic interventions for PLWD residing in the 
community, which could be a factor in their limited efficacy in improving BPSD 
outcomes (Kolanowsk et al., 2005). This dissertation was guided by a conceptual 
framework developed from prior research and theoretical models, and was 
subsequently modified based on findings from the three unique studies. Although 
research is needed to further substantiate concepts and relationships, future 
intervention studies can maximize their potential to demonstrate meaningful effects on 
outcomes of importance to PLWD and their families (e.g., EPER, well-being) by using 
this framework as a guide. This is significant as care partners identified an 
overwhelming need for feasible and effective in-home care strategies even before the 
pandemic began.  
This research also provides preliminary support for 2 sensory stimulation therapies 
for PLWD, including acutherapy and weighted blankets. The high degree of safety 
demonstrated across acutherapy studies and the variations in cognitive impairment 
severity across samples demonstrates that these are safe and feasible therapy options 
for PLWD with potential to decrease BPSD. This dissertation was the first to explore the 
feasibility and acceptability of weighted blankets by PLWD, who have historically been 
excluded from weighted blanket intervention studies (Eron et al., 2020). Although this 
study did not examine the efficacy of weighted blankets for BPSD, it does provide 
preliminary data regarding feasibility and acceptability of a virtually delivered weighted 
blanket intervention, and the feasibility of collecting caregiver and care recipient specific 
outcomes. This information can inform futures efficacy studies focused on weighted 





PLWD. Overall, findings demonstrate sensory stimulation therapies, including 
acutherapy and weighted blankets are promising options for PLWD and offer multiple 
directions for future research. 
Strengths and Limitations 
This research aimed to address key gaps in this area of research including the lack 
of review and synthesis of acutherapy studies on BPSD outcomes; the limited research 
on family caregiver experiences with BPSD and BPSD management, particularly during 
the COVID-19 pandemic; and the paucity of studies exploring intervention acceptability 
in non-pharmacologic interventions focused on PLWD in the community. The strengths 
of phase 1 of this research (Chapter 2) included the use of a systematized database 
search of 5 databases, and the use of a search strategy that included multiple 
keywords, controlled vocabulary and MeSH terms that was developed with support from 
library informationalists focused on healthcare research.  
The strengths of phase 2 (Chapter 3) included multiple steps to maintain rigor of the 
qualitative analysis, most significant being the use of a 3-member coding team. This 
study also used a semi-structured interview guide that was fielded to 3 caregivers of 
PLWD and edited based on their recommendations prior to being finalized. This 
ensured that each question was relevant, clear, and distinct; that the guide flowed well 
and was cohesive; and that areas of importance to caregivers were addressed 
throughout the interview.  
The strengths of phase 3 (Chapter 4) included the use of multiple outcome 
measures that have been validated and determined to be reliable for use in community 
dwelling PLWD or caregivers. This study also used the Weighted Blanket Intervention 
Acceptability Tool to examine intervention satisfaction and benefit, which was modified 
from a tool with established validity and reliability (Northouse et al., 2002; Titler et al., 
2020). This study also followed a standardized intervention protocol; used recruitment 
and intervention materials that were vetted by family caregivers; provided the weighted 
blankets for all participants in the study; set benchmarks a priori to determine feasibility.   
The results of this dissertation should be considered within the context of several 
limitations. First, the database search conducted in phase 1 (Chapter 2) only included 





given these exclusions, since the majority of included studies were conducted in China 
(n=11/15) and acutherapy is based in Traditional Chinese Medicine.  
A potential shortfall in the design of the phase 2 (Chapter 3) was the eligibility criteria 
that required family caregivers to live with their relative with ADRD. This criterion may 
have disproportionately excluded children caring for parents with ADRD as suggested 
by the majority of caregivers in this study being related to their relatives with ADRD by 
marriage (n=17). This is not congruent with the broad population of family caregivers of 
PLWD in the U.S., as over half are children caring for parents (Alzheimer’s Association, 
2021). Second, the recruitment strategies relied on reaching potential participants 
through organizations that provide ADRD support services. This likely limited the reach 
to families that do not have access to, or knowledge of services, or who do not regularly 
use them. This may have led to the underrepresentation of individuals from diverse 
socioeconomic backgrounds who historically have had limited access to and use of 
ADRD support services (Cooper et al., 2010). These limitations in eligibility criteria and 
recruitment were also relevant to phase 3 (Chapter 4). Together, these limitations raise 
questions regarding external validity of the studies and limit the generalizability of 
findings. 
Other limitations of the weighted blanket study relate to the high degree of missing 
data on self-reported measures by PLWD, the risk of response bias on self-reported 
measures of satisfaction and benefit, and the potential of the Weighted Blanket Use 
Diary not being a completely accurate indicator of actual blanket use. Although these 
limitations are relevant to this study, they are promising potential areas for future 
research in terms of measurement development. 
Directions for Future Research 
Findings of this research and the gaps identified through the integration of findings 
lead to several directions for future research that are described below. 
Explore the Concept of Well-Being of the Partnership and Examine its 
Relationship to the Well-Being of PLWD and Their Care Partners 
Research supports an interdependent relationship exists between the well-being of 
care partners and PLWD (Harris, Titler, & Hoffman, 2020; Bom et al., 2019; Kershaw et 





research focused on the well-being of the partnership as a holistic unit, which is a 
distinct concept identified through this research. It is possible that the well-being of the 
partnership is significant to spousal dyads but less relevant to dyads that are not 
partnered or married. A recent cross-sectional study of a large, more diverse sample 
(N=1283) of ADRD caring dyads demonstrated the quality of the relationship influences 
the well-being of both members (Rippon et al., 2020), which suggests that the well-
being of the partnership is applicable to a broad range of dyads. However, findings of 
the study by Rippon et al., (2020) and this dissertation research support that additional 
research is needed to explore the experiences of other familial dyads to further 
substantiate the well-being of the partnership as a distinct concept.  
Prior research supports that among caring dyads there are important factors that 
influence the well-being of both members of the dyad individually, and the dyad as a 
unit (Miller et al., 2019). Some of these factors include relationship closeness, degree of 
conflict or strain, and relationship quality (Quinn et al., 2009), yet few studies have 
included these measures in prior community based ADRD research. Examination of 
these factors is needed to better understand the concept of well-being of the partnership 
and the influence on other outcomes including well-being of PLWD and their care 
partners. Outcome measures specific to the well-being of the partnership need to be 
included in future non-pharmacologic intervention research to further substantiate 
hypothesized relationships in the conceptual framework. 
Examine Other Outcomes to Operationalize the Concept of EPER 
To substantiate the concept of emotional and psychological experiences and 
responses (EPER) of PLWD, other outcomes besides BPSD need to be examined in 
future non-pharmacologic intervention research. Outcomes may include feelings of 
connectedness, engagement, and sense of purpose of PLWD. Valid and reliable 
measures exist for these outcomes, which have been developed for this population of 
PLWD specifically or have been psychometrically tested among PLWD (Cohen-
Mansfield et al., 2017; Lara et al., 2019; Poey et al., 2017). The selection of outcomes 
will be dependent on the mechanism by which the intervention is hypothesized to 
influence EPER. For example, if an intervention is focused on improving relationship 





the intervention is designed to improve sleep, a measure of BPSD is likely more 
appropriate. For these reasons, conceptual frameworks must be used to guide 
intervention development and study design. This dissertation research provides a 
framework for sensory stimulation therapies for EPER that can guide outcome selection 
for studies focused on these interventions. 
Develop New and Modify Existing Tools to Measure Well-Being and BPSD That 
Can Feasibly Be Completed by PLWD  
Although the completion percentages were low for measures of well-being and 
BPSD completed by self-report by PLWD, the scores of these measures that were 
completed by PLWD varied from scores of their care partners in the weighted blanket 
study. These results are congruent with prior research, which suggests that reports by 
PLWD of their own experiences do not always align with those reported by care 
partners (Moyle et al., 2012). How PLWD view their own health and symptoms can 
influence their overall well-being (Orgeta et al., 2015), thus their self-report is important 
to capture when possible.  
Findings from this study, along with prior research, highlight a need for measures for 
PLWD who have varying degrees of cognitive impairment that they can feasibly 
complete.  (Clarke et al., 2020). Important considerations for measurement 
development is to ensure the number of items and response formats are suitable for a 
full range of PLWD with varying degrees of cognitive impairment. As measures that 
require reflection on past experiences may be more difficult for people with cognitive 
impairment to complete, measures that capture in the moment well-being and emotions 
are needed (Clarke et al., 2020).  Use of psychometrically sound measures of well-
being and EPER completed by PLWD will improve the internal validity of non-
pharmacologic intervention studies.   
Explore the Experiences of a Broader Range of PLWD and their Families During 
the COVID-19 Pandemic 
Given the lack of variation in the sociodemographic characteristics of the study 
samples in this research, additional studies are needed to explore the experiences and 
needs of families affected by ADRD from a broader range of backgrounds and contexts, 





with varying degrees of community service use. Future research must explore how the 
pandemic (an external factor) influences internal factors such as physical health of 
PLWD, and how the interplay of internal and external factors influences other key 
concepts such as use of non-pharmacologic interventions, EPER, and well-being. 
Exploration of the experiences of families affected by ADRD during the pandemic is 
critical to identifying needs and potential solutions that are feasible for the home setting, 
even during times of social isolation and limited access to in-person services.  
Explore the Feasibility and Acceptability of Acutherapy for PLWD Residing in the 
Community 
This dissertation supports that acupressure is a promising therapy for PLWD that is 
safe and can be feasibly delivered by non-licensed, non-healthcare trained individuals. 
Laser acutherapy is a relatively new and innovative acutherapy technique that is a 
promising treatment option for people with ADRD as it is easy to deliver, is non-
invasive, safe, and virtually pain free (Whittaker, 2004). Despite their high degrees of 
safety and ease of delivery, no studies have explored the use of acupressure or laser 
acutherapy among PLWD in the community. Future research is need to explore the 
feasibility and acceptability of acutherapies delivered to PLWD by their care partners 
living at home or delivered through community services that already offer programs to 
support PLWD (e.g., adult day programs, support groups, memory cafes). 
By exploring feasibility and acceptability, future research will be able to inform 
important components of intervention development for this population. Some of these 
components include acutherapy intervention content and modes of delivery, available 
resources, and time restraints relevant to community dwelling PLWD and their 
caregivers, and recruitment capacity. Feasibility and acceptability studies of these 
interventions are necessary to develop an acutherapy intervention that can undergo 
testing for efficacy with subsequent scale-up for community settings.  
Future research focused on acutherapy for PLWD will need to prioritize intervention 
fidelity by clearly defining and measuring intervention components and procedures 
including specific acupoints, dose, and delivery to promote consistency of delivery 
across participants and enhance the internal validity of studies. The Conceptual 





Psychological Experiences and Responses of People Living with Dementia may be 
used to guide the development of acutherapy interventions for PLWD as it hypothesizes 
mechanisms by which acutherapy may improve EPER. Outcomes of stress will need to 
be examined in future research to substantiate the relationship between acutherapy, the 
stress process, and EPER.  
Examine the Efficacy of Non-Pharmacologic Interventions for Improving EPER 
Among PLWD Living in the Community 
Care partners described several non-pharmacologic interventions that they use in 
the home that were beneficial to them, their relatives with ADRD, or both as a 
partnership (e.g., the use of humor, caregivers managing the environment and their own 
behaviors and reactions, pets and dementia service dogs, CBD oil, maintaining a daily 
routine, meditation, tai chi, yoga, mindfulness, reading, journaling, blogging, music, 
designated alone times for PLWD). Yet only 2 of these interventions have consistently 
demonstrated efficacy in reducing BPSD among community dwelling PLWD in prior 
research (i.e., music and interventions focused on caregivers’ managing their own 
behaviors and the environment). There is dire need for high quality studies to examine 
efficacy of care strategies that care partners already use in the home.  
Large and clinically meaningful effects of non-pharmacologic interventions on EPER 
may be more likely by combining strategies to form multicomponent interventions. 
Multicomponent interventions that combine more than one non-pharmacologic 
intervention have demonstrated significant reductions in BPSD in community dwelling 
PLWD (Özbe et al., 2019). The major drawback of multicomponent interventions is their 
complexity, and when not theoretically based, these interventions are often limited in 
terms of understanding active components that are necessary to demonstrate effects on 
outcomes (Özbe et al., 2019). This limits the ability to apply active ingredients of these 
interventions to other research. Additionally, as demonstrated through this research, 
using non-pharmacologic care strategies in the home often adds responsibility to care 
partners. Unnecessarily combining interventions may add burden to care partners who 
are likely already burdened, which can limit the broader implementation and sustained 





For these reasons, examinations of efficacy of non-pharmacologic interventions 
focused on improving EPER must prioritize examination of active ingredients, or 
components of the intervention that are necessary to influence outcomes. Adaptive 
study designs can be used to examine active ingredients of multicomponent 
interventions (Biron et al., 2016). These designs evaluate interventions by observing 
participant outcomes on a predetermined schedule and modifying parameters of the 
interventions based on the observations. Modification of parameters may include 
dosage changes, adding or dropping components of the interventions, or combining 
interventions. The study protocol predetermines the adaptation schedule and processes 
that occur throughout the study (Bothwell et al., 2018; Kairalla et al., 2012). Adaptive 
study designs can be used to screen out ineffective interventions and save resources 
for more promising ones (Shan et al., 2018). These designs have been used in ADRD 
clinical trials examining effects of medications, but have been underutilized in 
community-based, non-pharmacologic intervention studies (Cummings et al., 2012). 
Future research focused on community dwelling PLWD may benefit from adaptive 
designs to examine multiple interventions and to determine active components 
necessary to result in effects on outcomes of EPER. 
Results demonstrating efficacy for improving EPER of PLWD are needed to 
persuade policymakers and insurers to incentivize use of non-pharmacologic care 
strategies for PLWD residing in the community. Financial incentives and alternate 
payment models can encourage clinicians and ADRD community service providers to 
adopt, prioritize, and educate on feasible and effective interventions to better address 
the needs of individuals and families affected by ADRD (Boustani et al., 2019). 
Develop and Test Interventions for PLWD and Their Care Partners Residing in the 
Community During the Pandemic 
Care partners described a need for in-home care strategies that can be used during 
the pandemic. As Medicare expanded coverage for telehealth services due to the 
pandemic, ADRD telehealth care is being increasingly used and interventions will need 
to be tested for wider implementation to reach a broader range of families affected by 
ADRD (Kruse et al., 2020). Many care partners described virtual concerts as enjoyable 





pandemic. As music has demonstrated to be an effective intervention to reduce BPSD 
(Ueda et al., 2013), virtual concerts during this time of the pandemic represent a 
potential direction for virtual intervention development.  
To address the loss of socialization due to the pandemic but given the mixed 
feelings towards virtual resources described by care partners, future research will also 
need to focus on promoting socialization and engagement through alternative 
mechanisms. As described by care partners in this research, dementia service dogs 
and pets offer the opportunity to promote engagement and a sense of purpose among 
PLWD. Other socially engaging activities described included socially distanced walking, 
yoga, and tai chi. Additional research is needed to determine the broader acceptability 
of these interventions, as well as their efficacy in promoting engagement, and reducing 
feelings of isolation among PLWD and their care partners.  
Determine Effect Size for Future Efficacy Testing of Weighted Blankets  
The weighted blanket feasibility and acceptability study provides information that can 
be used to inform a future pilot study. The pilot study will be conducted to calculate an 
effect size, which will be used to determine the sample size needed for an RCT to 
determine efficacy of weighted blankets on BPSD. This dissertation’s feasibility and 
acceptability study provides information to inform measurement selection and 
recruitment capacity for the pilot study.  
This study demonstrated the feasibility of collecting several outcome measures 
relevant to the conceptual framework that can be included in the pilot study. These 
outcomes are included in Table 5.2. Those highlighted in gray have demonstrated 
feasibility through this dissertation research, those in white are new measures being 
proposed for the pilot study. 
Table 5.2 
Concepts and Measures for Future Pilot Study  
Concept Measure 
EPER NPI (Global measure of BPSD) 
CMAI (Agitation specific) 
PSQI (Sleep specific) 
ESS (Sleep specific) 
Cognitive function MoCA 
Well-being of PLWD QOL-AD CP Report 
Well-being of care partner CWBS 
Optum SF-12 
Stress Biomarker of physiologic stress (e.g., cortisol level collected through hair, urine, 





Well-being of the 
partnership 
Dyadic Relationship Scale (Sebern & Whitlatch, 2007) 
Note. CP care partner, CMAI Cohen-Mansfield Agitation Inventory, CWBS Caregiver Well-Being Scale, ESS Epworth 
Sleepiness Scale, MoCA Montreal Cognitive Assessment Test, NPI Neuropsychiatric Test, PSQI Pittsburgh Sleep 
Quality Index, QOL-AD Quality of Life in Alzheimer’s Disease  
 
Conclusion 
Due to the high prevalence and societal costs associated with ADRD and the 
limitations in treating BPSD among those living in the community, this dissertation was 
conducted to explore the potential use of non-pharmacologic care strategies, 
specifically acutherapy and weighted blankets as in-home care strategies for treating 
BPSD experienced by PLWD. Engagement of family caregivers of PLWD has been 
underutilized in prior research, possibly leading to limited uptake and sustained use of 
these interventions in the community. This research involved family caregivers at the 
onset of development of the weighted blanket intervention. Although findings of this 
research highlight the potential of these interventions for PLWD, research supporting 
their efficacy is desperately needed. As the burden of ADRD and associated BPSD is 
overwhelming for PLWD, their families, and the health system, we are in dire need of 
evidence-based non-pharmacological interventions to reduce the burden of these 
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Semi-Structured Interview Guide 
 
The participant was welcomed and answered 9 demographic related questions prior to beginning the 
interview. The PI answered any questions that the participant had before beginning the interview.  
 
Introduction 
Hello (name of participant), I’d like to welcome you and say thank you for your time in logging in today. 
We truly value your time; I recognize that we both have busy schedules and we are hoping to get as 
much as possible from this interview. I anticipate that this interview will last about an hour.  
The purpose of this meeting is to get a better understanding of your experiences as a family caregiver of 
an older adult with dementia. Today I am interested in hearing your experiences and thoughts about 
some of the challenging behaviors and symptoms displayed by your loved one. I am also interested in 
your experiences in handling these challenging symptoms in the home setting and in how your 
experiences as a caregiver has been affected by the COVID-19 pandemic. Near the end of this session, I 
will describe a therapy option for such symptoms that we are working on and I will ask you about your 
initial thoughts on this treatment option. I plan to use your input and input from other family caregivers to 
develop a therapy that can be used in the home to better manage challenging symptoms and behaviors 
of dementia.  
This interview will be recorded and then transcribed for analysis. There will be no names attached to the 
transcripts so your words will remain confidential. I have a series of questions that I would like to ask to 
prompt your responses, examples and stories about your caregiving experience and dementia symptoms; 
there are no right or wrong answers here, just your own thoughts and insights. I will mute my audio when 
I am not asking questions to help improve the quality of your audio. Again, thank you so much for your 
participation, if you are ready, I will begin with the first question. [Zoom recording turned on] 
Interview Questions 
Opening questions relating to the caregiver experience 
1. Share your name and who it is that you provide care for. 
2. Describe what is the best part of caring for your loved one 
3. What is the hardest part of caring for them? 
4. How does caring for someone with dementia impact your ability to manage your daily life? 
 Potential probe question: Compared to a time before your loved one had  dementia, how has your 
 life changed? 
5. In general, how has your life changed or been affected during this time of COVID-19? 
6. How has your experience as a caregiver been affected during this time of COVID-19? 
 
Key questions related to dementia symptoms 
7. Describe an example where it was particularly challenging for you to care for your loved one  
 Potential probe question: Please explain further why that situation was so challenging compared 
 to other days/situations? 
8. Please describe specific behaviors or things your loved one does that is particularly challenging for you 
as a caregiver. 
9. How has your loved one’s behaviors been affected, if at all, during this time of COVID-19? 
 Potential probe question: Can you describe a specific situation where his/her behavior has 
 changed during this pandemic? 
 
Questions related to treatment strategies 
10. What are some of the approaches you have used to help your loved one when they are agitated, 
anxious, upset, withdrawn, restless or angry? 
11. We discussed challenging behaviors already. What strategies have you tried to manage these 
behaviors? 
12.  Please give a detailed example of a time when a strategy worked well for managing a challenging 
behavior. 





13. Please describe an example of when a particular strategy did not work well? 
 Potential probe question: Please provide your insights about why you think this strategy did not 
 work well?  
14. How have your approaches to managing your loved one’s challenging symptoms and behaviors been 
affected during this time of COVID-19? 
15. Please describe any resources or strategies that you used before to help manage your loved one’s 
symptoms that were affected in some way by the pandemic. 
16. In general, has the COVID-19 pandemic made it more or less challenging to manage your love one’s 
symptoms and behaviors? 
 Potential probe question: If so, in what ways is it more (or less) challenging? 
 
(PI then provided a brief description of weighted blankets and shared a visual presentation of weighted 
blankets using the Zoom share screen function)  
“Weighted blankets feel like a regular blanket or comforter; however they are filled with materials to add 
weight to the blanket and can range from 10 to 12.5 pounds. The feeling of weighted blankets is said to 
have a grounding effect that increases a person’s level of relaxation. People have compared it to a feeling 
of being swaddled, while others describe it as a feeling like a long-term gentle hug. They are commonly 
used for people with dementia in hospital settings and are typically used multiple times throughout the 
day for 15-25 minutes at a time when individuals are anxious, restless, or agitated. There is not enough 
research to say definitively that weighted blankets help with challenging dementia symptoms. The goal of 
the next stage of my dissertation work is to explore the potential use of weighted blankets as a treatment 
option for individuals with dementia who live at home to help with symptoms such as anxiety, agitation 
and restlessness. (if participant is able to view my video, I will share my screen and show a picture of a 
weighted blanket as an example as I describe it) 
Questions related to weighted blankets 
17. What do you think about use of the weighted blanket for your loved one? 
18. Can you give any examples as to why the weighted blanket might work or not work for them? 
19. Do you have any questions, worries, or concerns about using a weighted blanket? 
 
(PI provided a brief (less than 2 minute) oral summary of key points of the interview)  
 
Final question 
20. Are there any corrections, additions or other comments that you would like to share? 
 
Conclusion 
Thank you for participating today. I truly appreciate your time and unique insights; your contributions 
today have been truly valuable. Is there anything else that you would like to share? 
 







Recruitment and Enrollment Materials Used for Weighted Blanket Intervention 








































































Appendix B-3: Eligibility Determination Form  
Date and time:    
  
Reviewer’s initials: 
Caregiver and care recipient initials: 
Caregiver Eligibility Questions Yes (✓) No (✓) 
Is the individual 21 years of age or older?    
Does the individual live with a family member with Alzheimer’s 
disease or related dementia? 
  
Has the individual lived with the family member with dementia 
for at least one month? 
  
Does the individual identify as a primary caregiver of the 
diagnosed family member? 
  
Can the individual read and speak English?   
Does the individual have any hearing or visual impairment that 
may limit their ability to participate in the screening process or 
read and sign a consent form? 
  
Does the individual have access and ability to use a 
telephone, smart phone (with internet access), tablet (with 
internet access), or computer (with internet access) to access 
the virtual Zoom sessions? 
  
Care Recipient Eligibility Questions Yes (✓) No (✓) 
Is this individual 60 years of age or older?   
Does this individual have Alzheimer’s disease or related 
dementia 
  
Does this individual live in an assisted living, or long-term care 
setting? 
  
Does the individual weigh 100 pounds, or more?   
Is the individual able to lift at least 10 pounds? (this is about 
the weight of a cat, a small dog, or a gallon paint can) 
  
Has the individual demonstrated any of the following behaviors 
or symptoms during the last two weeks? 
(Need to report yes to at least 2 to be eligible) 






Delusions    
Hallucinations    
Agitation or aggression    
Depression or dysphoria    
Anxiety    
Elation or euphoria    
Apathy or indifference    
Disinhibition    
Irritability or lability    
Motor disturbance    
Nighttime behaviors    
Appetite or eating changes    
 Yes (✓) No (✓) 
Does this individual have asthma, sleep apnea, or other 






Does the individual have paralysis or limited mobility of the 
upper or lower limbs? 
  
Does the individual have a history of claustrophobia, or fear of 
confined and/or enclosed spaces? 
  
Does the individual have diabetes?   
Does the individual have open wounds or rashes on the skin?   
If yes, please describe: 
 
 
Has the individual used a weighted blanket within the past 
month? 
  
Does this individual have an acute or chronic unstable medical 
condition that may limit their ability to participate in the study? 
  
 
Is this caregiver eligible to participate in the study?   
Is this care recipient eligible to participate in the study?   
Is this dyad eligible to participate in the study?   
 
Assigned caregiver participant ID for eligible 
individuals: 
 
Assigned care recipient participant ID for eligible 
individuals: 
 











































































Appendix C-2: Weekly Intervention Telephone Check-In Form 
Weekly Intervention Telephone Check in Form 
 
Date:   
Participant dyad ID:    
Week of Check-In (circle):    Week 1  Week 2 Week 3 Week 4 
 
Directions for completion of form:  
Use this form to direct the conversation with the family caregiver and keep brief notes 
electronically as the person responds to each question. This form is only meant to guide the 
conversation, the focus can change based on the needs of the caregiver and not all questions 
need detailed responses. Immediately after completion of the call, review the form again and 
add in details that you remember from the conversation as appropriate. 
 
Introduction: 
(Start by greeting the family caregiver and asking how they are doing today) 
 
“I’ve been looking forward to the chance to check in with you today to discuss how the use of 
the weighted blanket by your loved one has been this week, as well as to address any questions 
or concerns you have about the blanket. I anticipate this conversation will last about 25 minutes. 
I encourage you to refer to your Weighted Blanket Daily Use Diary throughout our conversation 
as a reference.  
 
I do have some specific questions to guide our conversation today, but first can you give me a 
brief one to two-minute summary of how this week has gone in terms of your loved one using 
the weighted blanket? “ 
 
 
Questions relating to frequency and duration of blanket use: 












4) What time of day did your loved one use the weighted blanket the most over the past week? 
 Morning     Evening    Afternoon   
 At bedtime      Overnight 
Questions relating to how the person with dementia responded and tolerated use of 
blanket: 
 






6) On a scale of 0 to 10, with 0 being did not tolerate the blanket at all and 10 being tolerated 
the blanket all of the time, what number best describes how your loved one tolerated the 
weighted blanket over the past week (Circle)? 
 
Did not        Tolerated the 
tolerate the        blanket all  
blanket        of the time 
at all  
1   2   3   4   5   6   7   8   9   10  
 
7. Can you describe a specific situation when your loved one did not tolerate the blanket? 
 
If the person with dementia used the blanket less than every day this week: 
8) If your loved one did not use the blanket every day this week, can you describe why and 
include any situations or circumstance that made using the blanket a challenge: 
 
 Help the caregiver identify strategies to increase use of the blanket as necessary 
 (some  examples below): 
 -Encourage use of the blanket during passive activity times that the person enjoys (e.g. 
 watching television, reading, while doing puzzles). 
 -Encourage the person with dementia to use the blanket by using a blanket yourself, 
 suggest that it is “blanket time” and that everyone is using a blanket to relax. 
 -Ask the person with dementia why they like, or do not like using the blanket. 
 -Set aside 5-minute increments throughout the day to encourage use of the blanket that 
 fits into your usual routine (e.g. during meal preparation times, during times you as the 
 caregiver are working on other tasks or chores). 
 -Encourage use of the blanket while you are filling out the Weighted Blanket Daily Use 
 Diary at the end of each day. 
 
9) Do you have any concerns, comments or questions relating to the use of the weighted 
blanket by your loved one? 
 
Questions relating to the study materials: 
 
10) Did you use or refer to the Weighted Blanket Use Guide at all this week? 
 -If so, was it helpful? 
 
11) Do you have any concerns, comments or questions relating to the Weighted Blanket Use 
Guide? 
 
 Encourage continued use of the Weighted Blanket Use Guide throughout the 
 upcoming week. 
 
12) How did filling out the daily diary entries at the end of each day go this week? 
 
 Help address difficulties and identify strategies for increasing completion of the 
 diary entries as needed. 
 







 Encourage continued completion of the Weighted Blanket Daily Use Diary 
 throughout the upcoming week. 
 
14) Any final comments or questions before we end the conversation? 
 
Conclusion: 
Thank you so much for taking the time to talk with me today. Please do not hesitate to call me 
throughout the upcoming week if you have any comments, questions or concerns. Just to 




























































Appendix D-1: Study Completion Form 
Participant ID: 
Date and time of form completion: 
Initials of individual completing form: 
 
Date of study completion: _______________________ 
 
Primary reason for termination of participation in the study (✓ appropriate box): 
 
 Completed study 
 Participant(s) was determined after enrollment to be ineligible (provide description in 
comments section) 
Participant(s) withdrew consent to participate (please ask participant(s) for their 
reason for withdrawing, but know that they are not required to provide this information) 
 In the principal investigator’s opinion, it was not in the participant’s best interest to 
continue (provide additional comments as appropriate) 
 Adverse event (adverse event form must also be completed) 
 Death 
 Hospitalization 
 Lost to follow up 
 Other (please specify) 




























Appendix D-2: Adverse Event Form 
Adverse Event Form 
Please fill out a new form for each adverse event. 






2. Start date of adverse event 
________________________ 
3. Stop date of AE 
________________________ 
 




 Life threatening 
 
5. Relationship to the study intervention (check box) 
 Not related 
 Unlikely related 
 Possibly related 
 Probably related 
 Definitely related 
 
6. Action taken for AE (check box) 
 None 
 Dose or protocol modification 
 Medical intervention 
 Hospitalization 







Please describe if other:  
 
7. Outcome of AE (check box) 
 Resolved 
 Recovered with minor sequelae 
 Recovered with major sequelae 
 Ongoing/continuing treatment 




8. Was this AE expected? (check box) 
 Yes  No 
 
9. Was this a serious adverse event? (If yes, please describe below) 
















Appendix D-3: Weighted Blanket Daily Use Diary 




















University of Michigan School of Nursing Research Study 
 
Exploring the Use of Weighted Blankets as a Non-Pharmacologic Intervention for Home 
Dwelling Older Adults with Dementia  
 
U-M IRBMED ID: HUM00186832 
 
Principal Investigator: Melissa Harris, BSN, RN, PhD Student 









This daily diary is designed for you to write down information each 
day about use of the weighted blanket by your family member 
with dementia. We are asking you as the family caregiver to 




























Date: ___/___/___             Time: ______ AM / PM (circle) 
Weighted Blanket Use Day 1 (Actual diary included 28 daily entries in total) 
If your loved one did not use the blanket at all today, please skip questions 2-5 and only 
answer questions 1 and 6. If your loved one used the blanket at least once today, 
please answer questions 1-5, skip question 6. Space for additional comments is at the 
end of today’s entry. 
 
1. About how many times did your loved one with dementia use the weighted blanket 
today (Check best response)? 
 Not at all      2 to 4 times 
 Once     5 or more times 
 
2. On average, how long did your loved one use the blanket each time they used it 
today? 
____________________ minutes / hours (Circle) 
 
3. About how long was the blanket used in total for today? 
____________________ minutes / hours (Circle) 
 
4. What time of day did your loved one use the blanket today (Check all that apply)? 
 Morning     Evening    Overnight  
 Afternoon     At bedtime  
 
5. How did your loved one appear while using the weighted blanket today (Check all 
that apply)? 
 Aggressive  Agitated   Angry  Anxious   Calm 
 Comfortable  Distracted   Fell asleep  Irritated  Relaxed  
 Restless  Showed no change in behavior   Stressed   Tired 
 Other 











6. If your loved one did not use the blanket at all today, please describe why and include 








If you have any other comments for today regarding the weighted blanket use by your 


















Appendix D-4: Weighted Blanket Intervention Acceptability Tools – Caregiver 
version 
Instrument Completion Information: The Weighted Blanket Intervention Acceptability Tool 
Caregiver Version was completed by the caregiver by questionnaire at post-intervention. 
Instructions for completing the tool are listed below and were included in the Follow-Up 
Caregiver Questionnaire (Appendix F-2).  
 
Now that you and your relative with dementia have completed all 4 weeks of using the weighted 
blanket, we would like to know how satisfied you as the caregiver was with the weighted blanket 




Please answer these questions from your perspective as the caregiver of a family member with 
dementia. We encourage you to provide honest answers relating to the use of weighted blanket 




Indicate with a ✓ your response. 
 
 





1 2 3 4 5 
1. 
Having the weighted blanket to be 
used by your relative in the home? 
     
2. 
Having the intervention materials 
delivered to your home? 
     
3. 
How the weighted blanket was 
explained to you during the Weighted 
Blanket Introduction session? 
     
4. 
Using a web-based platform to learn 
how to use the weighted blanket? 
     
5. 
Participating in weekly check-in 
telephone call with the research team? 
     
6. 
With the Weighted Blanket Use Guide 
that came with the blanket? 
     
7. 
With the way your questions were 
answered throughout the study 
period? 
     
8. 
You with how you were involved in the 
process of encouraging your relative 
to use the weighted blanket? 
     
 
9. How heavy was the blanket that your relative used? 
 10 pounds 






10. What did you think about the weight of the blanket for your relative? 
 The weight was about right for my relative 
 I would have liked it to be heavier. 
 I would have liked it to be lighter. 
 
11. What is your opinion about the recommendation that the weighted blanket be 
used daily by your relative? 
 The recommended everyday use of the weighted blanket was about right for us. 
 I would have liked the recommended use of the weighted blanket be less than every 
day.  
 I would have liked the recommended use of the weighted blanket be multiple times a 
day. 
 
12. What is your opinion about the recommended amount of time the weighted 
blanket was to be used by your relative each day? (Reminder: the weighted blanket 
was recommended to be used for at least 5 minutes at a time for a total of at least 20 
minutes throughout each day) 
 The recommended amount of time was about right for us. 
 I would have liked less recommended blanket use time. 
 I would have liked more recommended blanket use time. 
 
13. What did you think about completing a Weighted Blanket Daily Use Diary? 
 Completing a diary entry every day was about right for me. 
 I would have liked to complete fewer diary entries. 












Not at all Some A great 
deal 
1 2 3 
14. 
How much did the use of the weighted blanket help in 
decreasing challenging symptoms displayed by your 
relative with dementia? (such as anxiety, agitation, 
restlessness, difficulty sleeping) 
   
15. 
How beneficial was the study information booklet in 
explaining the study process? 
   
16. 
How beneficial was the Weighted Blanket Use Guide 
in explaining the use of the weighted blanket? 
   
17.  
How beneficial were the weekly telephone check ins 
throughout the 4-week intervention period? 
   
18.  
How much did the use of the weighted blanket by 
your relative benefit you as the caregiver of someone 
with dementia? 
   
19. 
How much did the use of the weighted blanket benefit 
your family member with dementia? 
   
 
20. Overall, would you recommend the use of a weighted blanket to other 
individuals caring for someone with dementia? 
 Yes                         No 
 
21. Will you continue to encourage your relative to use the weighted blanket? 
 Yes                         No 
 



























24. Do you have any comments or suggestions about the study materials (such as 
the study information booklet, the Weighted Blanket Use Guide, or the Blanket Daily 
Use Diary)? 
 Yes  No  













25. Do you have any comments or suggestions about the weighted blankets 
specifically? 















26. Would you recommend or suggest any other changes for the weighted 
blanket study? 
 Yes  No  





















Appendix D-5: Weighted Blanket Intervention Acceptability Tools – Care recipient 
version 
Instrument Completion Information: The Weighted Blanket Intervention Acceptability Tool 
Care Recipient Version was completed by the care recipient with dementia by questionnaire at 
post-intervention. Care recipients were prompted to complete the care recipient specific 
questions independently but could receive assistance from their family caregivers if unable to do 
so. Instructions for completing the tool are listed below.  
 




Now that you have completed all 4 weeks of using the weighted blanket, we would like 
to know how satisfied you were with the weighted blanket and how beneficial the 




Please answer these questions the best you can, you can ask for help from your family 
caregiver as needed. Please circle one answer for each question. 
______________________________________________________________________ 
 
1. How did you like using the weighted blanket in the home? 
 
Not at all  Some     A great deal 
 
2. How did you like being able to choose when you used the weighted blanket? 
 
Not at all  Some     A great deal 
 
3. How did you like being able to choose how often you used the weighted 
blanket? 
 
Not at all  Some     A great deal 
 
4. How comfortable did you feel when using the weighted blanket? 
 





comfortable  comfortable    comfortable  
 
5. How did you like the feeling of the fabric of the blanket that you used? 
 
Not at all  Some     A great deal 
 
6. How did you like the warmth of the blanket that you used? 
 
Not at all  Some     A great deal 
 
7. How did the weight of the blanket feel to you? 
 
The weight was about  I would have liked   I would have liked 
       right for me.  It to be heavier.      It to be lighter. 
 
8. How relaxed did you feel when using the weighted blanket? 
 
Not at all  Some    A great deal 
 



















10. Will you continue to use the weighted blanket?  
 
Yes  No 
 
11. Overall, would you recommend using a weighted blanket to other individuals 
with dementia? 
 
Yes  No 





























14. Would you recommend or suggest any changes for using the weighted 
blanket? 
 
Yes  No 
  
























































Appendix E-1: Montreal Cognitive Assessment Test 
Instrument Completion Information: The MoCA was completed by interview of the care 
recipient with dementia using audio-visual conferencing at baseline and at post-intervention. 
Instructions for completing the MoCA via audio-visual conferencing were followed and are 





All subscale scores listed on the right-hand side are summed. One point is added for subject 
who has 12 years or fewer of formal education, for a possible maximum of 30 points. A final 




Appendix E-2: Neuropsychiatric Inventory 
Instrument Completion Information: The NPI was completed by interview of the family caregiver at 
baseline and at post-intervention. Caregivers were asked to reflect on the care recipient with dementia’s 
behaviors and symptoms displayed over the most recent 4 weeks. The family caregiver was interviewed 
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(add all domain scores) 
 
TOTAL DISTRESS SCORE (add all distress scores)  
 
Scoring Instructions: Each domain subscale receives a frequency score (1-4), a severity score (1-3), 
and a caregiver distress score (0-5). A domain score is calculated for each subscale by multiplying the 
frequency score and severity score. A total NPI score is calculated by adding the scores of the 12 domain 









Appendix E-3: Cohen-Mansfield Agitation Inventory-Relatives 
 
Instrument Completion Information: The CMAI-Relatives version was completed by the 
family caregiver by questionnaire at baseline and at post-intervention. Instructions for 
completing the CMAI are listed below and were included in the Baseline Caregiver 
Questionnaire (Appendix F-1) and the Follow-Up Caregiver Questionnaire (Appendix F-2). 
 
The section below asks about specific behaviors displayed by your relative with dementia. We 
have listed behaviors that are sometimes associated with older adults; they are arranged from 
physical to verbal, and from benign to aggressive. We do not expect that all these behaviors will 




Read each of the behaviors, and circle how often (from 1-7) each applied to your relative over 




1 = Never 
2 = Less than once a week 
3 = Once or twice a week 
4 = Several times a week 
5 = Once or twice a day 
6 = Several times a day 


































































3. Pacing, aimless 
wandering, constantly 
walking back and forth 
(including wandering 





















































4. Trying to get to a 
different place 
(sneaking out of the 
room, out of the house, 


































6. Hiding or hoarding 
things 
 
1 2 3 4 5 6 7 
7. Grabbing things 





2 3 4 5 6 7 









clothes on in a strange 






































































































































































































19. Intentional falling 
(including from 

































21. Hurting others 

































23. Relevant verbal 
interruptions (i.e. cut 
others short who are 
speaking to relative; 
being rude, even if 



































































24. Unrelated verbal 
interruptions (i.e. 


























questions or sentences 























26. Constant requests 


























































29. Negativism, bad 
attitude, doesn’t like 









































31. Temper outburst 
(verbal or non-verbal 
















32. Strange noises 

































34. Making verbal 
















Scoring instructions: Each behavior is rated on a 1-7-point scale, 1=never, 7=several times an 
hour that a behavior is demonstrated in the last 2 weeks. Individual behavior scores are added 





Appendix E-4: Rating Anxiety in Dementia Scale 
Instrument Completion Information: The RAID scale was completed by first interviewing the 
family caregiver, and then the care recipient with dementia separately over Zoom or by phone. 
The caregiver and care recipient were asked to answer based on the care recipient’s behaviors 
over the most recent 2 weeks. The RAID scale was completed at baseline and at post-
intervention. Instructions for completing the RAID scale were followed and are available at 
https://discovery.ucl.ac.uk/id/eprint/136552/1/13607869956424.pdf. 
 
 Score (✓) 
Worry 1. Worry about physical health.    U. Unable to evaluate     
   0. Absent                         
   1. Mild or intermittent     
   2. Moderate                     
   3. Severe                         
2.  Worry about cognitive performance 
(failing memory, getting lost when goes 
out, not able to follow conversations) 
   U. Unable to evaluate     
   0. Absent                         
   1. Mild or intermittent     
   2. Moderate                     
   3. Severe                         
3.  Worry over finances, family problems, 
physical health of relatives. 
   U. Unable to evaluate     
   0. Absent                         
   1. Mild or intermittent     
   2. Moderate                     
   3. Severe                         
4. Worry associated with false beliefs 
and/or perception 
   U. Unable to evaluate     
   0. Absent                         
   1. Mild or intermittent     
   2. Moderate                     
   3. Severe                         
5. Worry over trifles (repeatedly calling for 
attention over trivial matters). 
   U. Unable to evaluate     
   0. Absent                         
   1. Mild or intermittent     
   2. Moderate                     
   3. Severe                         
Apprehension 
and vigilance 
6.  Frightened and anxious (keyed up and 
on edge). 
   U. Unable to evaluate     
   0. Absent                         
   1. Mild or intermittent     
   2. Moderate                    
   3. Severe                         
7. Sensitivity to noise (exaggerated startle 
response). 
   U. Unable to evaluate     
   0. Absent                         
   1. Mild or intermittent     
   2. Moderate                     
   3. Severe                         
8. Sleep disturbance (trouble falling or 
staying asleep). 
   U. Unable to evaluate     
   0. Absent                         
   1. Mild or intermittent     
   2. Moderate                     
   3. Severe                         
9. Irritability (more easily annoyed than 
usual, short tempered, and angry 
outbursts). 
   U. Unable to evaluate     
   0. Absent                         
   1. Mild or intermittent     
   2. Moderate                     




Motor tension 10. Trembling.    U. Unable to evaluate     
   0. Absent                         
   1. Mild or intermittent     
   2. Moderate                     
   3. Severe                         
11. Motor tension (complain of headache, 
other body aches, and pains). 
   U. Unable to evaluate     
   0. Absent                         
   1. Mild or intermittent     
   2. Moderate                     
   3. Severe                         
12. Restlessness (fidgeting, cannot sit still, 
pacing, wringing hands, picking clothes). 
   U. Unable to evaluate     
   0. Absent                         
   1. Mild or intermittent     
   2. Moderate                     
   3. Severe                         
13. Fatigability, excessive tiredness.    U. Unable to evaluate     
   0. Absent                         
   1. Mild or intermittent     
   2. Moderate                     
   3. Severe                         
Autonomic 
hypersensitivity 
14. Palpitations (complains of heart racing or 
thumping). 
   U. Unable to evaluate     
   0. Absent                         
   1. Mild or intermittent     
   2. Moderate                     
   3. Severe                         
15. Dry mouth (not due to medication), 
sinking feeling in the stomach. 
   U. Unable to evaluate     
   0. Absent                         
   1. Mild or intermittent     
   2. Moderate                     
   3. Severe                         
16. Hyperventilating, shortness of breath 
(even when not exerting) 
   U. Unable to evaluate     
   0. Absent                         
   1. Mild or intermittent     
   2. Moderate                     
   3. Severe                         
17. Dizziness or light-headedness 
(complains as if going to faint). 
   U. Unable to evaluate     
   0. Absent                         
   1. Mild or intermittent     
   2. Moderate                     
   3. Severe                         
18. Sweating, flushes or chills, tingling or 
numbness of fingers and toes. 
   U. Unable to evaluate     
   0. Absent                         
   1. Mild or intermittent     
   2. Moderate                     
   3. Severe                         
 
Scoring Instructions: Rating options include: U. Unable to evaluate, 0. Absent, 1. Mild or 
intermittent, 2. Moderate, 3. Severe. No score should be given if symptoms result from physical 
disability or illness. Scores of items 1 to 18 are summed for the caregiver and the care recipient 
to yield a caregiver score and a care recipient score. These two scores are then averaged to 







Appendix E-5: Pittsburgh Sleep Quality Index 
 
Instrument Completion Information: The PSQI was completed by the family caregiver by 
questionnaire at baseline and at post-intervention. Instructions for completing the PSQI are 
listed below and were included in the Baseline Caregiver Questionnaire (Appendix F-1) and the 
Follow-Up Caregiver Questionnaire (Appendix F-2). 
 
The section below asks about your relative with dementia’s sleep quality over the past month. 
We have included questions relating to your relative’s sleep quality, sleep duration and onset, 
use of medicine to help with sleep, daytime function, and sleep disturbances. We do not expect 




The following questions relate to your relative’s usual sleep habits during the past month only. 
Your answers should indicate the most accurate reply for the majority of days and nights in the 
past month. Please answer all questions. 
______________________________________________ 
 
1. During the past month, what time has your relative usually gone to bed at night? 
 
   BED TIME ___________________ 
 
2. During the past month, how long (in minutes) has it usually taken for your relative to fall 
asleep each night? 
   NUMBER OF MINUTES___________________ 
 
3. During the past month, what time has your relative usually gotten up in the morning? 
     
   GETTING UP TIME ___________________ 
 
4. During the past month, how many hours of actual sleep did your relative get at night? (This 
may be different than the number of hours he/she spent in bed) 
 
   HOURS OF SLEEP PER NIGHT ___________________ 
 
For each of the remaining questions, check the one best response. Please answer all questions. 
 
5. During the past month, how often has your 
















a) Could not get to sleep within 30 minutes     
b) Woke up in the middle of the night or 
early morning 
    
c) Had to get up to use the bathroom     
d) Could not breathe comfortably     
e) Coughed or snored loudly     
f) Felt too cold     




h) Had bad dreams     
i) Had pain     




    
6. During the past month, how often has your 
relative taken medicine to help with sleep 
(prescribed or “over the counter”)? 
    
7. During the past month, how often have you 
had trouble staying awake while driving, eating 
meals, or engaging in social activity? 









t of a 
problem 
A very big 
problem 
8. During the past month, how much of a 
problem has it been for you to keep up enough 
enthusiasm to get things done? 
    
 Very good Fairly 
good 
Fairly bad Very bad 
9. During the past month, how would you rate 
your sleep quality overall? 
    
 
Scoring Instructions: Each of the component scores range from 0-3 with higher scores 
indicative of worse sleep quality (Component 1), longer sleep latency (Component 2), shorter 
sleep duration (Component 3), lower sleep habitual sleep efficiency (Component 4), more 
severe sleep disturbances, more sleep medication use (Component 4), and more severe 
daytime dysfunction due to sleep disturbances (Component 7). Subscale component scores are 
added together to yield a global score that ranges from 0-21, with higher scores indicative of 

























Appendix E-6: Epworth Sleepiness Scale 
 
Instrument Completion Information: The ESS was completed by the family caregiver by 
questionnaire at baseline and at post-intervention. Instructions for completing the ESS are listed 
below and were included in the Baseline Caregiver Questionnaire (Appendix F-1) and the 
Follow-Up Caregiver Questionnaire (Appendix F-2). 
 
The section below asks about daytime sleepiness that your relative with dementia may or may 
not experience. How likely is your relative to doze off or fall asleep in the following situations, in 




Use the following scale to choose the most appropriate number for each situation: 
  0  =  no chance of dozing  
  1  =  slight chance of dozing 
  2  =  moderate chance of dozing 
  3  =  high chance of dozing 
 




 Situation Chance of Dozing (0-3) 
   
   
1. Sitting and reading  _________________________________  ___ 
   
2. Watching TV   _____________________________________  ___ 
   
3. Sitting inactive in a public place (e.g., a theater or a meeting)    ___ 
   
4. As a passenger in a car for an hour without a break   _______  ___ 
   
5. Lying down to rest in the afternoon when circumstances permit  
 ________________________________________________  
___ 
   
6. Sitting and talking to someone   _______________________  ___ 
   
7. Sitting quietly after a lunch without alcohol   ______________  ___ 
   
8. In a car or bus, while stopped for a few minutes in traffic   ___  ___ 
   
 
Scoring instructions: Items are rated, on a 4-point scale (0- would never dose, 3=high chance 
of dozing), to indicate an individual’s chances of dozing off or falling asleep while engaged in 






Appendix E-7: Quality of Life in Alzheimer’s Disease Scale-Care Recipient Version 
 
Instrument Completion Information: The care recipient version of the QOL-AD scale was 
completed by interview of the care recipient with dementia. The interviews occurred over Zoom 
or by phone. Instructions for completed the QOL-AD care recipient version were followed and 
are available at https://eprovide.mapi-trust.org/instruments/quality-of-life-in-alzheimer-s-disease. 
 
 
1. Physical health. Poor Fair Good Excellent 
2. Energy. Poor Fair Good Excellent 
3. Mood. Poor Fair Good Excellent 
4. Living situation. Poor Fair Good Excellent 
5. Memory. Poor Fair Good Excellent 
6. Family. Poor Fair Good Excellent 
7. Marriage. Poor Fair Good Excellent 
8. Friends. Poor Fair Good Excellent 
9. Self as a whole. Poor Fair Good Excellent 
10. Ability to do chores around 
the house. 
Poor Fair Good Excellent 
11. Ability to do things for fun. Poor Fair Good Excellent 
12. Money. Poor Fair Good Excellent 

























Quality of Life in Alzheimer’s Disease Scale-Caregiver Version 
 
Instrument Completion Information: The QOL-AD Caregiver version was completed by the 
family caregiver by questionnaire at baseline and at post-intervention. Instructions for 
completing the QOL-AD Caregiver Version are listed below and were included in the Baseline 
Caregiver Questionnaire (Appendix F-1) and the Follow-Up Caregiver Questionnaire (Appendix 
F-2). 
 
The following questions are about your relative’s quality of life. When you think about your 




Please think about each item and rate your relative’s current quality of life in each area using 
one of four words: poor, fair, good, or excellent. Please rate these items based on your relative’s 




1. Physical health. Poor Fair Good Excellent 
2. Energy. Poor Fair Good Excellent 
3. Mood. Poor Fair Good Excellent 
4. Living situation. Poor Fair Good Excellent 
5. Memory. Poor Fair Good Excellent 
6. Family. Poor Fair Good Excellent 
7. Marriage. Poor Fair Good Excellent 
8. Friends. Poor Fair Good Excellent 
9. Self as a whole. Poor Fair Good Excellent 
10. Ability to do chores 
around the house. 
Poor Fair Good Excellent 
11. Ability to do things for 
fun. 
Poor Fair Good Excellent 
12. Money. Poor Fair Good Excellent 








Scoring Instructions: Caregiver and care recipient item scores are summed to yield a 







Appendix E-8: Caregiver Well-Being Scale-short form 
 
Instrument Completion Information: The CWBS-short form was completed by the family 
caregiver by questionnaire at baseline and at post-intervention. Instructions for completing the 
CWBS are listed below and were included in the Baseline Caregiver Questionnaire (Appendix 
F-1) and the Follow-Up Caregiver Questionnaire (Appendix F-2). 
 




Listed below are a number of activities that each of us do or someone does for us. Thinking 
over the past month, indicate to what extent you think each activity has been met by circling the 
appropriate number on the scale provided. You do not have to be the one doing the activity. You 





1. Rarely 2. Occasionally 3. Sometimes  4. Frequently  5. Usually 
 
1. Buying food       1 2 3 4 5 
 
2. Taking care of personal daily activities    1 2 3 4 5 
(meals, hygiene, laundry) 
 
 
3. Attending to medical needs    1 2 3 4 5 
 
4. Keeping up with home maintenance activities   1 2 3 4 5 
(lawn, cleaning, house repairs etc.) 
 
 
5. Participating in events at church    1 2 3 4 5 
 and/or in the community 
 
6. Taking time to have fun with friends and/or family 1 2 3 4 5 
 
7. Treating or rewarding yourself    1 2 3 4 5 
 












Below are listed a number of needs we all have. For each need listed, think about your life over 
the past three months. During this period of time, indicate to what extent you think each need 





1. Rarely 2. Occasionally 3. Sometimes  4. Frequently  5. Usually 
 
1. Eating a well-balanced diet    1 2 3 4 5 
 
2. Getting enough sleep     1 2 3 4 5 
 
3. Receiving appropriate health care    1 2 3 4 5 
 
4. Having adequate shelter     1 2 3 4 5 
 
5. Feeling good about yourself    1 2 3 4 5 
 
6. Feeling secure about your financial future   1 2 3 4 5 
 
Scoring Instructions: Scores are summed across items within each subscale then divided by 8 
to yield a basic needs score and an activities of daily living (ADL) score. All item scores are 






















Appendix E-9: Optum SF-12v.2 Health Survey 
 
Instrument Completion Information: The Optum SF-12v.2 was completed by the family 
caregiver by questionnaire at baseline and at post-intervention. Instructions for completing the 
Optum SF-12v.2 are listed below and were included in the Baseline Caregiver Questionnaire 
(Appendix F-1) and the Follow-Up Caregiver Questionnaire (Appendix F-2). 
 
 
The following section asks for your views about your own health. This information will help keep 




Answer each question by choosing just one answer. If you are unsure how to answer a 




1. In general would you say your health is:  
 
 Excellent              Very good   Good  Fair   Poor 
 
The following questions are about activities you might do during a typical day. Does your health 
now limit you in these activities? If so, how much? 
 
 Yes, limited a lot Yes, limited a 
little 
No, not limited 
at all 
2. Moderate activities such as 
moving a table, pushing a vacuum 
cleaner, bowling, or playing golf? 
   
3. Climbing several flights of stairs?    
 
 
During the past 4 weeks, have you had any of the following problems with your work or other 
regular daily activities as a result of your physical health? 
 
  Yes   No 
4. Accomplished less than you would like        
 
5. Were limited in the kind of work or other activities      
 
During the past 4 weeks, have you had any of the following problems with your work or other 
regular daily activities as a result of any emotional problems (such as feeling depressed or 
anxious)? 
   
  Yes   No 









8. During the past 4 weeks, how much did pain interfere with your normal work (including both 
work outside the home and housework)? 
 
 Not at all        A little bit       Moderately       Quite a bit         Extremely 
 
These questions are about how you feel and how things have been with you during the 
past 4 weeks. For each question, please give the one answer that comes closest to the 
way you have been feeling. How much of the time during the past 4 weeks: 
 
 




















9. Have you felt calm and 
peaceful?            
      
10. Did you have a lot of 
energy?                
      
10. Did you have a lot of 
energy?                
      
11. Have you felt downhearted 
and blue?    
      
 
 
12. During the past 4 weeks, how much of the time has your physical health or 
emotional health problems interfered with your social activities (like visiting with friends, 
relatives etc.)? 
 
 Not at all       Most of the time      Some of the time      A little of the time     None of  
            the time  
 
Scoring Instructions: Item responses are standardized into both physical and mental 
standardized values using the table available here:  
https://medicine.umich.edu/sites/default/files/content/downloads/Scoring%20Instructions%20for
%20the%20EPIC%2026.pdf. The physical standardized values from step 2 are summed across 
all 12 idems and added to 56.57706 to create the SF-12 physical health component score 
(PCS). The mental standardized values are summed and added to 60.75781 to create the SF-









Appendix E-10: Care Recipient and Caregiver Demographics Form 
 
Instrument Completion Information: The Demographic Form was completed by the caregiver 
by questionnaire at baseline. Instructions for completing the Demographics Form are listed 
below and were included in the Baseline Caregiver Questionnaire (Appendix F-1). 
 
The following section asks questions relating to the demographics of your relative with dementia 
and yourself. The first 6 questions pertain to your relative, while questions 7-15 relate to you as 
the caregiver. The last 3 questions relate to the caregiving you provide to your relative. 
Care Recipient Demographics 
____________________________________________________ 
Directions:  
Please answer the following questions (1-6) as they relate to your relative with dementia. 
____________________________________________________
1. What is your age (in years) 
 _____________________________ 
2. Race (Indicate with a ✓ for those with 
which you identify) 
  American Indian or Alaska Native 
  Asian 
  Black or African American 
  Native Hawaiian or Pacific 
 Islander 
  White or Caucasian 
  More than one race 
  Unknown or do not wish to report 
3. Ethnicity (Indicate with a ✓ for the choice 
you most closely identify) 
  Hispanic or Latino 
  Not Hispanic or Latino 
  Unknown or do not wish to report 
4. Gender (Indicate with a ✓ for the choice 
you most closely identify) 
  Male 
  Female 
  Other 
5. Education (Select highest education you 
have received) 
  Less than high school 
  High school graduate or GED 
  Some college 
  College and above  
6. What is your marital status? 
  Single / never married 
  Married / domestic partnership 
  Divorced 








Please answer the following questions (7-12) as they relate to you, the caregiver of the person 
with dementia. 
____________________________________________________________
7. What is your age (in years) 
 _____________________________ 
8. Race (Indicate with a ✓ for those with 
which you identify) 
  American Indian or Alaska Native 
  Asian 
  Black or African American 
  Native Hawaiian or Pacific 
 Islander 
  White or Caucasian 
  More than one race 
  Unknown or do not wish to report 
9. Ethnicity (Indicate with a ✓ for the choice 
you most closely identify) 
  Hispanic or Latino 
  Not Hispanic or Latino 
  Unknown or do not wish to report 
10. Gender (Indicate with a ✓ for the choice 
you most closely identify) 
  Male 
  Female 
  Other 
11. Education (Select highest education you 
have received) 
  Less than high school 
  High school graduate or GED 
  Some college 
  College and above  
6. What is your marital status? 
  Single / never married 
  Married / domestic partnership 
  Divorced or separated 
  Widowed 
12. How are you related to your family 
member with dementia? 
  Spouse 
  Child 
  Sibling 
  Other 










Please answer the following questions (13-18) as they relate to the caregiving you provide to 
your relative with dementia. 
____________________________________________________ 
 
13. How long have you been a primary caregiver for your family member with dementia? 
_________________ month(s) / year(s) (Circle) 
14. How long have you been living with your family member with dementia?  
_________________ month(s) / year(s) (Circle) 
15. On average, how many hours of caregiving do you provide on a weekly basis to your family 


















Appendix E-11: Health History Form  
 
Instrument Completion Information: The Health History Form was completed by the 
caregiver by questionnaire at baseline. The Health History Form relates to the health history of 
the care recipient with dementia. Instructions for completing the Health History Form are listed 
below and were included in the Baseline Caregiver Questionnaire (Appendix F-1).  
 
 
Health History of the Care Recipient with Dementia 
 




Please answer all the following questions as they relate to your relative with dementia. 
____________________________________________________ 
 
1. What type of dementia or memory-related disease does he/she have? 
  Alzheimer’s disease 
  Vascular dementia 
  Mixed type dementia 
  Frontotemporal dementia 
  Dementia with Lewy bodies 
  Parkinson’s disease dementia 
  Posterior cortical atrophy 
  Other 
  Not specified 
  Unknown 
2. Approximately when did he/she receive the dementia diagnosis? 
 _______________________________________________ 
















Please list any medications he/she is currently taking, include the dosage (how much), 
frequency (how often he/she takes it) and reason for taking it: 
Medication Dosage Frequency Reason 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 







Appendix E-12: Health Status Update Form 
 
Instrument Completion Information: The Health Status Update Form was completed by the 
caregiver by questionnaire at post-intervention. The Health History Form Update relates to 
changes in the health status of the care recipient with dementia. Instructions for completing the 
Health History Form are listed below and were included in the Follow-Up Caregiver 
Questionnaire (Appendix F-2). 
 
Health Status Update 
 




Please answer all the following questions as they relate to your relative with dementia.  
____________________________________________________ 
 
1. Please list any physical or mental health conditions, or diagnoses that your relative received 














3. Has he/she had a fall over the past 4 weeks? 
Yes  No 




Yes  No 




5. Has he/she been hospitalized over the past 4 weeks? 
Yes  No 





Please list any new medications he/she is taking, include the dosage (how much), frequency 
(how often he/she takes it) and reason for taking it: 
Medication Dosage Frequency Reason 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 



































Appendix F-1: Baseline Caregiver Questionnaire 
 
Baseline Caregiver Questionnaire 
You are receiving this questionnaire because you identified as a 
primary caregiver living with a family member with dementia. This 
questionnaire is designed to gather information relating to the 
health and well-being of you as the caregiver, and of your relative 
with dementia. It is composed of several parts. At the beginning of 
each section are directions on how to answer the questions that 
follow.  
This questionnaire is expected to take about an hour to complete 
and we ask that you complete it within the next 5 to 7 days. You 
do not have to complete the entire questionnaire at one time. You 
are welcome to take a break and return later to complete the 
remaining sections.  
The University of Michigan IRB reviewed and approved this study. 
All your responses are confidential and only reported in 
aggregate.   
Please contact Melissa if you have any questions about 





University of Michigan School of Nursing Research Study 
 
Exploring the Use of Weighted Blankets as a Non-Pharmacologic Intervention for Home 
Dwelling Older Adults with Dementia  
 
Principal Investigator: Melissa Harris, BSN, RN, PhD Student 







The first section of this questionnaire relates to behaviors and symptoms 
displayed by your relative with dementia in recent weeks. We hope to learn 
about some of the more challenging behaviors and symptoms experienced 
by your relative, such as agitation, anxiety, restlessness, and sleep 
disturbances.  
 
Section 1 - Part 1: Agitation Inventory 
 
The section below asks about specific behaviors displayed by your relative with 
dementia. We have listed behaviors that are sometimes associated with older adults; 
they are arranged from physical to verbal, and from benign to aggressive. We do not 




Read each of the behaviors, and circle how often (from 1-7) each applied to your 




1 = Never 
2 = Less than once a week 
3 = Once or twice a week 
4 = Several times a week 
5 = Once or twice a day 
6 = Several times a day 




































































































3. Pacing, aimless 
wandering, constantly 
walking back and forth 
(including wandering 















4. Trying to get to a 
different place 
(sneaking out of the 
room, out of the house, 


































6. Hiding or hoarding 
things 
 
1 2 3 4 5 6 7 
7. Grabbing things 





2 3 4 5 6 7 









clothes on in a strange 


























































2 3 4 5 6 7 




































































































































19. Intentional falling 
(including from 

































21. Hurting others 

































23. Relevant verbal 
interruptions (i.e. cut 
others short who are 
speaking to relative; 
being rude, even if 






























24. Unrelated verbal 
interruptions (i.e. 




























































questions or sentences 























26. Constant requests 


























































29. Negativism, bad 
attitude, doesn’t like 









































31. Temper outburst 
(verbal or non-verbal 
















32. Strange noises 

































34. Making verbal 




























Section 1 - Part 2: Sleep Quality Index 
 
The section below asks about your relative with dementia’s sleep quality over the past 
month. We have included questions relating to your relative’s sleep quality, sleep 
duration and onset, use of medicine to help with sleep, daytime function, and sleep 




The following questions relate to your relative’s usual sleep habits during the past 
month only. Your answers should indicate the most accurate reply for the majority of 
days and nights in the past month.  
______________________________________________________________________ 
 
1. During the past month, what time has your relative usually gone to bed at night? 
 
   BED TIME ___________________ 
 
2. During the past month, how long (in minutes) has it usually taken for your relative to 
fall asleep each night? 
   NUMBER OF MINUTES___________________ 
 
3. During the past month, what time has your relative usually gotten up in the morning? 
     
   GETTING UP TIME ___________________ 
 
4. During the past month, how many hours of actual sleep did your relative get at night? 
(This may be different than the number of hours he/she spent in bed) 
 




















For each of the remaining questions, check the one best response for all questions. 
 
5. During the past month, how 
often has your relative had trouble 













a) Could not get to sleep 
within 30 minutes 
    
b) Woke up in the middle of 
the night or early morning 
    
c) Had to get up to use the 
bathroom 
    
d) Could not breathe 
comfortably 
    
e) Coughed or snored loudly     
f) Felt too cold     
g) Felt too hot     
h) Had bad dreams     
i) Had pain     





    
6. During the past month, how 
often has your relative taken 
medicine to help with sleep 
(prescribed or “over the counter”)? 
    
7. During the past month, how 
often have you had trouble staying 
awake while driving, eating meals, 
or engaging in social activity? 










A very big 
problem 
8. During the past month, how 
much of a problem has it been for 
you to keep up enough 
enthusiasm to get things done? 
    
 Very good Fairly good Fairly bad Very bad 
9. During the past month, how 
would you rate your sleep quality 
overall? 










Section 1 - Part 3: Daytime Sleepiness Scale 
 
The section below asks about daytime sleepiness that your relative with dementia may 
or may not experience. How likely is your relative to doze off or fall asleep in the 
following situations, in contrast to just feeling tired? This refers to your relative’s usual 




Please indicate with a check (✓) the response that is most appropriate for your relative 
for each situation. It is important that you answer each item as best as you can.  
______________________________________________________________________ 
 












1. Sitting and reading    
 
 
   
2. Watching TV    
 
 
   
3. Sitting inactive in a public 
place (e.g., a theater or a 
meeting) 
    
4. As a passenger in a car for 
an hour without a break   
    
5. Lying down to rest in the 
afternoon when 
circumstances permit   
    
6. Sitting and talking to 




   
7. Sitting quietly after a lunch 




   
8. In a car or bus, while stopped 
for a few minutes in traffic   













Section two of this questionnaire relates to the quality of life and well-being 
of your relative with dementia.  
 
Section 2 - Part 1: Care Recipient with Dementia Quality of Life Scale 
 
The following questions are about your relative’s quality of life. When you think about 




Please think about each item and rate your relative’s current quality of life in each area 
using one of four words: poor, fair, good, or excellent. Please rate these items based on 




1. Physical health. Poor Fair Good Excellent 
2. Energy. Poor Fair Good Excellent 
3. Mood. Poor Fair Good Excellent 
4. Living situation. Poor Fair Good Excellent 
5. Memory. Poor Fair Good Excellent 
6. Family. Poor Fair Good Excellent 
7. Marriage. Poor Fair Good Excellent 
8. Friends. Poor Fair Good Excellent 
9. Self as a whole. Poor Fair Good Excellent 
10. Ability to do chores 
around the house. 
Poor Fair Good Excellent 
11. Ability to do things for 
fun. 
Poor Fair Good Excellent 
12. Money. Poor Fair Good Excellent 















Section three of this questionnaire relates to your own well-being and 
health as the caregiver of a relative with dementia. 
 
Section 3 - Part 1: Caregiver Well-Being Scale 
 





Listed below are a number of activities that each of us do or someone does for us. 
Thinking over the past month, indicate to what extent you think each activity has been 
met by circling the appropriate number on the scale provided. You do not have to be the 
one doing the activity. You are being asked to rate the extent to which each activity has 





1. Rarely 2. Occasionally 3. Sometimes 4. Frequently  5. Usually 
 
1. Buying food      1 2 3 4 5 
 
2. Taking care of personal daily activities   1 2 3 4 5 
(meals, hygiene, laundry) 
 
 
3. Attending to medical needs    1 2 3 4 5 
 
4. Keeping up with home maintenance activities  1 2 3 4 5 
(lawn, cleaning, house repairs etc.) 
 
 
5. Participating in events at church   1 2 3 4 5 
 and/or in the community 
 
6. Taking time to have fun with friends and/or family 1 2 3 4 5 
 
7. Treating or rewarding yourself    1 2 3 4 5 
 








Below are listed a number of needs we all have. For each need listed, think about your 
life over the past three months. During this period of time, indicate to what extent you 






1. Rarely 2. Occasionally 3. Sometimes 4. Frequently  5. Usually 
 
1. Eating a well-balanced diet    1 2 3 4 5 
 
2. Getting enough sleep     1 2 3 4 5 
 
3. Receiving appropriate health care   1 2 3 4 5 
 
4. Having adequate shelter    1 2 3 4 5 
 
5. Feeling good about yourself    1 2 3 4 5 
 






















Section 3 - Part 2: Caregiver Health Survey 
 
The following section asks for your views about your own health. This information will 




Answer each question by choosing just one answer. If you are unsure how to answer a 




1. In general would you say your health is:  
 
 Excellent              Very good   Good  Fair  Poor 
 
The following questions are about activities you might do during a typical day. Does your 
health now limit you in these activities? If so, how much? 
 
 Yes, limited a 
lot 
Yes, limited a 
little 
No, not limited 
at all 
2. Moderate activities such as 
moving a table, pushing a 
vacuum cleaner, bowling, or 
playing golf? 
   
3. Climbing several flights of 
stairs? 
   
 
 
During the past 4 weeks, have you had any of the following problems with your work or 
other regular daily activities as a result of your physical health? 
 
   Yes   No 
4. Accomplished less than you would like        
 
5. Were limited in the kind of work or other activities       
 
During the past 4 weeks, have you had any of the following problems with your work or 
other regular daily activities as a result of any emotional problems (such as feeling 
depressed or anxious)?  
   Yes   No 
6. Accomplished less than you would like        
 




8. During the past 4 weeks, how much did pain interfere with your normal work (including 
both work outside the home and housework)? 
 
 Not at all        A little bit       Moderately       Quite a bit         Extremely 
 
These questions are about how you feel and how things have been with you during the 
past 4 weeks. For each question, please give the one answer that comes closest to the 
way you have been feeling. How much of the time during the past 4 weeks: 
 
 



















9. Have you felt calm and 
peaceful?            
      
10. Did you have a lot of 
energy?                
      
10. Did you have a lot of 
energy?                
      
11. Have you felt 
downhearted and blue?    
      
 
 
12. During the past 4 weeks, how much of the time has your physical health or 
emotional health problems interfered with your social activities (like visiting with friends, 
relatives etc.)? 
 
 Not at all      
 Most of the time      
 Some of the time      
 A little of the time     

















Section four of this questionnaire relates to you and your relative’s 
demographic information, and information relating to the caregiving you 
provide to your relative. The last part of this section includes questions 
pertaining to the health history of your relative with dementia. 
 
Section 4 - Part 1: Demographics and Caregiving Information 
 
The following section asks questions relating to the demographics of your relative with 
dementia and yourself. The first 6 questions pertain to your relative, while questions 7-
15 relate to you as the caregiver. The last 3 questions relate to the caregiving you 
provide to your relative. 








1. What is his/her age (in years) 
 __________________________ 
2. Race (Indicate with a ✓ for the choice 
he/she most closely identifies) 
  American Indian or Alaska 
 Native 
  Asian 
  Black or African American 
  Native Hawaiian or Pacific 
 Islander 
  White or Caucasian 
  More than one race 
  Unknown or do not wish to 
 report 
3. Ethnicity (Indicate with a ✓ for the 
choice he/she most closely identifies) 
  Hispanic or Latino 
  Not Hispanic or Latino 
  Unknown or do not wish to 
 report 
4. Gender (Indicate with a ✓ for the 
choice he/she most closely identifies) 
  Male 
  Female 




5. Education (Select highest education 
he/she has received) 
  Less than high school 
  High school graduate or GED 
  Some college 
  College and above  
6. What is his/her marital status? 
  Single / never married 
  Married / domestic partnership 
  Divorced 









Please answer the following questions (7-12) as they relate to you, the caregiver of the 
person with dementia. 
____________________________________________________ 
 
7. What is your age (in years) 
 __________________________ 
8. Race (Indicate with a ✓ for those with 
which you identify) 
  American Indian or Alaska 
 Native 
  Asian 
  Black or African American 
  Native Hawaiian or Pacific 
 Islander 
  White or Caucasian 
  More than one race 
  Unknown or do not wish to 
 report 
9. Ethnicity (Indicate with a ✓ for the 
choice you most closely identify) 
  Hispanic or Latino 
  Not Hispanic or Latino 






10. Gender (Indicate with a ✓ for the 
choice you most closely identify) 
  Male 
  Female 
  Other 
11. Education (Select highest education 
you have received) 
  Less than high school 
  High school graduate or GED 
  Some college 
  College and above  
6. What is your marital status? 
  Single / never married 
  Married / domestic partnership 
  Divorced or separated 
  Widowed 
12. How are you related to your family 
member with dementia? 
  Spouse 
  Child 
  Sibling 
  Other 









Please answer the following questions (13-18) as they relate to the caregiving you 
provide to your relative with dementia. 
____________________________________________________ 
 
13. How long have you been a primary caregiver for your family member with 
dementia? 
_________________ month(s) / year(s) (Circle) 
14. How long have you been living with your family member with dementia?  
_________________ month(s) / year(s) (Circle) 
15. On average, how many hours of caregiving do you provide on a daily basis to your 


























Section 4 - Part 2: Care Recipient with Dementia Health History  
 




Please answer all the following questions as they relate to your relative with dementia. 
____________________________________________________ 
 
1. What type of dementia or memory-related disease does he/she have? 
  Alzheimer’s disease 
  Vascular dementia 
  Mixed type dementia 
  Frontotemporal dementia 
  Dementia with Lewy bodies 
  Parkinson’s disease dementia 
  Not specified 
  Unknown 
2. Approximately when did he/she receive the dementia diagnosis? 
 ________________________________________________________________ 













Please list any medications he/she is currently taking, include the dosage (how much), 
frequency (how often he/she takes it) and reason for taking it: 
Medication Dosage Frequency Reason 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 








Thank you for completing this Baseline Questionnaire, please indicate below how 
long it took you to complete. 
________________________________ minutes 
 
Please indicate with a check (✓) the option below that most closely matches your 
opinion about the length of this questionnaire: 
 The length of this questionnaire was about right for me. 
 I would have liked the questionnaire to be shorter. 
 I would have been okay with completing a longer questionnaire. 
. 
 
































Appendix F-2: Follow-Up Caregiver Questionnaire 
 
Follow-Up Caregiver Questionnaire 
You are receiving this questionnaire as you and your relative have 
completed the 4 weeks of using the weighted blanket in the home. 
This questionnaire is designed to gather information relating to 
the health and well-being of you as the caregiver, and of your 
relative with dementia. In addition, the last section addresses your 
overall satisfaction and perceived benefits of the weighted blanket 
use by your relative with dementia over the past 4 weeks.  
This questionnaire is composed of several parts. At the beginning 
of each section are directions on how to answer the questions 
that follow.  
This questionnaire is expected to take about an hour to complete 
and we ask that you complete it within the next 5 to 7 days. You 
do not have to complete the entire questionnaire at one time. You 
are welcome to take a break and return later to complete the 
remaining sections.  
The University of Michigan IRB reviewed and approved this study. 
All your responses are confidential and only reported in 
aggregate.   
Please contact Melissa if you have any questions about 
completing this questionnaire at 405-513-1271. 
 
 
University of Michigan School of Nursing Research Study 
 
Exploring the Use of Weighted Blankets as a Non-Pharmacologic Intervention for Home 
Dwelling Older Adults with Dementia  
 
Principal Investigator: Melissa Harris, BSN, RN, PhD Student 






The first section of this questionnaire relates to behaviors and symptoms 
displayed by your relative with dementia in recent weeks. We hope to learn 
about some of the more challenging behaviors and symptoms experienced 
by your relative, such as agitation, anxiety, restlessness, and sleep 
disturbances.  
 
Section 1 - Part 1: Agitation Inventory 
 
The section below asks about specific behaviors displayed by your relative with 
dementia. We have listed behaviors that are sometimes associated with older adults; 
they are arranged from physical to verbal, and from benign to aggressive. We do not 




Read each of the behaviors, and circle how often (from 1-7) each applied to your 





1 = Never    4 = Several times a week 
2 = Less than once a week 5 = Once or twice a day 
3 = Once or twice a week  6 = Several times a day 







































































































3. Pacing, aimless 
wandering, constantly 
walking back and forth 
(including wandering 















4. Trying to get to a 
different place 
(sneaking out of the 
room, out of the house, 


































6. Hiding or hoarding 
things 
 
1 2 3 4 5 6 7 
7. Grabbing things 





2 3 4 5 6 7 









clothes on in a strange 































































































































































































19. Intentional falling 
(including from 

































21. Hurting others 



































23. Relevant verbal 
interruptions (i.e. cut 
others short who are 
speaking to relative; 
being rude, even if 






























24. Unrelated verbal 
interruptions (i.e. 



























































questions or sentences 























26. Constant requests 
























































29. Negativism, bad 
attitude, doesn’t like 









































31. Temper outburst 
(verbal or non-verbal 
















32. Strange noises 

































34. Making verbal 





























Section 1 - Part 2: Sleep Quality Index 
 
The section below asks about your relative with dementia’s sleep quality over the past 
month. We have included questions relating to your relative’s sleep quality, sleep 
duration and onset, use of medicine to help with sleep, daytime function, and sleep 




The following questions relate to your relative’s usual sleep habits during the past 
month only. Your answers should indicate the most accurate reply for the majority of 
days and nights in the past month.  
______________________________________________________________________ 
 
1. During the past month, what time has your relative usually gone to bed at night? 
 
   BED TIME ___________________ 
 
2. During the past month, how long (in minutes) has it usually taken for your relative to 
fall asleep each night? 
   NUMBER OF MINUTES___________________ 
 
3. During the past month, what time has your relative usually gotten up in the morning? 
     
   GETTING UP TIME ___________________ 
 
4. During the past month, how many hours of actual sleep did your relative get at night? 
(This may be different than the number of hours he/she spent in bed) 
 




















For each of the remaining questions, check the one best response for all questions. 
 
5. During the past month, how 
often has your relative had trouble 













a) Could not get to sleep 
within 30 minutes 
    
b) Woke up in the middle of 
the night or early morning 
    
c) Had to get up to use the 
bathroom 
    
d) Could not breathe 
comfortably 
    
e) Coughed or snored loudly     
f) Felt too cold     
g) Felt too hot     
h) Had bad dreams     
i) Had pain     





    
6. During the past month, how 
often has your relative taken 
medicine to help with sleep 
(prescribed or “over the counter”)? 
    
7. During the past month, how 
often has your relative had trouble 
staying awake while driving, 
eating meals, or engaging in 
social activity? 










A very big 
problem 
8. During the past month, how 
much of a problem has it been for 
you relative to keep up enough 
enthusiasm to get things done? 
    
 Very good Fairly good Fairly bad Very bad 
9. During the past month, how 
would you rate your relative’s 
sleep quality overall? 









Section 1 - Part 3: Daytime Sleepiness Scale 
 
The section below asks about daytime sleepiness that your relative with dementia may 
or may not experience. How likely is your relative to doze off or fall asleep in the 
following situations, in contrast to just feeling tired? This refers to your relative’s usual 




Please indicate with a check (✓) the response that is most appropriate for your relative 
for each situation. 
 
It is important that you answer each item as best as you can.  
______________________________________________________________________ 
 












1. Sitting and reading    
 
 
   
2. Watching TV    
 
 
   
3. Sitting inactive in a public 
place (e.g., a theater or a 
meeting) 
    
4. As a passenger in a car for 
an hour without a break   
    
5. Lying down to rest in the 
afternoon when 
circumstances permit   
    
6. Sitting and talking to 




   
7. Sitting quietly after a lunch 




   
8. In a car or bus, while stopped 
for a few minutes in traffic   











Section two of this questionnaire relates to the quality of life and well-being 
of your relative with dementia.  
 
Section 2 - Part 1: Care Recipient with Dementia Quality of Life Scale 
 
The following questions are about your relative’s quality of life. When you think about 




Please think about each item and rate your relative’s current quality of life in each area 
using one of four words: poor, fair, good, or excellent. Please rate these items based on 




1. Physical health. Poor Fair Good Excellent 
2. Energy. Poor Fair Good Excellent 
3. Mood. Poor Fair Good Excellent 
4. Living situation. Poor Fair Good Excellent 
5. Memory. Poor Fair Good Excellent 
6. Family. Poor Fair Good Excellent 
7. Marriage. Poor Fair Good Excellent 
8. Friends. Poor Fair Good Excellent 
9. Self as a whole. Poor Fair Good Excellent 
10. Ability to do chores 
around the house. 
Poor Fair Good Excellent 
11. Ability to do things for 
fun. 
Poor Fair Good Excellent 
12. Money. Poor Fair Good Excellent 















Section three of this questionnaire relates to your own well-being and 
health as the caregiver of a relative with dementia. 
 
Section 3 - Part 1: Caregiver Well-Being Scale 
 





Listed below are a number of activities that each of us do or someone does for us. 
Thinking over the past month, indicate to what extent you think each activity has been 
met by circling the appropriate number on the scale provided. You do not have to be the 
one doing the activity. You are being asked to rate the extent to which each activity has 





1. Rarely 2. Occasionally 3. Sometimes 4. Frequently  5. Usually 
 
1. Buying food      1 2 3 4 5 
 
2. Taking care of personal daily activities   1 2 3 4 5 
(meals, hygiene, laundry) 
 
 
3. Attending to medical needs    1 2 3 4 5 
 
4. Keeping up with home maintenance activities  1 2 3 4 5 
(lawn, cleaning, house repairs etc.) 
 
 
5. Participating in events at church   1 2 3 4 5 
 and/or in the community 
 
6. Taking time to have fun with friends and/or family 1 2 3 4 5 
 
7. Treating or rewarding yourself    1 2 3 4 5 
 








Below are listed a number of needs we all have. For each need listed, think about your 
life over the past three months. During this period of time, indicate to what extent you 






1. Rarely 2. Occasionally 3. Sometimes 4. Frequently  5. Usually 
 
1. Eating a well-balanced diet    1 2 3 4 5 
 
2. Getting enough sleep     1 2 3 4 5 
 
3. Receiving appropriate health care   1 2 3 4 5 
 
4. Having adequate shelter    1 2 3 4 5 
 
5. Feeling good about yourself    1 2 3 4 5 
 






















Section 3 - Part 2: Caregiver Health Survey 
 
The following section asks for your views about your own health. This information will 




Answer each question by choosing just one answer. If you are unsure how to answer a 




1. In general would you say your health is:  
 
 Excellent              Very good   Good  Fair  Poor 
 
The following questions are about activities you might do during a typical day. Does your 
health now limit you in these activities? If so, how much? 
 
 Yes, limited a 
lot 
Yes, limited a 
little 
No, not limited 
at all 
2. Moderate activities such as 
moving a table, pushing a 
vacuum cleaner, bowling, or 
playing golf? 
   
3. Climbing several flights of 
stairs? 
   
 
 
During the past 4 weeks, have you had any of the following problems with your work or 
other regular daily activities as a result of your physical health? 
 
   Yes   No 
4. Accomplished less than you would like         
 
5. Were limited in the kind of work or other activities       
 
During the past 4 weeks, have you had any of the following problems with your work or 
other regular daily activities as a result of any emotional problems (such as feeling 
depressed or anxious)?  
   Yes   No 
6. Accomplished less than you would like        
 




8. During the past 4 weeks, how much did pain interfere with your normal work (including 
both work outside the home and housework)? 
 
 Not at all        A little bit       Moderately       Quite a bit         Extremely 
 
These questions are about how you feel and how things have been with you during the 
past 4 weeks. For each question, please give the one answer that comes closest to the 
way you have been feeling. How much of the time during the past 4 weeks: 
 
 



















9. Have you felt calm and 
peaceful?            
      
10. Did you have a lot of 
energy?                
      
10. Did you have a lot of 
energy?                
      
11. Have you felt 
downhearted and blue?    
      
 
 
12. During the past 4 weeks, how much of the time has your physical health or 
emotional health problems interfered with your social activities (like visiting with friends, 
relatives etc.)? 
 
 Not at all      
 Most of the time      
 Some of the time      
 A little of the time     
















Section five of this questionnaire relates to your overall satisfaction with the 
weighted blanket use by your relative with dementia and how beneficial the 
weighted blanket was for you and your relative.  
 
Section 5 – Part 1: Now that you and your relative with dementia have completed 
all 4 weeks of using the weighted blanket, we would like to know how satisfied you as 
the caregiver were with the weighted blanket and how beneficial the weighted blanket 




Please answer these questions from your perspective as the caregiver of a family 
member with dementia. We encourage you to provide honest answers relating to the 











1 2 3 4 5 
1. 
Having the weighted blanket to be 
used by your relative in the home? 
     
2. 
Having the intervention materials 
delivered to your home? 
     
3. 
How the weighted blanket was 
explained to you during the Weighted 
Blanket Introduction session? 
     
4. 
Using a web-based platform to learn 
how to use the weighted blanket? 
     
5. 
Participating in weekly check-in 
telephone call with the research team? 
     
6. 
How satisfied were you with the 
Weighted Blanket Use Guide that 
came with the blanket? 
     
7. 
How satisfied were you with the way 
your questions were answered 
throughout the study period? 
     
8. 
How satisfied were you with how you 
were involved in the process of 
encouraging your relative to use the 
weighted blanket? 







9. How heavy was the blanket that your relative used? 
 10 pounds 
 12 pounds  I don’t know 
 
10. What did you think about the weight of the blanket for your relative? 
 The weight was about right for my relative 
 I would have liked it to be heavier. 
 I would have liked it to be lighter. 
 
11. What is your opinion about the recommendation that the weighted blanket be 
used daily by your relative? 
 The recommended everyday use of the weighted blanket was about right for us. 
 I would have liked the recommended use of the weighted blanket be less than every 
day.  
 I would have liked the recommended use of the weighted blanket be multiple times a 
day. 
 
12. What is your opinion about the recommended amount of time the weighted 
blanket was to be used by your relative each day? (Reminder: the weighted blanket 
was recommended to be used for at least 5 minutes at a time for a total of at least 20 
minutes throughout each day) 
 The recommended amount of time was about right for us. 
 I would have liked less recommended blanket use time. 
 I would have liked more recommended blanket use time. 
 
13. What did you think about completing a Weighted Blanket Daily Use Diary? 
 Completing a diary entry every day was about right for me. 
 I would have liked to complete fewer diary entries. 








Not at all Some A great 
deal 
14. 
How much did the use of the weighted blanket help in 
decreasing challenging symptoms displayed by your 
relative with dementia? (such as anxiety, agitation, 
restlessness, difficulty sleeping) 
   
15. 
How beneficial was the study information booklet in 
explaining the study process? 
   
16. 
How beneficial was the Weighted Blanket Use Guide 
in explaining the use of the weighted blanket? 
   
17.  
How beneficial were the weekly telephone check ins 
throughout the 4-week intervention period? 
   
18.  
How much did the use of the weighted blanket by 
your relative benefit you as the caregiver of someone 
with dementia? 
   
19. 
How much did the use of the weighted blanket benefit 
your family member with dementia? 
   
 
20. Overall, would you recommend the use of a weighted blanket to other 
individuals caring for someone with dementia? 
 Yes                         No 
 
21. Will you continue to encourage your relative to use the weighted blanket? 
 Yes                         No 
 




























24. Do you have any comments or suggestions about the study materials (such as 
the study information booklet, the Weighted Blanket Use Guide, or the Blanket Daily 
Use Diary)? 
 Yes  No  

















25. Do you have any comments or suggestions about the weighted blankets 
specifically? 
 Yes  No  










26. Would you recommend or suggest any other changes for the weighted 
blanket study? 
 Yes  No  




















Section six of this questionnaire relates to your relative with dementia’s 
health status over the past four weeks. This section is meant to provide an 
update to the health history information you provided at the beginning of 
this study. 
 
Section 4 - Part 1: The following section relates to your relative with dementia’s health 
status over the past 4 weeks. 
____________________________________________________ 
Directions: 
Please answer all the following questions as they relate to your relative with dementia.  
____________________________________________________ 
 
1. Please list any physical or mental health conditions, or diagnoses that your relative 













3. Has he/she had a fall over the past 4 weeks? 
Yes  No 
4. Has he/she sustained any injuries over the past 4 weeks? 








5. Has he/she been hospitalized over the past 4 weeks? 
Yes  No 
 If yes, please specify reason for hospitalization and how long he/she was 




Please list any new medications he/she is taking, include the dosage (how much), 
frequency (how often he/she takes it) and reason for taking it: 
Medication Dosage Frequency Reason 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 







Thank you for completing this Follow-Up Questionnaire, please indicate below 
how long it took you to complete. 
________________________________ minutes 
 
Please indicate with a check (✓) the option below that most closely aligns with your 
opinion about the length of this questionnaire: 
 The length of this questionnaire was about right for me. 
 I would have liked the questionnaire to be shorter. 
 I would have been okay with completing a longer questionnaire. 
. 
 
End of Questionnaire 
 
